<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD006915.pub3" GROUP_ID="ARI" ID="138307010301010557" MERGED_FROM="" MODIFIED="2015-09-16 00:53:06 +0100" MODIFIED_BY="Liz Dooley" REVIEW_NO="A140" REVMAN_SUB_VERSION="5.3.5 " REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="7.0">
<COVER_SHEET MODIFIED="2015-09-16 00:53:06 +0100" MODIFIED_BY="Liz Dooley">
<TITLE>Heliox inhalation therapy for bronchiolitis in infants</TITLE>
<CONTACT MODIFIED="2015-09-16 00:53:06 +0100" MODIFIED_BY="Liz Dooley"><PERSON ID="D03AD08F82E26AA201A79FAAC6CFC8B6" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Jean-Michel</FIRST_NAME><LAST_NAME>Liet</LAST_NAME><SUFFIX>MD, PhD, MSc</SUFFIX><POSITION>Pediatric Intensivist</POSITION><EMAIL_1>jeanmichel.liet@chu-nantes.fr</EMAIL_1><ADDRESS><DEPARTMENT>Pediatric Intensive Care Unit</DEPARTMENT><ORGANISATION>Hôpital Mère-Enfant, CHU de Nantes</ORGANISATION><ADDRESS_1>38 Boulevard Jean-Monnet</ADDRESS_1><ADDRESS_2>Faïencerie</ADDRESS_2><CITY>Nantes</CITY><ZIP>44093</ZIP><COUNTRY CODE="FR">France</COUNTRY><PHONE_1>+33 2 4008 7673</PHONE_1><FAX_1>+33 2 4008 3556</FAX_1></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2015-09-16 00:53:06 +0100" MODIFIED_BY="Liz Dooley"><PERSON ID="D03AD08F82E26AA201A79FAAC6CFC8B6" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Jean-Michel</FIRST_NAME><LAST_NAME>Liet</LAST_NAME><SUFFIX>MD, PhD, MSc</SUFFIX><POSITION>Pediatric Intensivist</POSITION><EMAIL_1>jeanmichel.liet@chu-nantes.fr</EMAIL_1><ADDRESS><DEPARTMENT>Pediatric Intensive Care Unit</DEPARTMENT><ORGANISATION>Hôpital Mère-Enfant, CHU de Nantes</ORGANISATION><ADDRESS_1>38 Boulevard Jean-Monnet</ADDRESS_1><ADDRESS_2>Faïencerie</ADDRESS_2><CITY>Nantes</CITY><ZIP>44093</ZIP><COUNTRY CODE="FR">France</COUNTRY><PHONE_1>+33 2 4008 7673</PHONE_1><FAX_1>+33 2 4008 3556</FAX_1></ADDRESS></PERSON><PERSON ID="DFEC306E82E26AA200ACC399C13D2019" ROLE="AUTHOR"><FIRST_NAME>Thierry</FIRST_NAME><LAST_NAME>Ducruet</LAST_NAME><SUFFIX>MSc</SUFFIX><EMAIL_1>thierry.ducruet@gmail.com</EMAIL_1><ADDRESS><DEPARTMENT>Research Center</DEPARTMENT><ORGANISATION>CHU Sainte-Justine</ORGANISATION><CITY>Montreal</CITY><REGION>QC</REGION><COUNTRY CODE="CA">Canada</COUNTRY></ADDRESS></PERSON><PERSON ID="DFE903AD82E26AA200ACC399B8472E28" ROLE="AUTHOR"><FIRST_NAME>Vineet</FIRST_NAME><LAST_NAME>Gupta</LAST_NAME><SUFFIX>MD, FAAP, FCCM</SUFFIX><EMAIL_1>vin_gupta@me.com</EMAIL_1><ADDRESS><DEPARTMENT>Pediatric Critical Care Medicine</DEPARTMENT><ORGANISATION>Moses Cone Hospital</ORGANISATION><ADDRESS_1>1200 N. Elm Street</ADDRESS_1><CITY>Greensboro</CITY><ZIP>27401</ZIP><REGION>NC</REGION><COUNTRY CODE="US">USA</COUNTRY></ADDRESS></PERSON><PERSON ID="DFF2322B82E26AA200ACC399B4C26996" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Gilles</FIRST_NAME><LAST_NAME>Cambonie</LAST_NAME><SUFFIX>MD, PhD</SUFFIX><EMAIL_1>g-cambonie@chu-montpellier.fr</EMAIL_1><ADDRESS><DEPARTMENT>Service de Réanimation Pédiatrique et Néonatale, Pédiatrie II</DEPARTMENT><ORGANISATION>Hôpital Arnaud de Villeneuve</ORGANISATION><ADDRESS_1>371 av du Doyen Gaston Giraud</ADDRESS_1><CITY>Montpellier CEDEX 5</CITY><ZIP>34295</ZIP><COUNTRY CODE="FR">France</COUNTRY><PHONE_1>+33 4 6733 6571</PHONE_1><PHONE_2>+33 4 6733 6626</PHONE_2><FAX_1>+33 4 6733 6228</FAX_1></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2015-04-09 13:18:36 +1000" MODIFIED_BY="[Empty name]">
<UP_TO_DATE>
<DATE DAY="25" MONTH="3" YEAR="2015"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="25" MONTH="3" YEAR="2015"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="25" MONTH="3" YEAR="2017"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="1" YEAR="2008"/>
<REVIEW_PUBLISHED ISSUE="4" YEAR="2010"/>
<LAST_CITATION_ISSUE ISSUE="9" YEAR="2015"/>
</DATES>
<WHATS_NEW MODIFIED="2015-09-14 17:43:16 +1000" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2015-09-14 17:43:16 +1000" MODIFIED_BY="[Empty name]">
<DATE DAY="25" MONTH="3" YEAR="2015"/>
<DESCRIPTION>
<P>The conclusions have not changed. Recommendations for further studies are appropriate.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2015-04-09 13:20:55 +1000" MODIFIED_BY="[Empty name]">
<DATE DAY="25" MONTH="3" YEAR="2015"/>
<DESCRIPTION>
<P>We re-wrote the meta-analysis. We updated the searches in March 2015 and included two new studies (<LINK REF="STD-Chowdhury-2013" TYPE="STUDY">Chowdhury 2013</LINK>; <LINK REF="STD-Kim-2011" TYPE="STUDY">Kim 2011</LINK>) and excluded three new studies (<LINK REF="STD-Colnaghi-2012" TYPE="STUDY">Colnaghi 2012</LINK>; <LINK REF="STD-Mayordomo_x002d_Colunga-2010" TYPE="STUDY">Mayordomo-Colunga 2010</LINK>; <LINK REF="STD-Montaguti-2011" TYPE="STUDY">Montaguti 2011</LINK>). </P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2015-09-14 20:09:29 +1000" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2015-09-14 20:09:29 +1000" MODIFIED_BY="[Empty name]">
<DATE DAY="17" MONTH="10" YEAR="2013"/>
<DESCRIPTION>
<P>Additional tables moved to the correct section of the review.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2009-06-18 08:18:40 +1000" MODIFIED_BY="[Empty name]">
<DATE DAY="14" MONTH="5" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT MODIFIED="2015-09-16 00:36:45 +1000" MODIFIED_BY="[Empty name]">
<INTERNAL_SOURCES MODIFIED="2015-09-14 20:00:01 +1000" MODIFIED_BY="[Empty name]">
<SOURCE MODIFIED="2015-03-06 03:35:08 +1000" MODIFIED_BY="[Empty name]">
<NAME>University of Wisconsin General Clinical Research Center</NAME>
<COUNTRY CODE="US">USA</COUNTRY>
<DESCRIPTION>
<P>Holmann 1998 was supported, in part, by grant M01 RR03186-07 from the University of Wisconsin General Clinical Research Center</P>
</DESCRIPTION>
</SOURCE>
<SOURCE MODIFIED="2015-09-14 20:00:01 +1000" MODIFIED_BY="[Empty name]">
<NAME>Fonds de la Recherche en Santé du Quebec (FRSQ)</NAME>
<COUNTRY CODE="CA">Canada</COUNTRY>
<DESCRIPTION>
<P>Liet 2005 was supported in part by a grant from the Fonds de la Recherche en Santé du Quebec (FRSQ)</P>
</DESCRIPTION>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES MODIFIED="2015-09-16 00:36:45 +1000" MODIFIED_BY="[Empty name]">
<SOURCE MODIFIED="2015-09-14 20:00:41 +1000" MODIFIED_BY="[Empty name]">
<NAME>British Oxygen Company Medical</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION>
<P>Chowdhury 2012 funding: supported by a research grant from British Oxygen Company (BOC) Medical, and equipment support from Fisher and Paykel Healthcare, EME (Electro-Medical Equipment)<BR/>Carefusion and Covidien Nellcor</P>
</DESCRIPTION>
</SOURCE>
<SOURCE MODIFIED="2015-03-06 03:26:47 +1000" MODIFIED_BY="[Empty name]">
<NAME>Praxair corporation</NAME>
<COUNTRY CODE="US">USA</COUNTRY>
<DESCRIPTION>
<P>Kim 2011 was funded in part by an unrestricted research grant from Praxair Corporation</P>
</DESCRIPTION>
</SOURCE>
<SOURCE MODIFIED="2015-09-14 20:00:54 +1000" MODIFIED_BY="[Empty name]">
<NAME>Air Liquide Santé International</NAME>
<COUNTRY CODE="FR">France</COUNTRY>
<DESCRIPTION>
<P>Liet 2005 was supported in part by Air Liquide Santé International</P>
</DESCRIPTION>
</SOURCE>
<SOURCE MODIFIED="2015-09-14 20:02:22 +1000" MODIFIED_BY="[Empty name]">
<NAME>Air Liquide Santé</NAME>
<COUNTRY CODE="FR">France</COUNTRY>
<DESCRIPTION>
<P>Air Liquide Santé provided the heliox and air tanks, set up the study equipment and was involved in the study design of Cambonie 2006</P>
</DESCRIPTION>
</SOURCE>
<SOURCE MODIFIED="2015-09-16 00:36:45 +1000" MODIFIED_BY="[Empty name]">
<NAME>None</NAME>
<COUNTRY CODE="NONE">Other</COUNTRY>
<DESCRIPTION>
<P>Authors of this meta analysis did not receive any financial support for this work</P>
</DESCRIPTION>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2015-09-16 09:49:29 +1000" MODIFIED_BY="Liz  Dooley">
<SUMMARY MODIFIED="2015-09-14 20:15:51 +1000" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2009-06-18 08:28:44 +1000" MODIFIED_BY="[Empty name]">Heliox inhalation therapy for bronchiolitis in infants</TITLE>
<SUMMARY_BODY MODIFIED="2015-09-14 20:15:51 +1000" MODIFIED_BY="[Empty name]">
<P>
<B>Review question</B>
</P>
<P>We reviewed the evidence about the effect of heliox inhalation therapy in infants with airway obstruction due to winter viral pulmonary infection.</P>
<P>
<B>Background</B>
</P>
<P>Approximately 20% of all infants experience trouble breathing associated with viral infection in the first year of life, and 2% to 3% of these infants require hospitalisation for marked breathing difficulties. In this review, we wanted to asses the effect of the addition of heliox to standard medical care. Heliox is a mixture of oxygen and the gas helium. Helium inhalation decreases the work of breathing by increasing gas flow in small or partially obstructed airways by lowering resistance to gas flow.</P>
<P>
<B>Study characteristics</B>
</P>
<P>We retrieved seven trials involving 447 infants requiring hospitalisation for marked breathing difficulties. Six trials recruited infants from paediatric intensive care units and one trial from the emergency department. Four trials were supported in part by unrestricted grants from a manufacturer with a commercial interest in the results. The evidence is current to March 2015.</P>
<P>
<B>Key results</B>
</P>
<P>Pooled results failed to demonstrate a reduction in the rate of emergency department discharge, in the rate of intubation to achieve respiratory support, or in the length of respiratory support. However, four trials involving 138 infants used a clinical respiratory score system, with increased severity receiving a higher score. The pooled results show that infants treated with heliox inhalation had a reduction in this respiratory score in the first hour. In a small subgroup of infants who were started on a nasal device providing a continuous positive airway pressure right from the start, because of the severity of their disease, heliox inhalation could reduce length of treatment.</P>
<P>
<B>Quality of the evidence</B>
</P>
<P>Each trial included in this review used a different method for delivering heliox. They also used different thresholds of clinical respiratory score for inclusion, and were often underpowered for the major endpoints. Further studies using a valid method of heliox application in addition to standard medical care are needed. Inclusion criteria must include a clinical severity score that reflects severe respiratory distress to avoid the inclusion of children who are not very sick, who may not benefit from heliox inhalation. Such studies would provide necessary information about the appropriate place of heliox in the management of seasonal pulmonary infection in infants.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2015-09-16 09:49:29 +1000" MODIFIED_BY="Liz  Dooley">
<ABS_BACKGROUND MODIFIED="2015-03-06 02:40:35 +1000" MODIFIED_BY="[Empty name]">
<P>Bronchiolitis is the leading cause of hospitalisation among infants in high-income countries. Acute viral bronchiolitis is associated with airway obstruction and turbulent gas flow. Heliox, a mixture of oxygen and the inert gas helium, may improve gas flow through high-resistance airways and decrease the work of breathing. In this review, we selected trials that objectively assessed the effect of the addition of heliox to standard medical care for acute bronchiolitis.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2015-09-15 14:43:57 +1000" MODIFIED_BY="Liz  Dooley">
<P>To assess heliox inhalation therapy in addition to standard medical care for acute bronchiolitis in infants with respiratory distress, as measured by clinical endpoints (in particular the rate of endotracheal intubation, the rate of emergency department discharge, the length of treatment for respiratory distress) and pulmonary function testing (mainly clinical respiratory scores).</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]">
<P>We searched CENTRAL (2015, Issue 2), MEDLINE (1966 to March week 3, 2015), EMBASE (1974 to March 2015), LILACS (1982 to March 2015) and the National Institutes of Health (NIH) website (May 2009).</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2010-01-26 08:40:14 +1000" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trials (RCTs) and quasi-RCTs of heliox in infants with acute bronchiolitis.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2015-07-25 01:59:55 +1000" MODIFIED_BY="[Empty name]">
<P>Two review authors independently extracted data and assessed trial quality. </P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2015-09-16 09:49:29 +1000" MODIFIED_BY="Liz  Dooley">
<P>We included seven trials involving 447 infants younger than two years with respiratory distress secondary to viral bronchiolitis. All children were recruited from a paediatric intensive care unit (PICU; 378 infants), except in one trial (emergency department; 69 infants). All children were younger than two (under nine months in two trials and under three months in one trial). Positive tests for respiratory syncytial virus (RSV) were required for inclusion in five trials. The two other trials were carried out in the bronchiolitis seasons. Seven different protocols were used for inhalation therapy with heliox.</P>
<P>When heliox was used in the PICU, we observed no significant reduction in the rate of intubation: risk ratio (RR) 2.73 (95% confidence interval (CI) 0.96 to 7.75, four trials, 408 infants, low quality evidence). When heliox inhalation was used in the emergency department, we observed no increase in the rate of discharge: RR 0.51 (95% CI 0.17 to 1.55, one trial, 69 infants, moderate quality evidence).</P>
<P>There was no decrease in the length of treatment for respiratory distress: mean difference (MD) -0.19 days (95% CI -0.56 to 0.19, two trials, 320 infants, moderate quality evidence). However, in the subgroup of infants who were started on nasal continuous positive airway pressure (nCPAP) right from the start, because of severe respiratory distress, heliox therapy reduced the length of treatment: MD -0.76 days (95% CI -1.45 to -0.08, one trial, 21 infants, low quality evidence). No adverse events related to heliox inhalation were reported.</P>
<P>We found that infants treated with heliox inhalation had a significantly lower mean clinical respiratory score in the first hour after starting treatment when compared to those treated with air or oxygen inhalation: MD -1.04 (95% CI -1.60 to -0.48, four trials, 138 infants, moderate quality evidence). This outcome had statistical heterogeneity, which remained even after removing the study using a standard high-concentration reservoir mask. Several factors may explain this heterogeneity, including first the limited number of patients in each trial, and the wide differences in the baseline severity of disease between studies, with the modified Wood Clinical Asthma Score (m-WCAS) in infants treated with heliox ranging from less than two to more than seven.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]">
<P>Current evidence suggests that the addition of heliox therapy may significantly reduce a clinical score evaluating respiratory distress in the first hour after starting treatment in infants with acute RSV bronchiolitis. We noticed this beneficial effect regardless of which heliox inhalation protocol was used. Nevertheless, there was no reduction in the rate of intubation, in the rate of emergency department discharge, or in the length of treatment for respiratory distress. Heliox could reduce the length of treatment in infants requiring CPAP for severe respiratory distress. Further studies with homogeneous logistics in their heliox application are needed. Inclusion criteria must include a clinical severity score that reflects severe respiratory distress to avoid inclusion of children with mild bronchiolitis who may not benefit from heliox inhalation. Such studies would provide the necessary information as to the appropriate place for heliox in the therapeutic schedule for severe bronchiolitis.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2015-09-16 09:40:24 +1000" MODIFIED_BY="Liz  Dooley">
<BACKGROUND MODIFIED="2015-09-14 20:59:41 +1000" MODIFIED_BY="[Empty name]">
<CONDITION MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]">
<P>Bronchiolitis, an acute inflammatory process of the small airways, is the leading cause of hospitalisation among infants in high-income countries (<LINK REF="REF-Hall-2013" TYPE="REFERENCE">Hall 2013</LINK>; <LINK REF="REF-Welliver-2003" TYPE="REFERENCE">Welliver 2003</LINK>). Common symptoms include a runny nose, cough and dyspnoea often with bronchospasm, mucus production and wheezing. Apnoea may be the initial manifestation before other respiratory signs are present and is most common in premature infants (<LINK REF="REF-Ralston-2009" TYPE="REFERENCE">Ralston 2009</LINK>). Respiratory syncytial virus (RSV) is the most common pathogen isolated (<LINK REF="REF-Mansbach-2012" TYPE="REFERENCE">Mansbach 2012</LINK>). Approximately 20% of all infants have RSV-associated wheezing in the first year of life and 2% to 3% require hospitalisation as part of the management strategy (<LINK REF="REF-AAP-2006" TYPE="REFERENCE">AAP 2006</LINK>). Young age (under six months of age) at the onset of the RSV season increases the risk of RSV hospitalisation (<LINK REF="REF-Carbonell_x002d_Estrany-2000" TYPE="REFERENCE">Carbonell-Estrany 2000</LINK>; <LINK REF="REF-Figueras_x002d_Aloy-2008" TYPE="REFERENCE">Figueras-Aloy 2008</LINK>; <LINK REF="REF-Law-2004" TYPE="REFERENCE">Law 2004</LINK>; <LINK REF="REF-Liese-2003" TYPE="REFERENCE">Liese 2003</LINK>). Analysis of representative studies over the last 30 years found that the risk ratio of boys to girls is 1.4:1 (<LINK REF="REF-Simoes-2003" TYPE="REFERENCE">Simoes 2003</LINK>). More than 50% of hospitalisations caused by RSV infections are in infants and children with no known risk factors (<LINK REF="REF-Boyce-2000" TYPE="REFERENCE">Boyce 2000</LINK>).</P>
<P>Even though there are many treatments, there is no evidence to endorse a specific treatment other than supportive care (<LINK REF="REF-Davison-2004" TYPE="REFERENCE">Davison 2004</LINK>). Current evidence suggests that nebulised 3% saline may significantly reduce the length of hospital stay among infants hospitalised with non-severe acute viral bronchiolitis and improve the clinical severity score in both outpatient and inpatient populations (<LINK REF="REF-Zhang-2013" TYPE="REFERENCE">Zhang 2013</LINK>). Supplemental oxygen and judicious fluid management remain the mainstays of therapy. Ventilatory support can be necessary in 7.5% of infants hospitalised for bronchiolitis with an overall clinical score of at least 4 on a scale of 0 to 10 (<LINK REF="REF-Skjerven-2013" TYPE="REFERENCE">Skjerven 2013</LINK>). The use of heated, humidified, high-flow nasal cannula (HFNC) therapy may reduce the need for invasive respiratory support thus potentially lowering costs, with clinical advantages and fewer adverse effects (<LINK REF="REF-Beggs-2014" TYPE="REFERENCE">Beggs 2014</LINK>; <LINK REF="REF-Bressan-2013" TYPE="REFERENCE">Bressan 2013</LINK>; <LINK REF="REF-Hough-2014" TYPE="REFERENCE">Hough 2014</LINK>; <LINK REF="REF-Mayfield-2014" TYPE="REFERENCE">Mayfield 2014</LINK>; <LINK REF="REF-Milesi-2013" TYPE="REFERENCE">Milesi 2013</LINK>).</P>
<P>Premature or low birth weight infants, infants with bronchopulmonary dysplasia and patients with haemodynamically significant congenital heart disease merit special attention. Recipients of hematopoetic stem cell transplants have had especially high rates of severe disease.The relatively smaller airways of select infant groups places them at higher risk of respiratory failure and need for specialised management. For example, the percentage of patients requiring endotracheal intubation or positive pressure ventilation (PPV) is higher in infants with congenital heart disease, immunocompromised status (<LINK REF="REF-Wang-1995" TYPE="REFERENCE">Wang 1995</LINK>), chronic lung disease or those born prematurely (<LINK REF="REF-Meert-1990" TYPE="REFERENCE">Meert 1990</LINK>). Mortality rates of infants hospitalised in a paediatric intensive care unit (PICU) for RSV-bronchiolitis range from 0% to 3% if patients have no risk factors, and 2.5% to 6% if they have at least one risk factor (<LINK REF="REF-Chevret-2005" TYPE="REFERENCE">Chevret 2005</LINK>; <LINK REF="REF-Prais-2003" TYPE="REFERENCE">Prais 2003</LINK>; <LINK REF="REF-Wang-1995" TYPE="REFERENCE">Wang 1995</LINK>). Mortality associated with RSV infection is relatively rare among young children in high-income countries. The majority of deaths occur in infants with complex chronic conditions and in those with other acute conditions, such as sepsis, which could have contributed to their deaths (<LINK REF="REF-Byington-2015" TYPE="REFERENCE">Byington 2015</LINK>). It was estimated that between 66,000 and 199,000 children younger than five years died from RSV-associated acute lower respiratory infection in 2005, with 99% of these deaths occurring in low-income countries (<LINK REF="REF-Nair-2010" TYPE="REFERENCE">Nair 2010</LINK>).<BR/>
</P>
</CONDITION>
<INTERVENTION MODIFIED="2015-09-14 20:59:41 +1000" MODIFIED_BY="[Empty name]">
<P>In 1934, Barach first described the use of helium-oxygen gas mixtures (heliox) for the treatment of upper airway obstruction (<LINK REF="REF-Barach-1934" TYPE="REFERENCE">Barach 1934</LINK>). Heliox has subsequently been shown to be a useful adjunctive therapy in children with asthma (<LINK REF="REF-Carter-1996" TYPE="REFERENCE">Carter 1996</LINK>; <LINK REF="REF-Kudukis-1997" TYPE="REFERENCE">Kudukis 1997</LINK>), bronchiolitis (<LINK REF="STD-Gross-2000" TYPE="STUDY">Gross 2000</LINK>; <LINK REF="STD-Hollmann-1998" TYPE="STUDY">Hollmann 1998</LINK>; <LINK REF="STD-Paret-1996" TYPE="STUDY">Paret 1996</LINK>), upper airway obstruction (<LINK REF="STD-Duncan-1979" TYPE="STUDY">Duncan 1979</LINK>; <LINK REF="STD-Tobias-1997" TYPE="STUDY">Tobias 1997</LINK>), acute respiratory distress (<LINK REF="STD-Winters-2000" TYPE="STUDY">Winters 2000</LINK>), and in children with post-extubation stridor (<LINK REF="REF-Kemper-1991" TYPE="REFERENCE">Kemper 1991</LINK>). Heliox may also increase the effectiveness of nasal continuous positive airway pressure (nCPAP) in the treatment of respiratory distress syndrome in premature infants (<LINK REF="STD-Colnaghi-2012" TYPE="STUDY">Colnaghi 2012</LINK>). Although heliox can be an effective treatment option, the existing evidence does not provide support for the administration of heliox mixtures to all emergency department patients with acute asthma (<LINK REF="REF-Rodrigo-2010" TYPE="REFERENCE">Rodrigo 2010</LINK>).</P>
</INTERVENTION>
<THEORY MODIFIED="2015-09-14 20:19:02 +1000" MODIFIED_BY="[Empty name]">
<P>In bronchiolitis, breathing becomes more difficult due to an increased end-expiratory lung volume, decreased lung compliance and relative upper airway obstruction with increased airway resistance. Infection of bronchiolar respiratory and ciliated epithelial cells produces increased mucus secretion, cell death and sloughing. This is followed by a peribronchiolar lymphocytic infiltrate and submucosal oedema (<LINK REF="REF-AAP-2006" TYPE="REFERENCE">AAP 2006</LINK>; <LINK REF="REF-Piedimonte-2002" TYPE="REFERENCE">Piedimonte 2002</LINK>). The combination of debris and oedema produces obstruction of the smaller airways. This critical narrowing results in turbulent flow and increased airway resistance. Decreased ventilation in affected areas causes ventilation/perfusion mismatching, resulting in hypoxia. During the expiratory phase of respiration, dynamic collapse of the airways produces a disproportionate decrease in airflow and resultant air trapping. Since bronchiolitis is associated with airway obstruction and turbulent gas flow, this disease process could theoretically be improved by heliox, which improves gas flow through high-resistance airways because of the lower density of helium compared to air (<LINK REF="REF-Gupta-2005" TYPE="REFERENCE">Gupta 2005</LINK>; <LINK REF="REF-Panitch-2003" TYPE="REFERENCE">Panitch 2003</LINK>). Helium is an inert gas with no intrinsic bronchodilatory or anti-inflammatory properties. Helium has the lowest density of any gas other than hydrogen, which is unfortunately not medically useful because of its flammable properties. Helium acts as a 'carrier gas', resulting in lower resistance to gas flow allowing for increased bulk flow, increased oxygen flow and decreased work of breathing (<LINK REF="REF-Wolfson-1984" TYPE="REFERENCE">Wolfson 1984</LINK>). Equally important is the fact that carbon dioxide diffuses through helium four to five times faster than through air, which aids ventilation and carbon dioxide removal. The effects of heliox are relatively rapid and therefore any significant clinical effects are expected to be seen within minutes. A one-hour trial is usually enough to detect any beneficial effect of heliox (<LINK REF="REF-Martinon_x002d_Torres-2015" TYPE="REFERENCE">Martinon-Torres 2015</LINK>). Thus, the clinician quickly knows if heliox therapy will be beneficial for an individual patient or whether it should be abandoned for other possible therapies. For non-ventilated patients, it is also essential to ensure that there is no accidental contamination of the heliox mixture with air or oxygen. For instance, heliox administration via a standard high-concentration reservoir mask leads to significant dilution by room air (<LINK REF="REF-Standley-2008" TYPE="REFERENCE">Standley 2008</LINK>).</P>
<P>The use of premixed heliox tanks with at least a 21% oxygen concentration avoids accidental administration of a hypoxic gas mixture. Manufacturers supply pre-mixed bottles at different concentrations of helium/oxygen for clinical use.</P>
<P>The administration of heliox during mechanical ventilation must be carried out with vigilance and accurate, continuous monitoring. Helium can interfere with the accuracy of pneumotachometer and ventilator function, which are typically calibrated for nitrogen instead of helium as the primary balance gas (<LINK REF="REF-Berkenbosch-2003" TYPE="REFERENCE">Berkenbosch 2003</LINK>). New generation helium/oxygen administration systems have been developed to help circumvent these issues. Even if helium-oxygen can be safely delivered by modifying standard ventilators according to guidelines in the literature, caution must be applied when using this approach (<LINK REF="REF-Martinon_x002d_Torres-2012" TYPE="REFERENCE">Martinon-Torres 2012</LINK>).</P>
</THEORY>
<IMPORTANCE MODIFIED="2010-01-07 20:21:48 +1000" MODIFIED_BY="[Empty name]">
<P>The hypothesis of this review is that heliox inhalation is beneficial in the management of acute bronchiolitis as assessed by clinically relevant outcomes. In order to critically evaluate the clinical data, we undertook a systematic review of trials that use heliox for the treatment of bronchiolitis.</P>
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES MODIFIED="2015-09-15 14:44:15 +1000" MODIFIED_BY="Liz  Dooley">
<P>To assess heliox inhalation therapy in addition to standard medical care for acute bronchiolitis in infants with respiratory distress, as measured by clinical endpoints (in particular the rate of endotracheal intubation, the rate of emergency department discharge, the length of treatment for respiratory distress) and pulmonary function testing (mainly clinical respiratory scores).</P>
</OBJECTIVES>
<METHODS MODIFIED="2015-09-14 20:23:40 +1000" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]">
<CRIT_STUDIES MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trials (RCTs) and quasi-RCTs. We considered both parallel-group and cross-over designs. We excluded studies where heliox was used as a vector for nebulisation (to improve aerosol drug delivery), or studies where helium was used to assess lung volumes.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2010-02-09 04:39:45 +1000" MODIFIED_BY="Jenny Bellorini">
<P>Infants hospitalised for acute bronchiolitis. For the purpose of this review, acute bronchiolitis is defined by the presence of signs of respiratory distress secondary to respiratory syncytial virus (RSV) infection and/or those patients with respiratory distress and symptoms that occur within RSV epidemic periods and are not due to other medical conditions.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2009-07-08 13:57:07 +1000" MODIFIED_BY="[Empty name]">
<P>Treatment with inhaled heliox versus a placebo (oxygen or air).</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2015-07-22 15:44:44 +1000" MODIFIED_BY="[Empty name]">
<CRIT_OUTCOMES_PRIMARY MODIFIED="2015-07-22 15:44:44 +1000" MODIFIED_BY="[Empty name]">
<OL>
<LI>In-hospital mortality.</LI>
<LI>Need for mechanical ventilation (invasive or not).</LI>
<LI>Rate of endotracheal intubation.</LI>
<LI>Rate of emergency department discharge.</LI>
<LI>Length of treatment for respiratory distress.</LI>
<LI>Length of paediatric intensive care unit (PICU) stay.</LI>
<LI>Adverse effects.</LI>
</OL>
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY MODIFIED="2015-04-09 13:29:09 +1000" MODIFIED_BY="[Empty name]">
<OL>
<LI>Gas exchange (effects on oxygenation and CO<SUB>2</SUB> elimination) within the first 24 hours after starting heliox treatment.</LI>
<LI>Respiratory mechanics (effects on pulmonary compliance and resistance of airways) within the first 24 hours after starting heliox treatment.</LI>
<LI>Clinical respiratory scores within the first 24 hours after starting heliox treatment.</LI>
<LI>Total duration of hospitalisation (including duration in PICU).</LI>
</OL>
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2015-09-14 20:20:55 +1000" MODIFIED_BY="[Empty name]">
<ELECTRONIC_SEARCHES MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]">
<P>For the 2015 update we searched the Cochrane Central Register of Controlled Trials (CENTRAL 2015, Issue 2), which includes the Cochrane Acute Respiratory Infection Group's Specialised Register, MEDLINE (Ovid) (June 2009 to March week 3, 2015), Embase.com (June 2009 to March 2015), LILACS (BIREME) (2009 to March 2015) and the NIH website (May 2009). See <A HREF="http://archie.cochrane.org/sections/documents/viewDiff?documentPK=E5424DE882E26AA2017127F4A6D52463&amp;versionPK1=32646930422658091798110721070841&amp;versionPK2=z1310162330186129185817723449999#APP-01">Appendix 1</A> for details of previous searches.</P>
<P>We used the search strategy in <LINK REF="APP-02" TYPE="APPENDIX">Appendix 2</LINK> to search MEDLINE and CENTRAL. We combined the MEDLINE search with the Cochrane Highly Sensitive Search Strategy for identifying RCTs randomised trials in MEDLINE: sensitivity- and precision-maximising version (2008 revision); Ovid format (<LINK REF="REF-Lefebvre-2011" TYPE="REFERENCE">Lefebvre 2011</LINK>). We adapted the search terms to search EMBASE (see <LINK REF="APP-03" TYPE="APPENDIX">Appendix 3</LINK>) and LILACS (see <LINK REF="APP-04" TYPE="APPENDIX">Appendix 4</LINK>). We did not apply any date, language or publication limits.</P>
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES MODIFIED="2015-09-14 20:20:55 +1000" MODIFIED_BY="[Empty name]">
<P>We searched the trials registries World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) (<A HREF="http://apps.who.int/trialsearch/default.aspx">http://apps.who.int/trialsearch/default.aspx</A>) and the US National Institutes of Health (<A HREF="http://www.clinicaltrials.gov">www.clinicaltrials.gov</A>) for completed and ongoing trials (latest search 30 March 2015). We checked the references of relevant systematic reviews and identified RCTs. Two review authors (VG, JML) contacted trial authors of all studies to locate other unpublished or in progress studies that met the inclusion criteria.</P>
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2015-09-14 20:23:40 +1000" MODIFIED_BY="[Empty name]">
<STUDY_SELECTION MODIFIED="2015-03-18 09:26:38 +1000" MODIFIED_BY="[Empty name]">
<P>Two review authors (JML, GC) independently reviewed titles, abstracts and citations to assess potential relevance for full review. From the full text, both review authors independently assessed studies for inclusion based on the criteria for study design, population, intervention and outcomes. We excluded trials that did not meet our inclusion criteria and noted the reasons for their exclusion (see <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK> table). We resolved any disagreement between the two review authors about study inclusion by discussion.</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]">
<P>Two review authors (JML, GC) independently extracted data from the included trials using a standardised data extraction form. We resolved any disagreement between the two review authors by discussion. We entered results into the Cochrane Collaboration's software program (Review Manager 5.3) (<LINK REF="REF-RevMan-2014" TYPE="REFERENCE">RevMan 2014</LINK>). Data extraction included the following items.</P>
<OL>
<LI>Methods (method of randomisation, allocation concealment, blinding, analysis by intention-to-treat (ITT), withdrawals).</LI>
<LI>Participants (age, gender, number of patients studied, location, RSV and other organisms, patient demographics, risk factors, withdrawals).</LI>
<LI>Interventions (fraction of inspired helium, duration of therapy, route of delivery, mechanical ventilation, intubation).</LI>
<LI>Control; concurrent treatments.</LI>
<LI>Outcomes. We extracted the results based upon the ITT population.</LI>
</OL>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]">
<P>Two review authors (JML, GC) assessed the methodological quality of the included trials. We assessed each study for validity using the Cochrane Collaboration's tool for assessing risk of bias (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). We classified six domains as low risk, unclear risk or high risk: random sequence generation, allocation concealment, blinding (participants and personnel, and outcome assessment), incomplete outcome data, selective reporting and other potential sources of bias. We resolved any disagreement between the two review authors by discussion.<BR/>
</P>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2010-02-09 04:44:27 +1000" MODIFIED_BY="Jenny Bellorini">
<P>We compared treatment with inhaled heliox to a placebo (oxygen or air) for primary and secondary outcomes. For endpoints with dichotomous measures (for example, mortality, need for endotracheal intubation), we measured effect size using the risk ratio (RR) and 95% confidence interval (CI). We calculated the mean difference (MD) and 95% CI for numerical outcomes.</P>
</EFFECT_MEASURES>
<UNIT_OF_ANALYSIS MODIFIED="2015-03-18 09:33:12 +1000" MODIFIED_BY="[Empty name]">
<P>We analysed studies with non-standard designs, such as cross-over trials, according to particular biases. The main concerns over risk of bias in cross-over trials are whether the cross-over design is suitable, whether there is a carry-over effect, whether only first trial period data are available, incorrect analysis and comparability of results with those from parallel-group trials. Since helium is an inert gas with no intrinsic bronchodilatory or anti-inflammatory properties and could be useful only by improving gas flow, there is unlikely to be carry-over of treatment effect across trial periods.</P>
</UNIT_OF_ANALYSIS>
<MISSING_DATA MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]">
<P>In case of missing values, we contacted the original trial authors to request missing data. Otherwise, we assumed data to be missing at random. We also addressed the potential impact of missing data on the findings of the review in the <LINK TAG="DISCUSSION" TYPE="SECTION">Discussion</LINK> section.</P>
</MISSING_DATA>
<HETEROGENEITY_ASSESSMENT MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]">
<P>We assessed heterogeneity between studies by using the I<SUP>2</SUP> statistic (<LINK REF="REF-Higgins-2003" TYPE="REFERENCE">Higgins 2003</LINK>). We considered heterogeneity weak when the I<SUP>2 </SUP>statistic was less than 0.25.</P>
</HETEROGENEITY_ASSESSMENT>
<BIAS_ASSESSMENT MODIFIED="2015-03-18 08:15:18 +1000" MODIFIED_BY="[Empty name]">
<P>We assessed publication bias by funnel plots. Publication bias need not lead to asymmetry in funnel plots. In the absence of any intervention effect, selective publication based on the P value alone will lead to a symmetrical funnel plot in which studies on the extreme left or right are more likely to be published than those in the middle. This could bias the estimated between-study heterogeneity variance.</P>
</BIAS_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]">
<P>We used a random-effects model to meta-analyse data.</P>
<SUBSECTION>
<HEADING LEVEL="3">GRADE and 'Summary of findings' table</HEADING>
<P>We created <LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK> using the following primary outcomes: need for mechanical ventilation (invasive or not); rate of endotracheal intubation; rate of emergency department discharge; and length of treatment for respiratory distress. We did not include the primary outcome 'in-hospital mortality'. This primary outcome is unavoidable but it is not relevant to a clinician who uses heliox, which is an inert gas. This data would unnecessarily overburden the 'Summary of findings' table.<BR/>We also included the secondary outcome clinical respiratory scores within the first 24 hours after starting heliox treatment. This outcome was the most investigated outcome and was the primary endpoint of four trials. Nevertheless, we classified this outcome in our protocol as a secondary outcome as it involves an element of subjectivity.</P>
<P>We used the five GRADE considerations (study limitations, consistency of effect, imprecision, indirectness and publication bias) to assess the quality of the body of evidence as it relates to the studies that contribute data to the meta-analyses for the prespecified outcomes (<LINK REF="REF-GRADE-2004" TYPE="REFERENCE">GRADE 2004</LINK>). We used methods and recommendations described in Section 8.5 and Chapter 12 of the <I>Cochrane Handbook for Systematic Reviews of Interventions </I>(<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>) using GRADEpro GDT software (<LINK REF="REF-GRADEpro-GDT-2015" TYPE="REFERENCE">GRADEpro GDT 2015</LINK>). We justified all decisions to downgrade or upgrade the quality of studies using footnotes and we made comments to aid the reader's understanding of the review where necessary.</P>
</SUBSECTION>
</DATA_SYNTHESIS>
<SUBGROUP_ANALYSIS MODIFIED="2015-09-14 20:23:40 +1000" MODIFIED_BY="[Empty name]">
<P>We used <LINK REF="REF-RevMan-2014" TYPE="REFERENCE">RevMan 2014</LINK> to perform statistical analysis of extracted data. Planned subgroup analyses included infants younger than 12 months of age still hospitalised but not receiving mechanical ventilation, and infants younger than 12 months of age recruited receiving mechanical ventilation. The main endpoint in the first subgroup was the need for mechanical ventilation, and in the second subgroup the change in oxygenation index one hour after heliox administration. We did not undertake these because of the limited number of included trials.</P>
</SUBGROUP_ANALYSIS>
<SENSITIVITY_ANALYSIS MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]">
<P>We planned sensitivity analyses, but we did not undertake these because of the limited number of included trials.</P>
</SENSITIVITY_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2015-09-16 09:40:24 +1000" MODIFIED_BY="Liz  Dooley">
<STUDY_DESCRIPTION MODIFIED="2015-09-14 20:59:54 +1000" MODIFIED_BY="[Empty name]">
<SEARCH_RESULTS MODIFIED="2015-09-14 20:24:00 +1000" MODIFIED_BY="[Empty name]">
<P>The 2009 MEDLINE search retrieved 227 citations, CENTRAL 273 citations, EMBASE 209 and LILACS a total of 41 citations.</P>
<P>The update on 25 March 2015 retrieved from the following databases: MEDLINE (Ovid) from 1 May 2009 to March week 3, 2015 (34 search results), Embase.com from 1 June 2009 to 25 March 2015 (103 search results), CENTRAL from 2009 Issue 2 to 2015 Issue 3 (41 search results), LILACS limited to year published 2009 to 2015 (17 search results); NB no filter for RCTs used. With duplicates removed there were 145 search results from the update.</P>
<P>Searches in registries (WHO ICTRP and clinicaltrials.gov) found two ongoing trials:</P>
<OL>
<LI>NCT02373683 'Helium-oxygen gas mixtures delivered by a high flow nasal cannula in bronchiolitis' &#8211; date of registration 23 February 2015 &#8211; recruiting.</LI>
<LI>NCT00116584 'Heliox-driven racemic epinephrine nebulization in treatment of moderate to severe bronchiolitis in pediatric emergency department patients' &#8211; date of registration 29 June 2005.</LI>
</OL>
</SEARCH_RESULTS>
<INCLUDED_STUDIES_DESCR MODIFIED="2015-09-14 20:59:54 +1000" MODIFIED_BY="[Empty name]">
<P>Seven trials met the criteria for study selection for this review (see <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> table). Six trials were performed in non-intubated children.</P>
<P>Four studies were parallel-group trials (<LINK REF="STD-Cambonie-2006" TYPE="STUDY">Cambonie 2006</LINK>; <LINK REF="STD-Chowdhury-2013" TYPE="STUDY">Chowdhury 2013</LINK>; <LINK REF="STD-Kim-2011" TYPE="STUDY">Kim 2011</LINK>; <LINK REF="STD-Liet-2005" TYPE="STUDY">Liet 2005</LINK>), and two studies used a cross-over design (<LINK REF="STD-Hollmann-1998" TYPE="STUDY">Hollmann 1998</LINK>; <LINK REF="STD-Martin_x00f3_n_x002d_Torres-2008" TYPE="STUDY">Martinón-Torres 2008</LINK>). Two studies were multi-centre trials, one involving three hospitals in Canada and one hospital in France (<LINK REF="STD-Liet-2005" TYPE="STUDY">Liet 2005</LINK>), and the other four centres in the UK and Australia (<LINK REF="STD-Chowdhury-2013" TYPE="STUDY">Chowdhury 2013</LINK>). The other studies were conducted in France (<LINK REF="STD-Cambonie-2006" TYPE="STUDY">Cambonie 2006</LINK>), the USA (<LINK REF="STD-Hollmann-1998" TYPE="STUDY">Hollmann 1998</LINK>; <LINK REF="STD-Kim-2011" TYPE="STUDY">Kim 2011</LINK>), and Spain (<LINK REF="STD-Martin_x00f3_n_x002d_Torres-2008" TYPE="STUDY">Martinón-Torres 2008</LINK>). In one trial not all infants were randomised, but it was possible to recover data from the randomised infants separately (<LINK REF="STD-Hollmann-1998" TYPE="STUDY">Hollmann 1998</LINK>). We only extracted these data for this review.</P>
<P>One other trial (unblinded, cross-over design) included 13 mechanically ventilated sedated and paralysed infants (<LINK REF="STD-Kneyber-2009" TYPE="STUDY">Kneyber 2009</LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="4">Participants</HEADING>
<P>All children were recruited from paediatric intensive care units (PICU) (n = 378), except in one trial conducted in an emergency department (n = 69) (<LINK REF="STD-Kim-2011" TYPE="STUDY">Kim 2011</LINK>). All children were under two years of age; they were all under nine months in two trials (<LINK REF="STD-Cambonie-2006" TYPE="STUDY">Cambonie 2006</LINK>; <LINK REF="STD-Liet-2005" TYPE="STUDY">Liet 2005</LINK>), and all under three months in one trial (<LINK REF="STD-Cambonie-2006" TYPE="STUDY">Cambonie 2006</LINK>). Infants were all treated for acute bronchiolitis. Positive tests for RSV were required for inclusion in five trials (<LINK REF="STD-Cambonie-2006" TYPE="STUDY">Cambonie 2006</LINK>; <LINK REF="STD-Hollmann-1998" TYPE="STUDY">Hollmann 1998</LINK>; <LINK REF="STD-Kneyber-2009" TYPE="STUDY">Kneyber 2009</LINK>; <LINK REF="STD-Liet-2005" TYPE="STUDY">Liet 2005</LINK>; <LINK REF="STD-Martin_x00f3_n_x002d_Torres-2008" TYPE="STUDY">Martinón-Torres 2008</LINK>). <LINK REF="STD-Kim-2011" TYPE="STUDY">Kim 2011</LINK> enrolled infants from 1 October through 31 March (RSV+ 58%). <LINK REF="STD-Chowdhury-2013" TYPE="STUDY">Chowdhury 2013</LINK> was carried out in the bronchiolitis seasons (RSV+ 80%).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Interventions</HEADING>
<P>All infants were treated with inhaled heliox versus a placebo (oxygen or air).</P>
<P>Seven different protocols were used for inhalation therapy with heliox:</P>
<OL>
<LI>by a standard non-rebreather reservoir mask 7 L/min for two 20-minute study periods (<LINK REF="STD-Hollmann-1998" TYPE="STUDY">Hollmann 1998</LINK>);</LI>
<LI>by inflatable head hood 9 to 15 L/min continuously (until ventilation or weaning after at least 24 hours of therapy) (<LINK REF="STD-Liet-2005" TYPE="STUDY">Liet 2005</LINK>);</LI>
<LI>by oxy hood 7 L/min for one hour (<LINK REF="STD-Cambonie-2006" TYPE="STUDY">Cambonie 2006</LINK>);</LI>
<LI>by non-invasive ventilation equipment (nasal continuous positive airway pressure with minimum level of 5 cm H<SUB>2</SUB>O) for two 30-minute study periods (<LINK REF="STD-Martin_x00f3_n_x002d_Torres-2008" TYPE="STUDY">Martinón-Torres 2008</LINK>);</LI>
<LI>through intratracheal tube with mechanical ventilation for three 30-minute study periods (<LINK REF="STD-Kneyber-2009" TYPE="STUDY">Kneyber 2009</LINK>);</LI>
<LI>via high-flow nasal cannula 6 L/min for four hours (<LINK REF="STD-Kim-2011" TYPE="STUDY">Kim 2011</LINK>);</LI>
<LI>by a tight-fitting 3-valve, non-rebreathing facemask 10 L/min (nasal cannula 3 L/min, if facemask intolerant) or CPAP 6 cmH<SUB>2</SUB>O if severe respiratory distress (until recovery) (<LINK REF="STD-Chowdhury-2013" TYPE="STUDY">Chowdhury 2013</LINK>).</LI>
</OL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Outcome measures</HEADING>
<OL>
<LI>In four trials the primary outcome measure was the effect on respiratory distress using a clinical scoring system, the modified Wood Clinical Asthma Score (m-WCAS) (<LINK REF="STD-Cambonie-2006" TYPE="STUDY">Cambonie 2006</LINK>; <LINK REF="STD-Hollmann-1998" TYPE="STUDY">Hollmann 1998</LINK>; <LINK REF="STD-Kim-2011" TYPE="STUDY">Kim 2011</LINK>; <LINK REF="STD-Martin_x00f3_n_x002d_Torres-2008" TYPE="STUDY">Martinón-Torres 2008</LINK>). The m-WCAS (initially described by Wood, <LINK REF="REF-Wood-1972" TYPE="REFERENCE">Wood 1972</LINK>) grades cyanosis, inspiratory breath sounds, accessory muscles used, expiratory wheezing and cerebral function from 0 to 2, with increased severity receiving a higher score. The respiratory distress assessment instrument (RDAI) was first described by Lowell (<LINK REF="REF-Lowell-1987" TYPE="REFERENCE">Lowell 1987</LINK>), and grades wheezing and retractions with the maximum total points for wheezing being eight and for retractions nine. In <LINK REF="STD-Kim-2011" TYPE="STUDY">Kim 2011</LINK>, m-WCAS and RDAI scores were recorded in the first four hours by video and recordable stethoscope with a standardised auscultatory examination covering eight positions for each time point and scores were assessed by the same masked investigator to eliminate interobserver variability.</LI>
<LI>In <LINK REF="STD-Liet-2005" TYPE="STUDY">Liet 2005</LINK>, the primary outcome measure was the rate of initiation of positive pressure, with a clinical score using the respiratory distress assessment instrument (RDAI).</LI>
<LI>In <LINK REF="STD-Chowdhury-2013" TYPE="STUDY">Chowdhury 2013</LINK>, the primary endpoint was the length of treatment required to alleviate hypoxia and respiratory distress.</LI>
<LI>The cross-over study that included already intubated children considered ventilatory mechanics parameters with data determined by electrical impedance tomography (<LINK REF="STD-Kneyber-2009" TYPE="STUDY">Kneyber 2009</LINK>).</LI>
</OL>
</SUBSECTION>
</INCLUDED_STUDIES_DESCR>
<EXCLUDED_STUDIES_DESCR MODIFIED="2015-03-18 10:41:26 +1000" MODIFIED_BY="[Empty name]">
<P>We excluded 22 trials. Many trials were case reports with no control groups (<LINK REF="STD-Duncan-1979" TYPE="STUDY">Duncan 1979</LINK>; <LINK REF="STD-Gross-2000" TYPE="STUDY">Gross 2000</LINK>; <LINK REF="STD-Gupta-2004" TYPE="STUDY">Gupta 2004</LINK>; <LINK REF="STD-Iglesias_x002d_Fernandez-2007" TYPE="STUDY">Iglesias-Fernandez 2007</LINK>; <LINK REF="STD-Kneyber-2006" TYPE="STUDY">Kneyber 2006</LINK>; <LINK REF="STD-Martinon_x002d_Torres-2005" TYPE="STUDY">Martinon-Torres 2005</LINK>; <LINK REF="STD-Martinon_x002d_Torres-2006" TYPE="STUDY">Martinon-Torres 2006</LINK>; <LINK REF="STD-Mayordomo_x002d_Colunga-2010" TYPE="STUDY">Mayordomo-Colunga 2010</LINK>; <LINK REF="STD-Montaguti-2011" TYPE="STUDY">Montaguti 2011</LINK>; <LINK REF="STD-Tobias-1999" TYPE="STUDY">Tobias 1999</LINK>; <LINK REF="STD-Ulhoa-2000" TYPE="STUDY">Ulhoa 2000</LINK>; <LINK REF="STD-Williams-2004" TYPE="STUDY">Williams 2004</LINK>). We also excluded paediatric publications reporting the effects of heliox therapy for conditions other than bronchiolitis (<LINK REF="STD-Abd_x002d_Allah-2003" TYPE="STUDY">Abd-Allah 2003</LINK>; <LINK REF="STD-Colnaghi-2012" TYPE="STUDY">Colnaghi 2012</LINK>; <LINK REF="STD-Dieperink-2007" TYPE="STUDY">Dieperink 2007</LINK>; <LINK REF="STD-Elleau-1993" TYPE="STUDY">Elleau 1993</LINK>; <LINK REF="STD-Tobias-1997" TYPE="STUDY">Tobias 1997</LINK>; <LINK REF="STD-Winters-2000" TYPE="STUDY">Winters 2000</LINK>). One study was not blinded and had an inadequate method of randomisation (alternate inclusion) (<LINK REF="STD-Martinon_x002d_Torres-2002" TYPE="STUDY">Martinon-Torres 2002</LINK>).</P>
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2015-09-16 09:40:24 +1000" MODIFIED_BY="Liz  Dooley">
<P>Risk of bias in the included studies is summarised in <LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>.</P>
<ALLOCATION MODIFIED="2015-09-15 23:02:23 +1000" MODIFIED_BY="[Empty name]">
<P>Five trials described adequate allocation concealment (<LINK REF="STD-Cambonie-2006" TYPE="STUDY">Cambonie 2006</LINK>; <LINK REF="STD-Chowdhury-2013" TYPE="STUDY">Chowdhury 2013</LINK>; <LINK REF="STD-Hollmann-1998" TYPE="STUDY">Hollmann 1998</LINK>; <LINK REF="STD-Kim-2011" TYPE="STUDY">Kim 2011</LINK>; <LINK REF="STD-Liet-2005" TYPE="STUDY">Liet 2005</LINK>). The method of randomisation was explicitly described and considered to be adequate in four trials (<LINK REF="STD-Chowdhury-2013" TYPE="STUDY">Chowdhury 2013</LINK>; <LINK REF="STD-Hollmann-1998" TYPE="STUDY">Hollmann 1998</LINK>; <LINK REF="STD-Kim-2011" TYPE="STUDY">Kim 2011</LINK>; <LINK REF="STD-Liet-2005" TYPE="STUDY">Liet 2005</LINK>). In <LINK REF="STD-Cambonie-2006" TYPE="STUDY">Cambonie 2006</LINK>, the authors were requested to provide details regarding the method of randomisation and upon review we judged this study adequate. In <LINK REF="STD-Martin_x00f3_n_x002d_Torres-2008" TYPE="STUDY">Martinón-Torres 2008</LINK>, after assessing information provided by the trial authors, we judged the method of randomisation and allocation concealment adequate only for the first infant (coin tossing only for the first infant, then alternate inclusion in the treatment group or control group for the first cross-over study period). We classified this trial as a quasi-RCT and kept it in the review because of its cross-over design and other research methodologies.</P>
</ALLOCATION>
<BLINDING MODIFIED="2015-09-14 20:59:54 +1000" MODIFIED_BY="[Empty name]">
<P>We considered the methods for double-blinding appropriate in five trials where only the respiratory therapists were unmasked to the type of gas because they controlled and monitored the mixing of gases at the blender (<LINK REF="STD-Cambonie-2006" TYPE="STUDY">Cambonie 2006</LINK>; <LINK REF="STD-Chowdhury-2013" TYPE="STUDY">Chowdhury 2013</LINK>; <LINK REF="STD-Hollmann-1998" TYPE="STUDY">Hollmann 1998</LINK>; <LINK REF="STD-Kim-2011" TYPE="STUDY">Kim 2011</LINK>; <LINK REF="STD-Liet-2005" TYPE="STUDY">Liet 2005</LINK>). The labelling of intervention gases as cylinder A and B potentially exposed two trials to assessment bias (<LINK REF="STD-Cambonie-2006" TYPE="STUDY">Cambonie 2006</LINK>; <LINK REF="STD-Chowdhury-2013" TYPE="STUDY">Chowdhury 2013</LINK>).</P>
<P>The two other trials were not blinded (<LINK REF="STD-Kneyber-2009" TYPE="STUDY">Kneyber 2009</LINK>; <LINK REF="STD-Martin_x00f3_n_x002d_Torres-2008" TYPE="STUDY">Martinón-Torres 2008</LINK>). This point is of concern as the main significant retrieved effect of heliox therapy is a respiratory score based on a clinical observation. Nevertheless, we kept these trials because of their cross-over design and because of the sparse data available for this meta-analysis.</P>
</BLINDING>
<EXCLUSIONS MODIFIED="2015-01-28 00:44:15 +1000" MODIFIED_BY="[Empty name]">
<P>We extracted all available data from the seven studies.</P>
</EXCLUSIONS>
<SELECTIVE_REPORTING MODIFIED="2010-02-09 04:52:42 +1000" MODIFIED_BY="Jenny Bellorini">
<P>All outcomes were available in the included studies. We cannot be certain that selective reporting did not occur, but have no reason to suspect this potential bias.</P>
</SELECTIVE_REPORTING>
<OTHER_BIAS_SOURCES MODIFIED="2015-09-16 09:40:24 +1000" MODIFIED_BY="Liz  Dooley">
<OL>
<LI>Diagnosis of bronchiolitis. Three trials included infants quite old (up to one year in <LINK REF="STD-Chowdhury-2013" TYPE="STUDY">Chowdhury 2013</LINK>, and up to two years in <LINK REF="STD-Hollmann-1998" TYPE="STUDY">Hollmann 1998</LINK> and <LINK REF="STD-Martin_x00f3_n_x002d_Torres-2008" TYPE="STUDY">Martinón-Torres 2008</LINK>) whether or not it was their first episode of acute bronchiolitis. Using this criterion, the inclusion of asthmatic infants was possible in these trials.</LI>
<LI>Aetiology of the respiratory distress. Two trials included, respectively, about 20% and 42% infants without established RSV contamination (<LINK REF="STD-Chowdhury-2013" TYPE="STUDY">Chowdhury 2013</LINK>; <LINK REF="STD-Kim-2011" TYPE="STUDY">Kim 2011</LINK>).</LI>
<LI>Age of children. Results from infants less than one month old (often born prematurely) and results from older children were collected together.</LI>
<LI>The flow rate of heliox delivery should always be higher than the inspiratory peak flow rate of the infant to avoid dilution by room air.</LI>
</OL>
<P>The inspiratory peak flow rate can be very high for a brief time and so the inclusion of a large reservoir device is suggested for any investigation using a medical nebuliser driven by heliox, to prevent the dilution of the gas by the room air (<LINK REF="REF-Corcoran-2004" TYPE="REFERENCE">Corcoran 2004</LINK>). To obtain the full potential benefits of heliox in infants breathing spontaneously, heliox should be administered via a system that achieves a gas tight seal, without leakage between the dispenser and the ambient air (<LINK REF="REF-Standley-2008" TYPE="REFERENCE">Standley 2008</LINK>). Thus, different protocols used for delivering heliox (see above) could represent a potential bias. <LINK REF="STD-Liet-2005" TYPE="STUDY">Liet 2005</LINK> used an inflatable head hood with a gas flow rate of 9 to 15 L/min. As there was no collapse of the non-rigid plastic head hood, one can assume there was no room air dilution. This argument is not valid for <LINK REF="STD-Cambonie-2006" TYPE="STUDY">Cambonie 2006</LINK>, as a classic rigid head hood with a gas flow rate of 7 L/min was used. To deliver heliox, a standard high-concentration reservoir mask was used in <LINK REF="STD-Hollmann-1998" TYPE="STUDY">Hollmann 1998</LINK>. However, significant dilution by room air has recently been well documented during heliox administration by this kind of reservoir mask (<LINK REF="REF-Roche_x002d_Campo-2011" TYPE="REFERENCE">Roche-Campo 2011</LINK>; <LINK REF="REF-Standley-2008" TYPE="REFERENCE">Standley 2008</LINK>). Although <LINK REF="STD-Hollmann-1998" TYPE="STUDY">Hollmann 1998</LINK> demonstrated a reduction in the clinical respiratory distress score following heliox inhalation, the benefit was lower compared to the other trials that used the same score to assess respiratory distress (<LINK REF="STD-Cambonie-2006" TYPE="STUDY">Cambonie 2006</LINK>; <LINK REF="STD-Kim-2011" TYPE="STUDY">Kim 2011</LINK>; <LINK REF="STD-Martin_x00f3_n_x002d_Torres-2008" TYPE="STUDY">Martinón-Torres 2008</LINK>). <LINK REF="STD-Martin_x00f3_n_x002d_Torres-2008" TYPE="STUDY">Martinón-Torres 2008</LINK> used a device routinely used in neonatal units for non-invasive ventilation, with specific nasal equipment, called nasal continuous positive airway pressure (nCPAP) with a minimum level of 5 cmH<SUB>2</SUB>O. A room air dilution of helium could theoretically occur if the infant breathes by the mouth. Nevertheless, this device, equipped with a heated humidifier, delivered a flow rate of 10 to 15 L/min, which limited this risk. Moreover, the humidifier included a reservoir system large enough to accommodate the increased tidal volumes that would be expected with heliox inhalation (<LINK REF="REF-Corcoran-2004" TYPE="REFERENCE">Corcoran 2004</LINK>). In <LINK REF="STD-Kim-2011" TYPE="STUDY">Kim 2011</LINK>, participants were randomised to the helium-oxygen or oxygen group and received nebulised racaemic epinephrine via a face mask. Then, humidified helium-oxygen or oxygen was delivered by high-flow nasal cannula (HFNC) at 6 L/min for four hours. In addition to providing heated and humidified gases, the HFNC system provides a degree of continuous positive airway pressure better tolerated by the patient (<LINK REF="REF-McKiernan-2010" TYPE="REFERENCE">McKiernan 2010</LINK>; <LINK REF="REF-Schibler-2011" TYPE="REFERENCE">Schibler 2011</LINK>). The exact level generated depends on the flow delivered relative to the size of the patient and on the leak around the nasal cannula. In <LINK REF="STD-Chowdhury-2013" TYPE="STUDY">Chowdhury 2013</LINK>, children received heliox via by a tight-fitting three-valve, non-rebreathing facemask 10 L/min, or by nasal cannula 3 L/min (for facemask intolerant children), or by nasal CPAP 6 cm H<SUB>2</SUB>O in case of severe respiratory distress.</P>
<P>5. Another concern is the dispatching of the gases in the hood. The lower density of helium relative to oxygen and nitrogen means that helium tends to concentrate at the top of the hood, which potentially increases the density of the mixture inhaled by the infant (<LINK REF="REF-Stillwell-1989" TYPE="REFERENCE">Stillwell 1989</LINK>). However, this concern can be alleviated. Firstly, infants subjected to the hood were in a supine position to allow the respiratory distress evaluation, thus placing the mouth and nose at least in a median position relative to the top and bottom of the hood. Secondly, some clinical studies, like <LINK REF="REF-Weber-2001" TYPE="REFERENCE">Weber 2001</LINK>, show the efficacy of helium-oxygen mixtures administered by hood in patients with upper airways obstruction, suggesting that the activity of a dyspneic infant under the hood probably modifies the distribution of gases in the device. Thirdly, in <LINK REF="STD-Cambonie-2006" TYPE="STUDY">Cambonie 2006</LINK> oxymetry was continuously monitored at the top of the hood and did not show any difference between the prescribed and the measured concentrations of oxygen in the hood (and the density of oxygen and nitrogen are very similar). The continuous flow of the delivered gas with constant renewal, and the spontaneous ventilation of the infants maintain a good mixing of heliox with other gas.</P>
<P>6. Accuracy of the heliox administration in mechanical ventilation. In <LINK REF="STD-Kneyber-2009" TYPE="STUDY">Kneyber 2009</LINK>, heliox was delivered by a ventilator with a time cycled, pressure-limited ventilation mode. The accuracy of volumes delivered and monitored by the ventilator used for heliox administration has been previously studied.</P>
</OTHER_BIAS_SOURCES>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2015-09-15 23:53:35 +1000" MODIFIED_BY="[Empty name]">
<P>Seven randomised controlled trials involving 447 infants with acute bronchiolitis compared heliox inhalation to air or oxygen inhalation. The following clinical outcomes are representative of subgroups of these 447 participants.</P>
<SUBSECTION>
<HEADING LEVEL="3">Primary outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">1. In-hospital mortality</HEADING>
<P>Three trials considered in-hospital mortality (<LINK REF="STD-Cambonie-2006" TYPE="STUDY">Cambonie 2006</LINK>; <LINK REF="STD-Kim-2011" TYPE="STUDY">Kim 2011</LINK>; <LINK REF="STD-Liet-2005" TYPE="STUDY">Liet 2005</LINK>). The authors of <LINK REF="STD-Chowdhury-2013" TYPE="STUDY">Chowdhury 2013</LINK> provided this outcome after a request. We reported all results in <LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>. One child died in the experimental group due to irreversible respiratory failure 34 days after stopping helium treatment (<LINK REF="STD-Liet-2005" TYPE="STUDY">Liet 2005</LINK>). The comparative effect of intervention on late mortality can not be taken in account in the cross-over studies. No effects of helium can be related with mortality: risk ratio (RR) 3.47, 95% confidence interval (CI) 0.15 to 80.35, P value = 0.44, n = 408 (<LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2. Need for mechanical ventilation (invasive or not)</HEADING>
<P>Four trials used the need for mechanical ventilation, invasive or not (<LINK REF="STD-Cambonie-2006" TYPE="STUDY">Cambonie 2006</LINK>; <LINK REF="STD-Chowdhury-2013" TYPE="STUDY">Chowdhury 2013</LINK>; <LINK REF="STD-Kim-2011" TYPE="STUDY">Kim 2011</LINK>; <LINK REF="STD-Liet-2005" TYPE="STUDY">Liet 2005</LINK>). We reported this outcome measure in <LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK>. The pooled results failed to demonstrate a reduction in the need for mechanical ventilation with heliox: RR 0.95 (95% CI 0.61 to 1.49, P value = 0.83, n = 408) (<LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK>; <LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">3. Rate of endotracheal intubation</HEADING>
<P>Three trials used the rate of intubation as an outcome measure (<LINK REF="STD-Cambonie-2006" TYPE="STUDY">Cambonie 2006</LINK>; <LINK REF="STD-Kim-2011" TYPE="STUDY">Kim 2011</LINK>; <LINK REF="STD-Liet-2005" TYPE="STUDY">Liet 2005</LINK>). <A HREF="https://archie.cochrane.org/sections/documents/viewDiff?documentPK=E5424DE882E26AA2017127F4A6D52463&amp;versionPK1=z1507291925365954410867653059297&amp;versionPK2=z1507310255102724364505259458782#STD-Chowdhury-2013">Chowdhury 2013</A> provided this data after a request. We reported this outcome measure in <LINK REF="TBL-03" TYPE="TABLE">Table 3</LINK>. The pooled results failed to demonstrate a reduction in the rate of intubation with heliox use: RR 2.73 (95% CI 0.96 to 7.75, P value = 0.06, n = 408) (<LINK REF="CMP-001.03" TYPE="ANALYSIS">Analysis 1.3</LINK>; <LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK>). The risk of being intubated is even greater in the experimental (heliox) group. When considering the causes of intubation in <LINK REF="STD-Chowdhury-2013" TYPE="STUDY">Chowdhury 2013</LINK>, in which this ratio is the highest (6/140 infants intubated in the heliox group versus 0/141 in the control group), the cause of intubation does not seem to be related to treatment with heliox as they were technical problems (3/6) and undetected cardiopathy (1/6). The two other infants were intubated for apnoea. No significant trend was found when looking only at intubation for apnoea .</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">4. Rate of emergency department discharge</HEADING>
<P>
<LINK REF="STD-Kim-2011" TYPE="STUDY">Kim 2011</LINK> was conducted in the emergency department and considered the emergency department discharge (<LINK REF="TBL-04" TYPE="TABLE">Table 4</LINK>). No significant increase in the rate of emergency department discharge was observed between the two groups: RR 0.51, 95% CI 0.17 to 1.55, P value = 0.24, n = 69 (<LINK REF="CMP-001.04" TYPE="ANALYSIS">Analysis 1.4</LINK>; <LINK REF="FIG-04" TYPE="FIGURE">Figure 4</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">5. Length of treatment for respiratory distress</HEADING>
<P>
<LINK REF="STD-Chowdhury-2013" TYPE="STUDY">Chowdhury 2013</LINK> and <LINK REF="STD-Liet-2005" TYPE="STUDY">Liet 2005</LINK> used the length of treatment for respiratory distress as an outcome measure (<LINK REF="TBL-05" TYPE="TABLE">Table 5</LINK>). No significant reduction in the length of treatment was observed when heliox therapy was used: mean difference (MD) -0.19 days, 95% CI -0.56 to 0.19, P value = 0.33, n = 320 (<LINK REF="CMP-001.05" TYPE="ANALYSIS">Analysis 1.5</LINK>; <LINK REF="FIG-05" TYPE="FIGURE">Figure 5</LINK>). <LINK REF="STD-Chowdhury-2013" TYPE="STUDY">Chowdhury 2013</LINK> addressed a subgroup of infants with a respiratory distress severe enough to warrant nasal continuous positive airway pressure (nCPAP) right from the start. In this subgroup, a significant reduction was observed with heliox: MD -0.76 days, 95% CI -1.45 to -0.08; P value = 0.03, n = 21 (Analysis 1.5.2; <LINK REF="FIG-05" TYPE="FIGURE">Figure 5</LINK>). This subgroup analysis was pre-specified but not taken in account for the sample size calculation.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">6. Length of paediatric intensive care unit (PICU) stay</HEADING>
<P>
<LINK REF="STD-Cambonie-2006" TYPE="STUDY">Cambonie 2006</LINK> and <LINK REF="STD-Liet-2005" TYPE="STUDY">Liet 2005</LINK> used PICU length of stay as an outcome measure (<LINK REF="TBL-06" TYPE="TABLE">Table 6</LINK>). These trials failed to demonstrate a reduction in the length of PICU stay with heliox use: MD 0.09 days, 95% CI -1.54 to 1.71, P value = 0.92, n = 58) (<LINK REF="CMP-001.06" TYPE="ANALYSIS">Analysis 1.6</LINK>). In <LINK REF="STD-Liet-2005" TYPE="STUDY">Liet 2005</LINK>, a child included in the heliox group had contracted both respiratory syncytial virus (RSV) and adenoviral respiratory tract infection. He died 38 days after the beginning of mechanical ventilation due to irreversible respiratory failure. The weight of the results of this trial was 10.6% for this outcome and it does not result in a significant difference.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">7. Adverse effects</HEADING>
<P>No adverse effects were reported relating to heliox inhalation in any of the included or excluded trials.</P>
<P>In <LINK REF="STD-Liet-2005" TYPE="STUDY">Liet 2005</LINK>, one child included in the heliox group contracted both RSV and adenoviral respiratory tract infection, and died 38 days after the beginning of mechanical ventilation due to irreversible respiratory failure. Helium therapy was discontinued four days after randomisation.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Secondary outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">1. Gas exchange (effects on oxygenation and CO<SUB>2</SUB> elimination) within the first 24 hours after starting heliox treatment</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Change in O<SUB>2</SUB> needs after one hour of heliox treatment</HEADING>
<P>
<LINK REF="STD-Cambonie-2006" TYPE="STUDY">Cambonie 2006</LINK> used change in O<SUB>2</SUB> needs after one hour of heliox treatment as an outcome measure (<LINK REF="TBL-07" TYPE="TABLE">Table 7</LINK>). This trial failed to demonstrate a reduction in change in O<SUB>2</SUB> needs after one hour of heliox treatment: MD 2.06%, 95% CI -2.86 to 6.98, P value = 0.41, n = 19 (<LINK REF="CMP-001.07" TYPE="ANALYSIS">Analysis 1.7</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Change in SpO<SUB>2</SUB> within the first hour after starting heliox treatment</HEADING>
<P>
<LINK REF="STD-Martin_x00f3_n_x002d_Torres-2008" TYPE="STUDY">Martinón-Torres 2008</LINK> used change in oxygen saturation on pulse oximetry (SpO<SUB>2</SUB>) within the first hour after starting heliox treatment as an outcome measure (<LINK REF="TBL-08" TYPE="TABLE">Table 8</LINK>). This trial failed to demonstrate a reduction in change in SpO<SUB>2</SUB> in the first hour after starting heliox treatment: MD 1.10%, 95% CI -1.90 to 4.10, P value = 0.47, n = 24 (<LINK REF="CMP-001.08" TYPE="ANALYSIS">Analysis 1.8</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Change in CO<SUB>2</SUB> within the first hour after starting heliox treatment</HEADING>
<P>
<LINK REF="STD-Cambonie-2006" TYPE="STUDY">Cambonie 2006</LINK> and <LINK REF="STD-Martin_x00f3_n_x002d_Torres-2008" TYPE="STUDY">Martinón-Torres 2008</LINK> used change in CO<SUB>2</SUB> within the first hour after starting treatment as an outcome measure (<LINK REF="TBL-09" TYPE="TABLE">Table 9</LINK>). These studies failed to demonstrate a reduction in change in CO<SUB>2</SUB> within the first hour after starting heliox treatment: MD -2.09 mmHg, 95% CI -6.20 to 2.02, P value = 0.32, n = 43 (<LINK REF="CMP-001.09" TYPE="ANALYSIS">Analysis 1.9</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2. Respiratory mechanics (effects on pulmonary compliance and resistance of airways) within the first 24 hours after starting heliox treatment</HEADING>
<P>
<LINK REF="STD-Kneyber-2009" TYPE="STUDY">Kneyber 2009</LINK> studied the effects of heliox on pulmonary compliance and resistance of airways in 13 infants mechanically ventilated for acute bronchiolitis. Mechanical ventilation with heliox had an overall significant effect on respiratory system resistance. Respiratory system resistance decreased from 69.1 ± 6.9 cmH<SUB>2</SUB>O/L/sec to 50.2 ± 6.0 cmH<SUB>2</SUB>O/L/sec (P value = 0.02) after 30 minutes of ventilation with heliox.<BR/>Peak expiratory flow rate (PEFR) was not significantly improved with heliox compared with nitrox (P value = 0.52). Static compliance was 1.9 ± 0.4 L/ cmH<SUB>2</SUB>O at T = 0 and not significantly different throughout the study (P value = 0.21).<BR/>
</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">3. Clinical respiratory scores within the first 24 hours after starting heliox treatment</HEADING>
<P>
<LINK REF="STD-Cambonie-2006" TYPE="STUDY">Cambonie 2006</LINK>, <LINK REF="STD-Hollmann-1998" TYPE="STUDY">Hollmann 1998</LINK>, <LINK REF="STD-Kim-2011" TYPE="STUDY">Kim 2011</LINK>, and <LINK REF="STD-Martin_x00f3_n_x002d_Torres-2008" TYPE="STUDY">Martinón-Torres 2008</LINK> used as a clinical respiratory score the modified Wood Clinical Asthma Score (m-WCAS). All data are reported in <LINK REF="TBL-10" TYPE="TABLE">Table 10</LINK>. All four trials, with a total of 138 infants, demonstrated a benefit of heliox inhalation in reducing clinical respiratory scores. The pooled results demonstrate that infants treated with heliox inhalation had a statistically significant reduction in clinical respiratory scores: MD -1.04, 95% CI -1.60 to -0.48, P value = 0.0003, n = 138 (<LINK REF="CMP-001.10" TYPE="ANALYSIS">Analysis 1.10</LINK>; <LINK REF="FIG-06" TYPE="FIGURE">Figure 6</LINK>). If only trials where room air dilution of heliox is less probable are included, the pooled data show a statistically significant reduction in m-WCAS: MD -1.29, 95% CI -1.92 to -0.66, P value &lt; 0.0001, n = 112 (<LINK REF="STD-Cambonie-2006" TYPE="STUDY">Cambonie 2006</LINK>; <LINK REF="STD-Kim-2011" TYPE="STUDY">Kim 2011</LINK>; <LINK REF="STD-Martin_x00f3_n_x002d_Torres-2008" TYPE="STUDY">Martinón-Torres 2008</LINK>).</P>
<P>In <LINK REF="STD-Chowdhury-2013" TYPE="STUDY">Chowdhury 2013</LINK>, heliox reduced the clinical score for respiratory distress across all time points and was statistically significant at eight hours onwards: MD -0.13, 95% CI -0.20 to -0.06, P value &lt; 0.001.</P>
<P>The respiratory distress assessment instrument (RDAI) within the first hour after starting heliox treatment is available only in <LINK REF="STD-Kim-2011" TYPE="STUDY">Kim 2011</LINK>, with a statistically significant reduction: MD -2.28, 95% CI -3.44 to -1.12, P value = 0.0001, n = 69 (<LINK REF="CMP-001.10" TYPE="ANALYSIS">Analysis 1.10</LINK>; <LINK REF="FIG-06" TYPE="FIGURE">Figure 6</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">4. Total duration of hospitalisation (including duration in PICU)</HEADING>
<P>No available data.</P>
</SUBSECTION>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2015-09-15 23:55:51 +1000" MODIFIED_BY="[Empty name]">
<SUMMARY_OF_RESULTS MODIFIED="2015-09-14 20:59:54 +1000" MODIFIED_BY="[Empty name]">
<P>In this review we retrieved seven trials, which objectively assessed the effect of the addition of heliox to standard medical care on the course of acute bronchiolitis in 447 infants.</P>
<P>We examined six primary outcomes. For five of them (in-hospital mortality, need for mechanical ventilation (invasive or not), rate of endotracheal intubation, rate of emergency department discharge and length of paediatric intensive care stay), the pooled results failed to demonstrate a reduction in these outcomes. Length of treatment for respiratory distress was assessed in two trials (n = 320) and was not reduced by heliox therapy. However, in a subgroup of infants who were started on nasal continuous positive airway pressure (nCPAP) right from the start because of severe respiratory distress (n = 21; <LINK REF="STD-Chowdhury-2013" TYPE="STUDY">Chowdhury 2013</LINK>), a significant reduction of length of treatment was observed when adding a heliox therapy treatment (-0.76 days lower; P value = 0.03).<BR/>
<BR/>Secondary outcomes incorporated gas exchange effects and variation in clinical respiratory scores. Five trials used changes in the modified Wood Clinical Asthma Scores as outcomes (<LINK REF="STD-Cambonie-2006" TYPE="STUDY">Cambonie 2006</LINK>; <LINK REF="STD-Chowdhury-2013" TYPE="STUDY">Chowdhury 2013</LINK>; <LINK REF="STD-Hollmann-1998" TYPE="STUDY">Hollmann 1998</LINK>; <LINK REF="STD-Kim-2011" TYPE="STUDY">Kim 2011</LINK>; <LINK REF="STD-Martin_x00f3_n_x002d_Torres-2008" TYPE="STUDY">Martinón-Torres 2008</LINK>). This score, initially described by <LINK REF="REF-Wood-1972" TYPE="REFERENCE">Wood 1972</LINK>, grades cyanosis, inspiratory breath sounds, accessory muscles used, expiratory wheezing and cerebral function from zero to two, with increased severity receiving a higher score. All trials demonstrated a benefit of heliox inhalation in reducing clinical respiratory scores. The pooled results show that after one hour, infants treated with heliox inhalation had a statistically significant reduction in clinical respiratory scores: mean difference (MD) -1.04, 95% confidence interval (CI) -1.60 to -0.48, P value = 0.0003, n = 138. This benefit of heliox inhalation on clinical scores in the first hour after starting heliox treatment was not accompanied by an improvement in gas exchange: no reduction in CO<SUB>2</SUB>, needs in oxygen, or SpO<SUB>2</SUB>. The method of delivering heliox might alter the validity and the relevance of these results. Seven different protocols for delivering heliox were used. When removing the trial that used a standard non-rebreather reservoir mask, a method of delivery where there is a proven room air dilution (<LINK REF="REF-Roche_x002d_Campo-2011" TYPE="REFERENCE">Roche-Campo 2011</LINK>; <LINK REF="REF-Standley-2008" TYPE="REFERENCE">Standley 2008</LINK>), the benefit of heliox administration is observed in the clinical score only during the first hour after starting heliox therapy. Nevertheless, all these trials provide consistent results. <LINK REF="STD-Chowdhury-2013" TYPE="STUDY">Chowdhury 2013</LINK> showed that heliox is effective if delivered via a tight-fitting non-rebreathing face mask or nCPAP, but not via a nasal cannula at 3 L/minute because of insufficient flow rate.</P>
<P>
<LINK REF="STD-Kneyber-2009" TYPE="STUDY">Kneyber 2009</LINK> assessed the effect of the addition of heliox in 13 mechanically ventilated, sedated and paralysed infants. Mechanical ventilation significantly decreased respiratory system resistance. This was not accompanied by an improved CO<SUB>2</SUB> elimination, or a reduced air-trapping.</P>
<P>The available data suggest that heliox inhalation could be useful in addition to standard medical care in the management of acute bronchiolitis. Of note, this benefit is observed on clinical score only during the first hour after starting heliox therapy, and is not confirmed by gas exchange effects. No benefits were observed in terms of need for mechanical ventilation, rate of intubation or in the length of stay in the paediatric intensive care unit (PICU). The significant reduction of length of treatment observed when adding a heliox therapy treatment in a subgroup of infants directly treated by nCPAP because of severe respiratory distress is promising. It suggests that heliox therapy could be useful especially for the most severely affected children.</P>
</SUMMARY_OF_RESULTS>
<APPLICABILITY_OF_FINDINGS MODIFIED="2015-09-14 20:59:54 +1000" MODIFIED_BY="[Empty name]">
<P>
<LINK REF="STD-Martin_x00f3_n_x002d_Torres-2008" TYPE="STUDY">Martinón-Torres 2008</LINK> was considered a quasi-RCT (where there is alternate allocation to treatment and control groups) but we kept it in the review because of its cross-over design with brief periods. Data from this trial affect the results of the effects of heliox inhalation on clinical respiratory scores in the first hour after starting heliox treatment but the data provided were similar to those of the three other integrated trials with a comparable weight (25.8%).</P>
</APPLICABILITY_OF_FINDINGS>
<QUALITY_OF_EVIDENCE MODIFIED="2015-09-15 23:53:35 +1000" MODIFIED_BY="[Empty name]">
<P>The only outcome for which a benefit of heliox therapy in bronchiolitis was demonstrated (change in clinical respiratory scores within the first hour after starting heliox treatment) was found to have statistical heterogeneity (<LINK REF="FIG-06" TYPE="FIGURE">Figure 6</LINK>). This statistical heterogeneity remained even after removing the study that used a standard high-concentration reservoir mask.</P>
<P>Several factors may explain this heterogeneity, including the limited number of participants in each trial and wide differences in baseline severity of disease between studies, with m-WCAS in infants treated with heliox ranging from 3 in <LINK REF="STD-Chowdhury-2013" TYPE="STUDY">Chowdhury 2013</LINK> to 6.7 in <LINK REF="STD-Martin_x00f3_n_x002d_Torres-2008" TYPE="STUDY">Martinón-Torres 2008</LINK>. Different versions of m-WCAS were used: <LINK REF="STD-Hollmann-1998" TYPE="STUDY">Hollmann 1998</LINK> included a 'mild' category of 0.5 points for accessory muscle use and expiratory wheezing to better define the clinical response to heliox inhalation. This modification provided four scores for each of these two variables, i.e. 0 for none, 0.5 for mild, 1 for moderate and 2 for maximum. <LINK REF="STD-Cambonie-2006" TYPE="STUDY">Cambonie 2006</LINK> used a visual analogue scale to standardise the scoring of these two score variables. <LINK REF="STD-Martin_x00f3_n_x002d_Torres-2008" TYPE="STUDY">Martinón-Torres 2008</LINK> slightly modified this scoring and also adopted a 'mild' category of 0.5 points for cyanosis, inspiratory breath sounds and cerebral function. <LINK REF="STD-Kim-2011" TYPE="STUDY">Kim 2011</LINK> standardised auscultatory examination on four positions on the chest and used a recordable stethoscope and a video camcorder to assess later the score on videotape with a masked scorer. <LINK REF="STD-Chowdhury-2013" TYPE="STUDY">Chowdhury 2013</LINK> defined a maximum value for m-WCAS of 11, instead of 10 in the others studies, by the introduction of a supplementary variable to grade cyanosis. Finally, only two studies reported inter-observer agreement regarding the use of this score (<LINK REF="STD-Cambonie-2006" TYPE="STUDY">Cambonie 2006</LINK>; <LINK REF="STD-Kim-2011" TYPE="STUDY">Kim 2011</LINK>).</P>
</QUALITY_OF_EVIDENCE>
<POTENTIAL_BIASES MODIFIED="2015-09-15 23:55:51 +1000" MODIFIED_BY="[Empty name]">
<P>The funnel plots performed are symmetric on the median line (<LINK REF="FIG-07" TYPE="FIGURE">Figure 7</LINK>; <LINK REF="FIG-08" TYPE="FIGURE">Figure 8</LINK>). Nevertheless, only few studies were included in this review.</P>
</POTENTIAL_BIASES>
<AGREEMENT MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]">
<P>We found no disagreements between the few included studies.</P>
</AGREEMENT>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]">
<IMPLICATIONS_PRACTICE MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]">
<P>Heliox inhalation produces a significant reduction in the clinical respiratory score in unintubated infants with respiratory distress due to acute bronchiolitis. Nevertheless, this therapy does not reduce the need for mechanical ventilation, intubation or the length of stay in the paediatric intensive care unit (PICU). Given its good safety profile, heliox therapy could be used in addition to standard medical care to treat infants who are hospitalised in PICUs for acute bronchiolitis.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]">
<P>Large randomised controlled trials, preferably multi-centred, are required to evaluate the effectiveness of heliox inhalation in infants with acute bronchiolitis. Only infants less than 12 months old with severe respiratory distress should be included. Inclusion criteria must also include a clinical severity score that reflects severe respiratory distress (for example, a modified Wood Clinical Asthma Score (m-WCAS) of more than 3/10) to avoid the inclusion of children with mild bronchiolitis who may not benefit from heliox inhalation.</P>
<P>An additional consideration would be the potential benefit of heliox therapy in association with nasal continuous positive airway pressure (nCPAP) or high-flow nasal cannula (HFNC), to reduce the length of treatment for respiratory distress. In a small subgroup of infants with respiratory distress severe enough to warrant CPAP from the start, <LINK REF="STD-Chowdhury-2013" TYPE="STUDY">Chowdhury 2013</LINK> suggested a relevant reduction in length of treatment with heliox. To be adequately blinded such studies would have to compare the use of nCPAP with heliox and nCPAP with air/oxygen, bearing in mind that the different sound made by a CPAP device using helium may alert the investigators to the study intervention. HFNC could be a good alternative.<BR/>
</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2015-07-31 11:11:08 +1000" MODIFIED_BY="Liz Dooley">
<P>The review authors thank the following referees for reviewing the 2015 meta-analysis: Jennifer LaRosa, Robert Ware, Federico Martinon-Torres and Allen Cheng. We also thank the referees who commented on the draft review: Anne Lyddiatt, Sree Nair and Allen Cheng. They raised important points and we think that they helped us to improve the review and to clarify its content.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST MODIFIED="2015-09-14 19:21:13 +1000" MODIFIED_BY="[Empty name]">
<P>Jean-Michel Liet: I was investigator in one trial, supported by Air Liquide Santé International. Air Liquide provided the heliox and air tanks, set up the study equipment and was involved in the study design. Air Liquide Santé had no role in data management, data analysis or data interpretation, or writing of the report and decision to submit it for publication. I had no financial relationship with Air Liquide Santé. Currently I am a local investigator in a multicentre observational study promoted by Air Liquide Healthcare. My institution receives money when a child is included.</P>
<P>Gilles Cambonie et al performed a study with heliox referenced as Cambonie G, Milési C, Fournier-Favre S, Counil F, Jaber S, Picaud J-C, Matecki S. Clinical effects of heliox administration for acute bronchiolitis in young infants. Chest 2006; 129: 676-82. As indicated in the published article, for this study Air Liquide Santé provided the heliox and air tanks, set up the study equipment, and was involved in the study design; it had no role in data management, data analysis or data interpretation, or in the writing of the report and the decision to submit it for publication. The review author has no financial relationship with Air Liquide Santé.<BR/>
<BR/>Thierry Ducruet: none known.</P>
<P>Vineet Gupta: none known.</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]">
<P>Dr. Jean-Michel Liet (JML) had primary responsibility for protocol development and wrote the draft protocol and review. Dr. Gilles Cambonie (GC) participated in the development of the protocol and was responsible for study selection, quality assessment and data collection. Dr. Vineet Gupta (VG) contacted trial authors of all studies to locate other unpublished or in progress studies, and provided input for writing the protocol and review. Dr. Thierry Ducruet (TD) read the protocol and the review, and checked the statistical aspects. The final version of the review was approved by all review authors.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]">
<P>Not only first episodes of acute bronchiolitis were included. Not all infants were under 12 months of age.</P>
<P>This review was first published in 2010 (<LINK REF="REF-Liet-2010" TYPE="REFERENCE">Liet 2010</LINK>). Two new trials were included in this 2015 update (<LINK REF="STD-Chowdhury-2013" TYPE="STUDY">Chowdhury 2013</LINK>; <LINK REF="STD-Kim-2011" TYPE="STUDY">Kim 2011</LINK>). We modified the outcomes to include more results and to clarify others. Primary outcomes: (2) For purposes of clarity, the outcome 'Need for mechanical ventilation' became 'Need for mechanical ventilation (invasive or not)'. (4) The outcome 'Admission rate' was never investigated, in contrast to the 'Rate of emergency discharge', which replaced it advantageously. (5) 'Length of treatment for respiratory distress' replaced 'Duration of mechanical ventilation'. This new primary outcome is a more relevant outcome to the extent that very few children received mechanical ventilation.</P>
</PRO_REV_DIFF>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2015-09-15 23:38:22 +1000" MODIFIED_BY="[Empty name]">
<STUDIES MODIFIED="2015-09-15 23:38:22 +1000" MODIFIED_BY="[Empty name]">
<INCLUDED_STUDIES MODIFIED="2015-09-14 20:59:54 +1000" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Cambonie-2006" MODIFIED="2009-06-18 08:31:54 +1000" MODIFIED_BY="[Empty name]" NAME="Cambonie 2006" YEAR="2006">
<REFERENCE MODIFIED="2009-06-18 08:31:54 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cambonie G, Milési C, Fournier-Favre S, Counil F, Jaber S, Picaud JC, et al</AU>
<TI>Clinical effects of heliox administration for acute bronchiolitis in young infants</TI>
<SO>Chest</SO>
<YR>2006</YR>
<VL>129</VL>
<NO>3</NO>
<PG>676-82</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chowdhury-2013" MODIFIED="2015-03-06 00:03:25 +1000" MODIFIED_BY="[Empty name]" NAME="Chowdhury 2013" YEAR="2013">
<REFERENCE MODIFIED="2015-03-06 00:03:25 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chowdhury MM, McKenzie SA, Pearson CC, Carr S, Pao C, Shah AR, et al</AU>
<TI>Heliox therapy in bronchiolitis: phase III multicenter double-blind randomized controlled trial</TI>
<SO>Pediatrics</SO>
<YR>2013</YR>
<VL>131</VL>
<NO>4</NO>
<PG>661-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hollmann-1998" MODIFIED="2015-09-14 20:59:41 +1000" MODIFIED_BY="[Empty name]" NAME="Hollmann 1998" YEAR="1998">
<REFERENCE MODIFIED="2010-02-09 05:18:59 +1000" MODIFIED_BY="Jenny Bellorini" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hollman G, Shen G, Zeng L, Yngsdal-Krenz R, Perloff W, Zimmerman J, et al</AU>
<TI>Helium-oxygen improves clinical asthma scores in children with acute bronchiolitis</TI>
<SO>Critical Care Medicine</SO>
<YR>1998</YR>
<VL>26</VL>
<NO>10</NO>
<PG>1731-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kim-2011" MODIFIED="2015-07-30 04:20:50 +1000" MODIFIED_BY="[Empty name]" NAME="Kim 2011" YEAR="2011">
<REFERENCE MODIFIED="2015-07-30 04:20:50 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kim IK, Phrampus E, Sikes K, Pendleton J, Saville A, Corcoran T, et al</AU>
<TI>Helium-oxygen therapy for infants with bronchiolitis: a randomized controlled trial</TI>
<SO>Archives of Pediatrics and Adolescent Medicine</SO>
<YR>2011</YR>
<VL>165</VL>
<NO>12</NO>
<PG>1115-22</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kneyber-2009" MODIFIED="2009-07-08 11:37:01 +1000" MODIFIED_BY="[Empty name]" NAME="Kneyber 2009" YEAR="2009">
<REFERENCE MODIFIED="2009-07-08 11:37:01 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kneyber MC, van Heerde M, Twisk JW, Plötz FB, Markhors DG</AU>
<TI>Heliox reduces respiratory system resistance in respiratory syncytial virus induced respiratory failure</TI>
<SO>Critical Care</SO>
<YR>2009</YR>
<VL>13</VL>
<NO>3</NO>
<PG>R71</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Liet-2005" MODIFIED="2009-07-08 11:37:17 +1000" MODIFIED_BY="[Empty name]" NAME="Liet 2005" YEAR="2005">
<REFERENCE MODIFIED="2009-07-08 11:37:17 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Liet JM, Millotte B, Tucci M, Laflammme S, Hutchison J, Creery D, et al</AU>
<TI>Noninvasive therapy with helium-oxygen for severe bronchiolitis</TI>
<SO>Journal of Pediatrics</SO>
<YR>2005</YR>
<VL>147</VL>
<NO>6</NO>
<PG>812-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Martin_x00f3_n_x002d_Torres-2008" MODIFIED="2015-09-14 20:59:54 +1000" MODIFIED_BY="[Empty name]" NAME="Martinón-Torres 2008" YEAR="2008">
<REFERENCE MODIFIED="2009-06-18 08:33:53 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Martinón-Torres F, Rodríguez-Núñez A, Martinón-Sánchez JM</AU>
<TI>Nasal continuous positive airway pressure with heliox versus air oxygen in infants with acute bronchiolitis: a crossover study</TI>
<SO>Pediatrics</SO>
<YR>2008</YR>
<VL>121</VL>
<NO>5</NO>
<PG>e1190-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Abd_x002d_Allah-2003" MODIFIED="2009-06-19 01:14:20 +1000" MODIFIED_BY="[Empty name]" NAME="Abd-Allah 2003" YEAR="2003">
<REFERENCE MODIFIED="2009-06-19 01:14:20 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Abd-Allah SA, Rogers MS, Terry M, Gross M, Perkin RM</AU>
<TI>Helium-oxygen therapy for pediatric acute severe asthma requiring mechanical ventilation</TI>
<SO>Pediatric Critical Care Medicine</SO>
<YR>2003</YR>
<VL>4</VL>
<NO>3</NO>
<PG>353-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Colnaghi-2012" MODIFIED="2015-01-28 01:39:15 +1000" MODIFIED_BY="[Empty name]" NAME="Colnaghi 2012" YEAR="2012">
<REFERENCE MODIFIED="2015-01-28 01:39:12 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Colnaghi M, Pierro M, Migliori C, Ciralli F, Matassa PG, Vendettuoli V, et al</AU>
<TI>Nasal continuous positive airway pressure with heliox in preterm infants with respiratory distress syndrome</TI>
<SO>Pediatrics</SO>
<YR>2012</YR>
<VL>129</VL>
<NO>2</NO>
<PG>e333-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dieperink-2007" MODIFIED="2009-07-08 11:37:39 +1000" MODIFIED_BY="[Empty name]" NAME="Dieperink 2007" YEAR="2007">
<REFERENCE MODIFIED="2009-07-08 11:37:39 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dieperink W, Knol JA, Boersma HJ, Eindhoven GB, Aarts LP, Goorhuis JF, et al</AU>
<TI>Combination of heliox and CPAP without a ventilator: bench test and clinical observations</TI>
<SO>European Journal of Anaesthesiology</SO>
<YR>2007</YR>
<VL>24</VL>
<NO>10</NO>
<PG>889-91</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Duncan-1979" MODIFIED="2010-02-09 05:19:12 +1000" MODIFIED_BY="Jenny Bellorini" NAME="Duncan 1979" YEAR="1979">
<REFERENCE MODIFIED="2010-02-09 05:19:12 +1000" MODIFIED_BY="Jenny Bellorini" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Duncan PG</AU>
<TI>Efficacy of helium-oxygen mixtures in the management of severe viral and post-intubation croup</TI>
<SO>Canadian Anaesthetists' Society Journal</SO>
<YR>1979</YR>
<VL>26</VL>
<NO>3</NO>
<PG>206-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Elleau-1993" MODIFIED="2009-07-08 11:37:57 +1000" MODIFIED_BY="[Empty name]" NAME="Elleau 1993" YEAR="1993">
<REFERENCE MODIFIED="2009-07-08 11:37:57 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Elleau C, Galperine RI, Guenard H, Demarquez JL</AU>
<TI>Helium-oxygen mixture in respiratory distress syndrome: a double-blind study</TI>
<SO>Journal of Pediatrics</SO>
<YR>1993</YR>
<VL>122</VL>
<NO>1</NO>
<PG>132-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gross-2000" MODIFIED="2009-07-08 11:38:04 +1000" MODIFIED_BY="[Empty name]" NAME="Gross 2000" YEAR="2000">
<REFERENCE MODIFIED="2009-07-08 11:38:04 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gross MF, Spear RM, Peterson BM</AU>
<TI>Helium-oxygen mixture does not improve gas exchange in mechanically ventilated children with bronchiolitis</TI>
<SO>Critical Care</SO>
<YR>2000</YR>
<VL>4</VL>
<NO>3</NO>
<PG>188-92</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Grosz-2001" MODIFIED="2009-06-18 08:34:53 +1000" MODIFIED_BY="[Empty name]" NAME="Grosz 2001" YEAR="2001">
<REFERENCE MODIFIED="2009-06-18 08:34:53 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Grosz AH, Jacobs IN, Cho C, Schears GJ</AU>
<TI>Use of helium-oxygen mixtures to relieve upper airway obstruction in a pediatric population</TI>
<SO>Laryngoscope</SO>
<YR>2001</YR>
<VL>111</VL>
<NO>9</NO>
<PG>1512-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gupta-2004" MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]" NAME="Gupta 2004" YEAR="2004">
<REFERENCE MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gupta VK, Grayck EN, Cheifetz IM</AU>
<TI>Heliox administration during high-frequency jet ventilation augments carbon dioxide clearance</TI>
<SO>Respiratory Care</SO>
<YR>2004</YR>
<VL>49</VL>
<NO>9</NO>
<PG>1038-44</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Iglesias_x002d_Fernandez-2007" MODIFIED="2010-02-09 05:19:21 +1000" MODIFIED_BY="Jenny Bellorini" NAME="Iglesias-Fernandez 2007" YEAR="2007">
<REFERENCE MODIFIED="2010-02-09 05:19:21 +1000" MODIFIED_BY="Jenny Bellorini" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Iglesias Fernández C, López-Herce Cid J, Mencía Bartolomé S, Santiago Lozano MJ, Moral Torrero R, Carrillo Alvarez A</AU>
<TI>Efficacy of heliox therapy in respiratory insufficiency in infants and children</TI>
<TO>Eficacia del tratamiento con heliox en ninos con insuficiencia respiratoria</TO>
<SO>Anales de Pediatría</SO>
<YR>2007</YR>
<VL>66</VL>
<NO>3</NO>
<PG>240-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Isakov-1970" MODIFIED="2010-02-09 05:19:28 +1000" MODIFIED_BY="Jenny Bellorini" NAME="Isakov 1970" YEAR="1970">
<REFERENCE MODIFIED="2010-02-09 05:19:28 +1000" MODIFIED_BY="Jenny Bellorini" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Isakov IuF, Mikhel'son VA, Anokhin MI, Ostrekov IF, Dianov AG</AU>
<TI>Inhalation of helium in the complex treatment of children with respiratory insufficiency</TI>
<SO>Khirurgiia</SO>
<YR>1970</YR>
<VL>46</VL>
<NO>4</NO>
<PG>145-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kneyber-2006" MODIFIED="2009-07-08 11:38:54 +1000" MODIFIED_BY="[Empty name]" NAME="Kneyber 2006" YEAR="2006">
<REFERENCE MODIFIED="2009-07-08 11:38:54 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kneyber MC, van Heerde M, Markhorst DG, Plötz FB</AU>
<TI>Mechanical ventilation with heliox decreases respiratory system resistance and facilitates CO2 removal in obstructive airway disease</TI>
<SO>Intensive Care Medicine</SO>
<YR>2006</YR>
<VL>32</VL>
<NO>10</NO>
<PG>1676-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Martinon_x002d_Torres-2002" MODIFIED="2009-01-02 20:22:03 +1000" MODIFIED_BY="[Empty name]" NAME="Martinon-Torres 2002" YEAR="2002">
<REFERENCE MODIFIED="2009-01-02 20:21:31 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Martinon-Torres F, Rodriguez-Nunez A, Martinon-Sanchez JM</AU>
<TI>Heliox therapy in infants with acute bronchiolitis</TI>
<SO>Pediatrics</SO>
<YR>2002</YR>
<VL>109</VL>
<PG>68-73</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Martinon_x002d_Torres-2005" MODIFIED="2010-02-09 05:19:48 +1000" MODIFIED_BY="Jenny Bellorini" NAME="Martinon-Torres 2005" YEAR="2005">
<REFERENCE MODIFIED="2010-02-09 05:19:48 +1000" MODIFIED_BY="Jenny Bellorini" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Martinón-Torres F, Crespo Suárez PA, Silvia Barbàra C, Castelló Muñoz A, Rodríguez Núñez A, Martinón Sánchez JM</AU>
<TI>Noninvasive ventilation with heliox in an infant with acute respiratory distress syndrome</TI>
<TO>Ventilacion no invasiva con heliox en un lactante con sindrome de dificultad respiratoria aguda</TO>
<SO>Anales de Pediatría</SO>
<YR>2005</YR>
<VL>62</VL>
<NO>1</NO>
<PG>64-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Martinon_x002d_Torres-2006" MODIFIED="2009-07-08 11:39:17 +1000" MODIFIED_BY="[Empty name]" NAME="Martinon-Torres 2006" YEAR="2006">
<REFERENCE MODIFIED="2009-07-08 11:39:17 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Martinón-Torres F, Rodríguez-Núñez A, Martinón-Sánchez JM</AU>
<TI>Nasal continuous positive airway pressure with heliox in infants with acute bronchiolitis</TI>
<SO>Respiratory Medicine</SO>
<YR>2006</YR>
<VL>100</VL>
<NO>8</NO>
<PG>1458-62</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mayordomo_x002d_Colunga-2010" MODIFIED="2015-07-30 04:22:25 +1000" MODIFIED_BY="[Empty name]" NAME="Mayordomo-Colunga 2010" YEAR="2010">
<REFERENCE MODIFIED="2015-07-30 04:22:25 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mayordomo-Colunga J, Medina A, Rey C, Concha A, Los Arcos M, Menéndez S</AU>
<TI>Helmet-delivered continuous positive airway pressure with heliox in respiratory syncytial virus bronchiolitis</TI>
<SO>Acta Paediatrica</SO>
<YR>2010</YR>
<VL>99</VL>
<NO>2</NO>
<PG>308-11</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Montaguti-2011" MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]" NAME="Montaguti 2011" YEAR="2011">
<REFERENCE MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Montaguti A, Frontalini S, Carleo A, Deha A, Franceschi A, Lampugnani E, et al</AU>
<TI>Noninvasive ventilation for acute respiratory failure</TI>
<SO>Pediatric Critical Care Medicine</SO>
<YR>2011</YR>
<VL>12</VL>
<NO>Suppl 3</NO>
<PG>A83</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Paret-1996" MODIFIED="2009-07-08 11:40:20 +1000" MODIFIED_BY="[Empty name]" NAME="Paret 1996" YEAR="1996">
<REFERENCE MODIFIED="2009-07-08 11:40:20 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Paret G, Dekel B, Vardi A, Szeinberg A, Lotan D, Barzilay Z</AU>
<TI>Heliox in respiratory failure secondary to bronchiolitis: a new therapy</TI>
<SO>Pediatric Pulmonology</SO>
<YR>1996</YR>
<VL>22</VL>
<NO>5</NO>
<PG>322-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tobias-1997" MODIFIED="2009-07-08 11:40:31 +1000" MODIFIED_BY="[Empty name]" NAME="Tobias 1997" YEAR="1997">
<REFERENCE MODIFIED="2009-07-08 11:40:31 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tobias JD</AU>
<TI>Heliox in children with airway obstruction</TI>
<SO>Pediatric Emergency Care</SO>
<YR>1997</YR>
<VL>13</VL>
<NO>1</NO>
<PG>29-32</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tobias-1999" MODIFIED="2009-07-08 11:40:37 +1000" MODIFIED_BY="[Empty name]" NAME="Tobias 1999" YEAR="1999">
<REFERENCE MODIFIED="2009-07-08 11:40:37 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tobias JD, Grueber RE</AU>
<TI>High-frequency jet ventilation using a helium-oxygen mixture</TI>
<SO>Paediatric Anaesthesia</SO>
<YR>1999</YR>
<VL>9</VL>
<NO>5</NO>
<PG>451-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ulhoa-2000" MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]" NAME="Ulhoa 2000" YEAR="2000">
<REFERENCE MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ulhôa CA, Larner L</AU>
<TI>Helium-oxigen (Heliox) mixture in airway obstruction</TI>
<SO>Jornal de Pediatria</SO>
<YR>2000</YR>
<VL>76</VL>
<NO>1</NO>
<PG>73-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Williams-2004" MODIFIED="2009-07-08 11:40:54 +1000" MODIFIED_BY="[Empty name]" NAME="Williams 2004" YEAR="2004">
<REFERENCE MODIFIED="2009-07-08 11:40:54 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Williams J, Stewart K, Tobias JD, Berkenbosch JW</AU>
<TI>Therapeutic benefits of helium-oxygen delivery to infants via nasal cannula</TI>
<SO>Pediatric Emergency Care</SO>
<YR>2004</YR>
<VL>20</VL>
<NO>9</NO>
<PG>574-78</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Winters-2000" MODIFIED="2009-07-08 11:41:05 +1000" MODIFIED_BY="[Empty name]" NAME="Winters 2000" YEAR="2000">
<REFERENCE MODIFIED="2009-07-08 11:41:05 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Winters JW, Willing MA, Sanfilippo D</AU>
<TI>Heliox improves ventilation during high-frequency oscillatory ventilation in pediatric patients</TI>
<SO>Pediatric Critical Care Medicine</SO>
<YR>2000</YR>
<VL>1</VL>
<NO>1</NO>
<PG>33-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES MODIFIED="2009-06-17 19:15:23 +1000" MODIFIED_BY="[Empty name]"/>
<ONGOING_STUDIES MODIFIED="2015-09-15 23:38:22 +1000" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="UNPUB" ID="STD-Rotta-2015" MODIFIED="2015-09-15 23:38:22 +1000" MODIFIED_BY="[Empty name]" NAME="Rotta 2015" YEAR="2015">
<IDENTIFIERS MODIFIED="2015-09-15 23:38:22 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2015-09-15 23:38:22 +1000" MODIFIED_BY="[Empty name]" TYPE="CTG" VALUE="NCT02373683"/>
</IDENTIFIERS>
</STUDY>
</ONGOING_STUDIES>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2015-09-15 14:50:18 +1000" MODIFIED_BY="Liz  Dooley">
<ADDITIONAL_REFERENCES MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-AAP-2006" NAME="AAP 2006" TYPE="JOURNAL_ARTICLE">
<AU>American Academy of Pediatrics</AU>
<TI>Diagnosis and management of bronchiolitis</TI>
<SO>Pediatrics</SO>
<YR>2006</YR>
<VL>118</VL>
<NO>4</NO>
<PG>1774-93</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="17015575"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Barach-1934" MODIFIED="2010-02-09 05:22:09 +1000" MODIFIED_BY="Jenny Bellorini" NAME="Barach 1934" TYPE="JOURNAL_ARTICLE">
<AU>Barach AL</AU>
<TI>The therapeutic use of helium</TI>
<SO>Journal of the American Medical Association</SO>
<YR>1936</YR>
<VL>107</VL>
<PG>1273-80</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Beggs-2014" MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]" NAME="Beggs 2014" TYPE="COCHRANE_REVIEW">
<AU>Beggs S, Wong ZH, Kaul S, Ogden KJ, Walters JA</AU>
<TI>High-flow nasal cannula therapy for infants with bronchiolitis</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2014</YR>
<NO>1</NO>
<IDENTIFIERS MODIFIED="2015-03-06 01:36:01 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2015-03-06 01:36:01 +1000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD009609.pub2"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Berkenbosch-2003" MODIFIED="2009-07-08 11:41:51 +1000" MODIFIED_BY="[Empty name]" NAME="Berkenbosch 2003" TYPE="JOURNAL_ARTICLE">
<AU>Berkenbosch JW, Grueber RE, Dabbagh O, McKibben AW</AU>
<TI>Effect of helium-oxygen (heliox) gas mixtures on the function of four pediatric ventilators</TI>
<SO>Critical Care Medicine</SO>
<YR>2003</YR>
<VL>31</VL>
<NO>7</NO>
<PG>2052-8</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="12847403"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Boyce-2000" MODIFIED="2015-02-24 21:27:14 +1000" MODIFIED_BY="[Empty name]" NAME="Boyce 2000" TYPE="JOURNAL_ARTICLE">
<AU>Boyce TG, Mellen BG, Mitchel EF Jr, Wright PF, Griffin MR</AU>
<TI>Rates of hospitalization for respiratory syncytial virus infection among children in medicaid</TI>
<SO>Journal of Pediatrics</SO>
<YR>2000</YR>
<VL>137</VL>
<NO>6</NO>
<PG>865-70</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bressan-2013" MODIFIED="2015-02-25 16:55:25 +1000" MODIFIED_BY="[Empty name]" NAME="Bressan 2013" TYPE="JOURNAL_ARTICLE">
<AU>Bressan S, Balzani M, Krauss B, Pettenazzo A, Zanconato S, Baraldi E</AU>
<TI>High-flow nasal cannula oxygen for bronchiolitis in a pediatric ward: a pilot study</TI>
<SO>European Journal of Pediatrics</SO>
<YR>2013</YR>
<VL>172</VL>
<NO>12</NO>
<PG>1649-56</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Byington-2015" MODIFIED="2015-02-25 17:10:58 +1000" MODIFIED_BY="[Empty name]" NAME="Byington 2015" TYPE="JOURNAL_ARTICLE">
<AU>Byington CL, Wilkes J, Korgenski K, Sheng X</AU>
<TI>Respiratory syncytial virus-associated mortality in hospitalized infants and young children</TI>
<SO>Journal of Pediatrics</SO>
<YR>2015</YR>
<VL>135</VL>
<NO>1</NO>
<PG>e24-31</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Carbonell_x002d_Estrany-2000" MODIFIED="2015-02-24 20:58:16 +1000" MODIFIED_BY="[Empty name]" NAME="Carbonell-Estrany 2000" TYPE="JOURNAL_ARTICLE">
<AU>Carbonell-Estrany X, Quero J, Bustos G, Cotero A, Doménech E, Figueras-Aloy J, et al</AU>
<TI>Rehospitalization because of respiratory syncytial virus infection in premature infants younger than 33 weeks of gestation: a prospective study. IRIS Study Group</TI>
<SO>Pediatric Infectious Disease Journal</SO>
<YR>2000</YR>
<VL>19</VL>
<NO>7</NO>
<PG>592-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Carter-1996" NAME="Carter 1996" TYPE="JOURNAL_ARTICLE">
<AU>Carter ER, Webb CR, Moffitt DR</AU>
<TI>Evaluation of heliox in children hospitalized with acute severe asthma. A randomized crossover trial</TI>
<SO>Chest</SO>
<YR>1996</YR>
<VL>109</VL>
<NO>5</NO>
<PG>1256-61</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Chevret-2005" NAME="Chevret 2005" TYPE="JOURNAL_ARTICLE">
<AU>Chevret L, Mbieleu B, Essouri S, Durand P, Chevret S, Devictor D</AU>
<TI>Bronchiolitis treated with mechanical ventilation: prognosis factors and outcome in a series of 135 children</TI>
<SO>Archives de Pédiatrie</SO>
<YR>2005</YR>
<VL>12</VL>
<NO>4</NO>
<PG>385-90</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="15808426"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Corcoran-2004" MODIFIED="2010-02-09 06:32:31 +1000" MODIFIED_BY="Jenny Bellorini" NAME="Corcoran 2004" TYPE="JOURNAL_ARTICLE">
<AU>Corcoran TE, Gamard S</AU>
<TI>Development of aerosol drug delivery with helium oxygen gas mixtures</TI>
<SO>Journal of Aerosol Medicine</SO>
<YR>2004</YR>
<VL>17</VL>
<NO>4</NO>
<PG>299-309</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Davison-2004" MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]" NAME="Davison 2004" TYPE="JOURNAL_ARTICLE">
<AU>Davison C, Ventre KM, Luchetti M, Randolph AG</AU>
<TI>Efficacy of interventions for bronchiolitis in critically ill infants: a systematic review and meta-analysis</TI>
<SO>Pediatric Critical Care Medicine</SO>
<YR>2004</YR>
<VL>5</VL>
<NO>5</NO>
<PG>482-9</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="16684365"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Figueras_x002d_Aloy-2008" MODIFIED="2015-02-24 21:02:10 +1000" MODIFIED_BY="[Empty name]" NAME="Figueras-Aloy 2008" TYPE="JOURNAL_ARTICLE">
<AU>Figueras-Aloy J, Carbonell-Estrany X, Quero-Jiménez J, Fernández-Colomer B, Guzmán-Cabañas J, Echaniz-Urcelay I, et al</AU>
<TI>FLIP-2 Study: risk factors linked to respiratory syncytial virus infection requiring hospitalization in premature infants born in Spain at a gestational age of 32 to 35 weeks</TI>
<SO>Pediatric Infectious Disease Journal</SO>
<YR>2008</YR>
<VL>27</VL>
<NO>9</NO>
<PG>788-93</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-GRADE-2004" MODIFIED="2015-07-31 11:51:00 +1000" MODIFIED_BY="Liz Dooley" NAME="GRADE 2004" TYPE="JOURNAL_ARTICLE">
<AU>GRADE Working Group</AU>
<TI>Grading quality of evidence and strength of recommendations</TI>
<SO>BMJ</SO>
<YR>2004</YR>
<VL>328</VL>
<NO>7454</NO>
<PG>1490</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-GRADEpro-GDT-2015" MODIFIED="2015-07-31 11:49:12 +1000" MODIFIED_BY="Liz Dooley" NAME="GRADEpro GDT 2015" TYPE="COMPUTER_PROGRAM">
<TI>GRADEpro GDT: GRADEpro Guideline Development Tool. Available from www.gradepro.org</TI>
<YR>2015</YR>
<PB>McMaster University (developed by Evidence Prime, Inc.)</PB>
<CY>Hamilton</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Gupta-2005" NAME="Gupta 2005" TYPE="JOURNAL_ARTICLE">
<AU>Gupta VK, Cheifetz IM</AU>
<TI>Heliox administration in the pediatric intensive care unit: an evidence-based review</TI>
<SO>Pediatric Critical Care Medicine</SO>
<YR>2005</YR>
<VL>6</VL>
<PG>204-11</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="15730610"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Hall-2013" MODIFIED="2015-02-24 20:37:53 +1000" MODIFIED_BY="[Empty name]" NAME="Hall 2013" TYPE="JOURNAL_ARTICLE">
<AU>Hall CB, Sim&#337;es EA, Anderson LJ</AU>
<TI>Clinical and epidemiologic features of respiratory syncytial virus</TI>
<SO>Current Topics in Microbiology and Immunology</SO>
<YR>2013</YR>
<VL>372</VL>
<PG>39-57</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2003" MODIFIED="2015-03-18 07:17:17 +1000" MODIFIED_BY="[Empty name]" NAME="Higgins 2003" TYPE="JOURNAL_ARTICLE">
<AU>Higgins JP, Thompson SG, Deeks JJ, Altman DG</AU>
<TI>Measuring inconsistency in meta-analyses</TI>
<SO>BMJ</SO>
<YR>2003</YR>
<VL>327</VL>
<NO>7414</NO>
<PG>557-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2011" MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]" NAME="Higgins 2011" TYPE="JOURNAL_ARTICLE">
<AU>Higgins JP, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, et al</AU>
<TI>Cochrane Bias Methods Group; Cochrane Statistical Methods Group. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials</TI>
<SO>BMJ</SO>
<YR>2011</YR>
<VL>343</VL>
<PG>d5928</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hough-2014" MODIFIED="2015-02-25 16:47:18 +1000" MODIFIED_BY="[Empty name]" NAME="Hough 2014" TYPE="JOURNAL_ARTICLE">
<AU>Hough JL, Pham TM, Schilber A</AU>
<TI>Physiologic effects of high-flow nasal cannula in infants with bronchiolitis</TI>
<SO>Pediatric Critical Care Medicine</SO>
<YR>2014</YR>
<VL>15</VL>
<NO>5</NO>
<PG>e214-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kemper-1991" MODIFIED="2009-07-08 11:44:02 +1000" MODIFIED_BY="[Empty name]" NAME="Kemper 1991" TYPE="JOURNAL_ARTICLE">
<AU>Kemper KJ, Ritz RH, Benson MS, Bishop MS</AU>
<TI>Helium-oxygen mixture in the treatment of postextubation stridor in pediatric trauma patients</TI>
<SO>Critical Care Medicine</SO>
<YR>1991</YR>
<VL>19</VL>
<NO>3</NO>
<PG>356-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kudukis-1997" MODIFIED="2009-07-08 11:44:12 +1000" MODIFIED_BY="[Empty name]" NAME="Kudukis 1997" TYPE="JOURNAL_ARTICLE">
<AU>Kudukis TM, Manthous CA, Schmidt GA, Hall JB, Wylam ME</AU>
<TI>Inhaled helium-oxygen revisited: effect of inhaled helium-oxygen during the treatment of status asthmaticus in children</TI>
<SO>Journal of Pediatrics</SO>
<YR>1997</YR>
<VL>130</VL>
<NO>2</NO>
<PG>217-24</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Law-2004" MODIFIED="2015-02-24 21:08:56 +1000" MODIFIED_BY="[Empty name]" NAME="Law 2004" TYPE="JOURNAL_ARTICLE">
<AU>Law BJ, Langley JM, Allen U, Paes B, Lee DS, Mitchell I, et al</AU>
<TI>The Pediatric Investigators Collaborative Network on Infections in Canada study of predictors of hospitalization for respiratory syncytial virus infection for infants born at 33 through 35 completed weeks of gestation</TI>
<SO>Pediatric Infectious Disease Journal</SO>
<YR>2004</YR>
<VL>23</VL>
<NO>9</NO>
<PG>806-14</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lefebvre-2011" MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]" NAME="Lefebvre 2011" TYPE="OTHER">
<AU>Lefebvre C, Manheimer E, Glanville J</AU>
<TI>Chapter 6: Searching for studies. In: Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011</TI>
<SO>Available from www.cochrane-handbook.org</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Liese-2003" MODIFIED="2015-02-24 20:50:35 +1000" MODIFIED_BY="[Empty name]" NAME="Liese 2003" TYPE="JOURNAL_ARTICLE">
<AU>Liese JG, Grill E, Fischer B, Roeckl-Wiedmann I, Carr D, Belohradsky BH, et al</AU>
<TI>Incidence and risk factors of respiratory syncytial virus-related hospitalizations in premature infants in Germany</TI>
<SO>European Journal of Pediatrics</SO>
<YR>2003</YR>
<VL>162</VL>
<NO>4</NO>
<PG>230-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lowell-1987" MODIFIED="2009-06-18 08:38:43 +1000" MODIFIED_BY="[Empty name]" NAME="Lowell 1987" TYPE="JOURNAL_ARTICLE">
<AU>Lowell DI, Lister G, Von Koss H, McCarthy P</AU>
<TI>Wheezing in infants: the response to epinephrine</TI>
<SO>Pediatrics</SO>
<YR>1987</YR>
<VL>76</VL>
<NO>6</NO>
<PG>939-45</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Mansbach-2012" MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]" NAME="Mansbach 2012" TYPE="JOURNAL_ARTICLE">
<AU>Mansbach JM, Piedra PA, Teach SJ, Sullivan AF, Forgey T, Clark S, et al</AU>
<TI>Prospective multicenter study of viral etiology and hospital length of stay in children with severe bronchiolitis</TI>
<SO>Archives of Pediatrics and Adolescent Medicine</SO>
<YR>2012</YR>
<VL>166</VL>
<NO>8</NO>
<PG>769-70</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Martinon_x002d_Torres-2012" MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]" NAME="Martinon-Torres 2012" TYPE="JOURNAL_ARTICLE">
<AU>Martinon-Torres F</AU>
<TI>Noninvasive ventilation with helium-oxygen in children</TI>
<SO>Journal of Critical Care</SO>
<YR>2012</YR>
<VL>27</VL>
<NO>2</NO>
<PG>e1-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Martinon_x002d_Torres-2015" MODIFIED="2015-07-31 11:12:56 +1000" MODIFIED_BY="Liz Dooley" NAME="Martinon-Torres 2015" TYPE="JOURNAL_ARTICLE">
<AU>Martinón-Torres F</AU>
<TI>What's weighing down heliox?</TI>
<SO>Lancet Respiratory Medicine</SO>
<YR>2015</YR>
<VL>3</VL>
<NO>1</NO>
<PG>14-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Mayfield-2014" MODIFIED="2015-02-25 16:51:52 +1000" MODIFIED_BY="[Empty name]" NAME="Mayfield 2014" TYPE="JOURNAL_ARTICLE">
<AU>Mayfield S, Bogossian F, O'Malley L, Schibler A</AU>
<TI>High-flow nasal cannula oxygen therapy for infants with bronchiolitis: pilot study</TI>
<SO>Journal of Paediatrics and Children Health</SO>
<YR>2014</YR>
<VL>50</VL>
<NO>5</NO>
<PG>373-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-McKiernan-2010" MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]" NAME="McKiernan 2010" TYPE="JOURNAL_ARTICLE">
<AU>McKiernan C, Chua LC, Visintainer PF, Allen H</AU>
<TI>High flow nasal cannulae therapy in infants with bronchiolitis</TI>
<SO>Journal of Pediatrics</SO>
<YR>2010</YR>
<VL>156</VL>
<PG>634-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Meert-1990" MODIFIED="2009-07-08 11:45:20 +1000" MODIFIED_BY="[Empty name]" NAME="Meert 1990" TYPE="JOURNAL_ARTICLE">
<AU>Meert K, Heidemann S, Abella B, Sarnaik A</AU>
<TI>Does prematurity alter the course of respiratory syncytial virus infection?</TI>
<SO>Critical Care Medicine</SO>
<YR>1990</YR>
<VL>18</VL>
<NO>12</NO>
<PG>1357-9</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="2245609"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Milesi-2013" MODIFIED="2015-02-25 16:59:49 +1000" MODIFIED_BY="[Empty name]" NAME="Milesi 2013" TYPE="JOURNAL_ARTICLE">
<AU>Milési C, Baleine J, Matecki S, Durand S, Combes C, Novais AR, et al</AU>
<TI>Is treatment with a high flow nasal cannula effective in acute viral bronchiolitis? A physiologic study</TI>
<SO>Intensive Care Medicine</SO>
<YR>2013</YR>
<VL>39</VL>
<NO>6</NO>
<PG>1088-94</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Nair-2010" MODIFIED="2015-03-18 07:15:23 +1000" MODIFIED_BY="[Empty name]" NAME="Nair 2010" TYPE="JOURNAL_ARTICLE">
<AU>Nair H, Nokes DJ, Gessner BD, Dherani M, Madhi SA, Singleton RJ, et al</AU>
<TI>Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis</TI>
<SO>Lancet</SO>
<YR>2010</YR>
<VL>375</VL>
<NO>9725</NO>
<PG>1545-55</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Panitch-2003" MODIFIED="2009-07-08 11:45:34 +1000" MODIFIED_BY="[Empty name]" NAME="Panitch 2003" TYPE="JOURNAL_ARTICLE">
<AU>Panitch HB</AU>
<TI>Respiratory syncytial virus bronchiolitis: supportive care and therapies designed to overcome airway obstruction</TI>
<SO>Pediatric Infectious Disease Journal</SO>
<YR>2003</YR>
<VL>22</VL>
<NO>Suppl</NO>
<PG>83-7</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="12671457"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Piedimonte-2002" MODIFIED="2015-03-18 07:14:49 +1000" MODIFIED_BY="[Empty name]" NAME="Piedimonte 2002" TYPE="JOURNAL_ARTICLE">
<AU>Piedimonte G</AU>
<TI>Pathophysiological mechanisms for the respiratory syncytial virus-reactive airway disease link</TI>
<SO>Respiratory Research</SO>
<YR>2002</YR>
<VL>3</VL>
<NO>Suppl 1</NO>
<PG>21-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Prais-2003" NAME="Prais 2003" TYPE="JOURNAL_ARTICLE">
<AU>Prais D, Schonfeld T, Amir J, Israeli Respiratory Syncytial Virus Monitoring Group</AU>
<TI>Admission to the intensive care unit for respiratory syncytial virus bronchiolitis: a national survey before palivizumab use</TI>
<SO>Pediatrics</SO>
<YR>2004</YR>
<VL>113</VL>
<NO>3 Pt 1</NO>
<PG>629</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="12949282"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Ralston-2009" MODIFIED="2015-02-24 20:42:25 +1000" MODIFIED_BY="[Empty name]" NAME="Ralston 2009" TYPE="JOURNAL_ARTICLE">
<AU>Ralston S, Hill V</AU>
<TI>Incidence of apnea in infants hospitalized with respiratory syncytial virus bronchiolitis: a systematic review</TI>
<SO>Journal of Pediatrics</SO>
<YR>2009</YR>
<VL>155</VL>
<NO>5</NO>
<PG>728-33</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-RevMan-2014" MODIFIED="2015-03-18 07:14:30 +1000" MODIFIED_BY="[Empty name]" NAME="RevMan 2014" TYPE="COMPUTER_PROGRAM">
<TI>Review Manager (RevMan)</TI>
<YR>2014</YR>
<EN>5.3</EN>
<PB>The Nordic Cochrane Centre, The Cochrane Collaboration</PB>
<CY>Copenhagen</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Roche_x002d_Campo-2011" MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]" NAME="Roche-Campo 2011" TYPE="JOURNAL_ARTICLE">
<AU>Roche-Campo F, Vignaux L, Galia F, Lyazidi A, Vargas F, Texereau J, et al</AU>
<TI>Delivery of helium oxygen mixture during spontaneous breathing: evaluation of three high-concentration face masks</TI>
<SO>Intensive Care Medicine</SO>
<YR>2011</YR>
<VL>37</VL>
<PG>1787-92</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Rodrigo-2010" MODIFIED="2015-04-09 13:56:40 +1000" MODIFIED_BY="[Empty name]" NAME="Rodrigo 2010" TYPE="COCHRANE_REVIEW">
<AU>Rodrigo G, Pollack C, Rodrigo C, Rowe BH</AU>
<TI>Heliox for non-intubated acute asthma patients</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2010</YR>
<NO>10</NO>
<IDENTIFIERS MODIFIED="2015-04-08 19:57:55 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2015-04-08 19:57:55 +1000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD002884.pub2"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Schibler-2011" MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]" NAME="Schibler 2011" TYPE="JOURNAL_ARTICLE">
<AU>Schibler A, Pham TM, Dunster KR, Foster K, Barlow A, Gibbons K, et al</AU>
<TI>Reduced intubation rates for infants after introduction of high-flow nasal prong oxygen delivery</TI>
<SO>Intensive Care Medicine</SO>
<YR>2011</YR>
<VL>37</VL>
<PG>847-52</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Simoes-2003" MODIFIED="2015-09-14 19:56:36 +1000" MODIFIED_BY="[Empty name]" NAME="Simoes 2003" TYPE="JOURNAL_ARTICLE">
<AU>Simoes EA</AU>
<TI>Environmental and demographic risk factors for respiratory syncytial virus lower respiratory tract disease</TI>
<SO>Journal of Pediatrics</SO>
<YR>2003</YR>
<VL>143</VL>
<NO>5 Suppl</NO>
<PG>118-26</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Skjerven-2013" MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]" NAME="Skjerven 2013" TYPE="JOURNAL_ARTICLE">
<AU>Skjerven HO, Hunderi JO, Brügmann-Pieper SK, Brun AC, Engen H, Eskedal L, et al</AU>
<TI>Racemic adrenaline and inhalation strategies in acute bronchiolitis</TI>
<SO>New England Journal of Medicine</SO>
<YR>2013</YR>
<VL>368</VL>
<NO>24</NO>
<PG>2286-93</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Standley-2008" MODIFIED="2009-07-08 11:46:01 +1000" MODIFIED_BY="[Empty name]" NAME="Standley 2008" TYPE="JOURNAL_ARTICLE">
<AU>Standley TD, Smith HL, Brennan LJ, Wilkins IA, Bradley PG, Barrera Groba C, et al</AU>
<TI>Room air dilution of heliox given by facemask</TI>
<SO>Intensive Care Medicine</SO>
<YR>2008</YR>
<VL>34</VL>
<NO>8</NO>
<PG>1469-76</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Stillwell-1989" MODIFIED="2009-12-15 01:45:57 +1000" MODIFIED_BY="[Empty name]" NAME="Stillwell 1989" TYPE="JOURNAL_ARTICLE">
<AU>Stillwell PC, Quick JD, Munro PR, Mallory GB Jr</AU>
<TI>Effectiveness of open-circuit and oxyhood delivery of helium-oxygen</TI>
<SO>Chest</SO>
<YR>1989</YR>
<VL>95</VL>
<NO>6</NO>
<PG>1222-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Wang-1995" NAME="Wang 1995" TYPE="JOURNAL_ARTICLE">
<AU>Wang EE, Law BJ, Stephens D</AU>
<TI>Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) prospective study of risk factors and outcomes in patients hospitalized with respiratory syncytial viral lower respiratory tract infection</TI>
<SO>Journal of Pediatrics</SO>
<YR>1995</YR>
<VL>126</VL>
<NO>2</NO>
<PG>212-9</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="7844667"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Weber-2001" MODIFIED="2010-02-09 05:24:11 +1000" MODIFIED_BY="Jenny Bellorini" NAME="Weber 2001" TYPE="JOURNAL_ARTICLE">
<AU>Weber JE, Chudnofsky CR, Younger JG, Larkin GL, Boczar M, Wilkerson MD, et al</AU>
<TI>A randomized comparison of helium-oxygen mixture (Heliox) and racemic epinephrine for the treatment of moderate to severe croup</TI>
<SO>Pediatrics</SO>
<YR>2001</YR>
<VL>107</VL>
<NO>6</NO>
<PG>E96</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Welliver-2003" NAME="Welliver 2003" TYPE="JOURNAL_ARTICLE">
<AU>Welliver RC</AU>
<TI>Review of epidemiology and clinical risk factors for severe respiratory syncytial virus (RSV) infection</TI>
<SO>Journal of Pediatrics</SO>
<YR>2003</YR>
<VL>143</VL>
<NO>Suppl</NO>
<PG>112-7</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="14615709"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Wolfson-1984" NAME="Wolfson 1984" TYPE="JOURNAL_ARTICLE">
<AU>Wolfson MR, Bhutani VK, Shaffer TH, Bowen FW Jr</AU>
<TI>Mechanics and energetics of breathing helium in infants with bronchopulmonary dysplasia</TI>
<SO>Journal of Pediatrics</SO>
<YR>1984</YR>
<VL>104</VL>
<NO>5</NO>
<PG>752-7</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="6546945"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Wood-1972" MODIFIED="2009-07-08 11:46:38 +1000" MODIFIED_BY="[Empty name]" NAME="Wood 1972" TYPE="JOURNAL_ARTICLE">
<AU>Wood DW, Downes JJ, Lecks HI</AU>
<TI>A clinical scoring system for the diagnosis of respiratory failure. Preliminary report on childhood status asthmaticus</TI>
<SO>American Journal of Diseases of Children</SO>
<YR>1972</YR>
<VL>123</VL>
<NO>3</NO>
<PG>227-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Zhang-2013" MODIFIED="2015-03-18 07:03:26 +1000" MODIFIED_BY="[Empty name]" NAME="Zhang 2013" TYPE="COCHRANE_REVIEW">
<AU>Zhang L, Mendoza-Sassi RA, Wainwright C, Klassen TP</AU>
<TI>Nebulised hypertonic saline solution for acute bronchiolitis in infants</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2013</YR>
<NO>7</NO>
<IDENTIFIERS MODIFIED="2010-02-09 05:24:30 +1000" MODIFIED_BY="Jenny Bellorini">
<IDENTIFIER MODIFIED="2010-02-09 05:24:30 +1000" MODIFIED_BY="Jenny Bellorini" TYPE="DOI" VALUE="10.1002/14651858.CD006458.pub2"/>
</IDENTIFIERS>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES MODIFIED="2015-09-15 14:50:18 +1000" MODIFIED_BY="Liz  Dooley">
<REFERENCE ID="REF-Liet-2008" MODIFIED="2015-09-15 14:50:18 +1000" MODIFIED_BY="Liz  Dooley" NAME="Liet 2008" TYPE="COCHRANE_PROTOCOL">
<AU>Liet JM, Ducruet T, Gupta V, Cambonie G</AU>
<TI>Heliox inhalation therapy for bronchiolitis in infants</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2008</YR>
<NO>1</NO>
<IDENTIFIERS MODIFIED="2015-09-15 14:50:15 +1000" MODIFIED_BY="Liz  Dooley">
<IDENTIFIER MODIFIED="2015-09-15 14:50:15 +1000" MODIFIED_BY="Liz  Dooley" TYPE="DOI" VALUE="10.1002/14651858.CD006915"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Liet-2010" MODIFIED="2015-04-09 13:55:02 +1000" MODIFIED_BY="[Empty name]" NAME="Liet 2010" TYPE="COCHRANE_REVIEW">
<AU>Liet JM, Ducruet T, Gupta V, Cambonie G</AU>
<TI>Heliox inhalation therapy for bronchiolitis in infants</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2010</YR>
<NO>4</NO>
<IDENTIFIERS>
<IDENTIFIER TYPE="DOI" VALUE="10.1002/14651858.CD006915.pub2"/>
</IDENTIFIERS>
</REFERENCE>
</OTHER_VERSIONS_REFERENCES>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2015-09-16 02:01:43 +1000" MODIFIED_BY="[Empty name]">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2015-09-16 02:01:43 +1000" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Cambonie-2006">
<CHAR_METHODS MODIFIED="2009-07-08 14:47:01 +1000" MODIFIED_BY="[Empty name]">
<P>Prospective, randomised, double-blind study</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-03-18 08:11:59 +1000" MODIFIED_BY="[Empty name]">
<P>20 infants (all &lt; 3 months old) admitted to the PICU with moderate-to-severe RSV bronchiolitis<BR/>Criteria for inclusion: bronchiolitis RSV+, m-WCAS &gt; 5, PaCO<SUB>2</SUB> &gt; 42 mmHg<BR/>Group characteristics after randomisation, mean ± SD:<BR/>Age, d 29 ± 5 versus 34 ± 9<BR/>Weight, kg 3.5 ± 0.46 versus 3.83 ± 0.24<BR/>Clinical score, (m-WCAS, maximum score of 10): 5.4 ± 0.2 versus 5.6 ± 0.2<BR/>Respiratory rate, breaths/min 59.4 ± 6.4 versus 64.9 ± 5.7<BR/>FiO<SUB>2</SUB>, % 31.4 ± 4.0 versus 34.0 ± 2.6<BR/>PCO<SUB>2</SUB>, mmHg 56.5 ± 4.9 versus 53.6 ± 2.3</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-03-05 23:43:56 +1000" MODIFIED_BY="[Empty name]">
<P>Inhalation of either heliox <B>OR</B> air-oxygen, for 1 hour under a 7 L/min oxy hood</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]">
<P>Primary goal: to assess the effect on respiratory distress evaluated using the modified Wood Clinical Asthma Score (m-WCAS) at H1<BR/>Secondary endpoints: need for mechanical ventilation, rate of intubation, length of mechanical ventilation, length of stay in PICU, mortality, wheezing score evaluated at H1 and H24, pCO<SUB>2</SUB> at H1, respiratory rate at H1</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]">
<P>&#8212;</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Chowdhury-2013">
<CHAR_METHODS MODIFIED="2015-01-28 02:26:11 +1000" MODIFIED_BY="[Empty name]">
<P>Prospective, double-blind, multi-centre, randomised controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]">
<P>281 infants (&lt; 1 year old) with clinical bronchiolitis requiring admission for hypoxia or respiratory distress. The study was carried out in the bronchiolitis seasons<BR/>Criteria for inclusion: diagnosis of bronchiolitis and need of hospitalisation for respiratory distress or hypoxia (SpO<SUB>2</SUB> &lt; 93% in room air)<BR/>Baseline characteristics of subjects at presentation, median (IQRs):<BR/>Age, wk 10.90 (5.85 to 25.50) versus 17.70 (6.80 to 29.40)<BR/>Weight, kg 5.65 (4.34 to 7.70) versus 5.70 (4.40 to 7.70)<BR/>RSV+, % 79.3 versus 82.3<BR/>Modified Woods Clinical Asthma Score (m-WCAS, maximum score of 11, median interquartile): 3.0 (2.0 to 3.0) versus 3.0 (2.0 to 4.0)<BR/>Respiratory rate, breaths per min 56.0 (44.0 to 62.0) versus 53.0 (47.0 to 63.5)<BR/>SpO<SUB>2</SUB> in room air, % 92.0% (89.0 to 95.0) versus 91.0% (89.0 to 94.0)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-04-09 13:44:57 +1000" MODIFIED_BY="[Empty name]">
<P>Patients were randomised to receive via facemask 10 L/min (nasal cannula 3L/min, if facemask intolerant) or nCPAP 6 cm H<SUB>2</SUB>O if severe respiratory distress:<BR/>HeOx = Heliox21 (79% He + 21% O<SUB>2</SUB>) ± additional O<SUB>2</SUB> <B>OR</B> AirOx = Medical Air (79% N2 + 21% O<SUB>2</SUB>) ± additional O<SUB>2</SUB>, with humidification of the gases</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]">
<P>Primary endpoint was length of treatment (LoT) required to alleviate hypoxia and respiratory distress<BR/>Secondary endpoints were proportion of participants needing nCPAP; nCPAP (LoT); and change in respiratory distress score</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]">
<P>In the clinical score used, 2 variables are redundant: pulse oxymetry and cyanosis</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hollmann-1998">
<CHAR_METHODS MODIFIED="2010-02-09 05:07:46 +1000" MODIFIED_BY="Jenny Bellorini">
<P>Randomised, double-blind, controlled, cross-over study</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]">
<P>13 infants (3 weeks to 23 months old) admitted to the PICU with RSV bronchiolitis RSV+, FiO<SUB>2 </SUB>&lt; 50%,<BR/>Criteria for inclusion:<BR/>Bronchiolitis RSV+, with signs of lower respiratory tract disease<BR/>Baseline characteristics, median (range):<BR/>Age, mo 2.5 (3 wks to 24 mos)<BR/>Clinical Asthma Score (m-WCAS, maximum score of 10): 3.04 (1 to 7.5).</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-03-05 23:44:50 +1000" MODIFIED_BY="[Empty name]">
<P>Inhalation in a random order of heliox <B>AND</B> air-oxygen, by non-rebreather standard reservoir mask for two 20-minute study periods</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]">
<P>Primary endpoint: Clinical Asthma Score at 20 min<BR/>Secondary endpoints: respiratory rate, heart rate and SpO<SUB>2</SUB>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-02-28 01:29:20 +1000" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kim-2011">
<CHAR_METHODS MODIFIED="2015-01-28 02:29:34 +1000" MODIFIED_BY="[Empty name]">
<P>Prospective, randomised, single-blind study</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]">
<P>69 infants (2 to 12 months old) with bronchiolitis and m-WCAS &gt; 3 in the Emergency Department (ED)</P>
<P>A convenience sample of infants was enrolled from 1 October through 31 March each year when bronchiolitis had a high incidence<BR/>Criteria for inclusion:<BR/>Bronchiolitis with Modified Woods Clinical Asthma Score (m-WCAS) of 3 or higher<BR/>Baseline characteristics, median:</P>
<P>Age, mo 3.78 versus 5.03<BR/>RSV+, % 68 versus 49<BR/>m-WCAS, (maximum score of 10): 3.84 versus 3.67<BR/>RDAI, (maximum score of 17): 10</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]">
<P>Patients initially received nebulised albuterol treatment driven by 100% oxygen<BR/>Patients were randomised to the helium-oxygen <B>OR</B> oxygen group and received nebulised racaemic epinephrine via a face mask<BR/>After nebulisation, humidified helium-oxygen <B>OR</B> oxygen, was delivered by high-flow nasal cannula (HFNC) started at 6 L/min with humidified gases<BR/>After 60 minutes of inhalation therapy, patients with m-WCAS of 2 or higher received a second delivery of nebulised racaemic epinephrine followed by helium-oxygen or oxygen delivered by HFNC</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-04-09 13:48:16 +1000" MODIFIED_BY="[Empty name]">
<P>The primary outcome measure was the degree of improvement of m-WCAS for 240 minutes (at 60-minute intervals) or until ED discharge (if &lt; 240 minutes)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-01-28 02:30:18 +1000" MODIFIED_BY="[Empty name]">
<P>Family history of asthma: 50%</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kneyber-2009">
<CHAR_METHODS MODIFIED="2010-02-09 05:08:23 +1000" MODIFIED_BY="Jenny Bellorini">
<P>Prospective, cross-over study</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]">
<P>13 infants mechanically ventilated (AVEA® ventilator, Cardinal Health), sedated and paralysed<BR/>Criteria for inclusion:<BR/>RSV+ bronchiolitis admitted in PICU for mechanical ventilation<BR/>Baseline, range:<BR/>Age, wk 4 to 23<BR/>Weight, kg 3.2 to 10<BR/>PCO<SUB>2</SUB>, mmHg 35 to 75</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-03-05 23:45:33 +1000" MODIFIED_BY="[Empty name]">
<P>Three 30-minute periods: data collected at T0 and T60 (ventilation with nitrox), <B>AND</B> at T30 and T90 (ventilation with heliox)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-01-15 16:30:50 +1000" MODIFIED_BY="[Empty name]">
<P>Respiratory system resistance, peak expiratory flow rate, lung resistance, static compliance, change in end-expiratory lung volume<BR/>Response to heliox (electrical impedance tomography measurements: EIT)<BR/>Oxygenation index, alveolo-arterial oxygen gradient, ventilation index, dead-space/tidal volume ratio</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]">
<P>&#8212;</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Liet-2005">
<CHAR_METHODS MODIFIED="2010-02-09 05:08:40 +1000" MODIFIED_BY="Jenny Bellorini">
<P>Multi-centre, randomised, double-blind, placebo-controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]">
<P>39 infants (all &lt; 9 months old) admitted to PICU with first episode of RSV bronchiolitis and signs of respiratory failure<BR/>Criteria for inclusion: infants admitted to PICU with a first episode of RSV bronchiolitis and with criteria for respiratory failure (pulse oximetry saturation &lt; 92% in room air or PaO<SUB>2</SUB> &lt; 40 mmHg)<BR/>Baseline characteristics, mean ± SEM:<BR/>Age, mo 1.0 ± 0.2 versus 1.1 ± 0.2<BR/>Weight, kg 4.2 ± 0.3 versus 4.3 ± 0.3<BR/>Respiratory rate, per min 53 ± 1 versus 59 ± 1<BR/>FiO<SUB>2</SUB>, % 40 ± 1 versus 39 ± 1<BR/>pCO<SUB>2</SUB>, mmHg 65 ±1 versus 62 ± 1<BR/>RDAI (maximum score of 17): 8 ± 0 versus 9 ± 0</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-03-05 23:45:45 +1000" MODIFIED_BY="[Empty name]">
<P>Inhalation of either heliox <B>OR</B> air-oxygen, under an inflatable head hood with a gas flow of 9 to 15 L/min</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]">
<P>Primary outcome was initiation of positive pressure ventilation<BR/>Secondary endpoints: need for invasive mechanical ventilation, rate of intubation, length of mechanical ventilation, length of stay in PICU, mortality, FiO<SUB>2</SUB> at H24, pCO<SUB>2</SUB> at H24, respiratory distress assessment instrument (RDAI) at H24</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]">
<P>&#8212;</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Martin_x00f3_n_x002d_Torres-2008">
<CHAR_METHODS MODIFIED="2010-02-09 05:09:18 +1000" MODIFIED_BY="Jenny Bellorini">
<P>Prospective, interventional, single-centre, cross-over study</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]">
<P>12 infants (&lt; 2 years old) admitted to the PICU with RSV bronchiolitis RSV+, m-WCAS &gt; 5, SpO<SUB>2 </SUB>&lt; 92% or tcPCO<SUB>2 </SUB>&gt; 50 mmHg despite optimised supportive therapy<BR/>Criteria for inclusion:<BR/>RSV + bronchiolitis with Modified Woods Clinical Asthma Score &gt; 5, arterial oxygen saturation &lt; 92%, or transcutaneous CO<SUB>2</SUB> pressure &gt; 50 mmHg<BR/>Baseline, mean (SD):<BR/>Age, mo 5 (2.9) versus 4.5 (2.2)<BR/>m-WCAS, maximum score of 10, mean standard deviation: 7.6 (1.2) versus 7.7 (1.0)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-03-18 08:04:31 +1000" MODIFIED_BY="[Empty name]">
<P>Inhalation in a random order of heliox <B>AND</B> air-oxygen, by non-invasive ventilation equipment (nasal continuous positive airway pressure with minimum level of 5 cmH<SUB>2</SUB>O) for 2 30-minute study periods<BR/>The heliox mixture was delivered to the patient, warmed, and humidified by means of a standard device</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-03-18 08:05:07 +1000" MODIFIED_BY="[Empty name]">
<P>Main outcome measures: modified Woods Clinical Asthma Score (m-WCAS), and pCO<SUB>2</SUB> at 30 minutes<BR/>Secondary outcomes: rate of intubation, length of mechanical ventilation, length of stay in PICU, mortality, m-WCAS at H24 and H48, pCO<SUB>2</SUB> at H24</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]">
<P>&#8212;</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>ED: emergency department<BR/>FiO<SUB>2</SUB>: fraction of inspired oxygen<BR/>H1: first hour<BR/>H24: twenty-fourth hour<BR/>IQR: interquartile range<BR/>m-WCAS: modified Wood Clinical Asthma Score<BR/>min: minute<BR/>mo: month<BR/>nCPAP: nasal continuous positive airway pressure<BR/>pCO<SUB>2</SUB>: carbon dioxide pressure<BR/>PICU: paediatric intensive care unit<BR/>RDAI: respiratory distress assessment instrument<BR/>RSV: respiratory syncytial virus<BR/>SD: standard deviation<BR/>SEM: standard error of the mean<BR/>SpO<SUB>2</SUB>: oxygen saturation on pulse oximetry<BR/>wk: week<BR/>
</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Abd_x002d_Allah-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]">
<P>No infants, no bronchiolitis</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-01-28 02:38:08 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Colnaghi-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-01-28 02:38:08 +1000" MODIFIED_BY="[Empty name]">
<P>No bronchiolitis</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-08 14:51:22 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Dieperink-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-08 14:51:22 +1000" MODIFIED_BY="[Empty name]">
<P>No bronchiolitis</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-08 14:51:26 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Duncan-1979">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-08 14:51:26 +1000" MODIFIED_BY="[Empty name]">
<P>Case report</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-02-09 05:10:18 +1000" MODIFIED_BY="Jenny Bellorini" STUDY_ID="STD-Elleau-1993">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-02-09 05:10:18 +1000" MODIFIED_BY="Jenny Bellorini">
<P>No infants, no bronchiolitis</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-02-09 05:10:36 +1000" MODIFIED_BY="Jenny Bellorini" STUDY_ID="STD-Gross-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-02-09 05:10:36 +1000" MODIFIED_BY="Jenny Bellorini">
<P>Series of case reports</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-02-09 05:10:22 +1000" MODIFIED_BY="Jenny Bellorini" STUDY_ID="STD-Grosz-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-02-09 05:10:22 +1000" MODIFIED_BY="Jenny Bellorini">
<P>Series of case reports</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-08 14:51:37 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gupta-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-08 14:51:37 +1000" MODIFIED_BY="[Empty name]">
<P>Case report</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-02-09 05:10:26 +1000" MODIFIED_BY="Jenny Bellorini" STUDY_ID="STD-Iglesias_x002d_Fernandez-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-02-09 05:10:26 +1000" MODIFIED_BY="Jenny Bellorini">
<P>Series of case reports</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-08 14:51:42 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Isakov-1970">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-08 14:51:42 +1000" MODIFIED_BY="[Empty name]">
<P>No bronchiolitis</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-08 14:51:44 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kneyber-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-08 14:51:44 +1000" MODIFIED_BY="[Empty name]">
<P>Case report</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-02-09 05:10:42 +1000" MODIFIED_BY="Jenny Bellorini" STUDY_ID="STD-Martinon_x002d_Torres-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-02-09 05:10:42 +1000" MODIFIED_BY="Jenny Bellorini">
<P>Inadequate method of randomisation (alternate inclusion), unblinded study</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-08 14:51:52 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Martinon_x002d_Torres-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-08 14:51:52 +1000" MODIFIED_BY="[Empty name]">
<P>Case report</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-02-09 05:10:48 +1000" MODIFIED_BY="Jenny Bellorini" STUDY_ID="STD-Martinon_x002d_Torres-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-02-09 05:10:48 +1000" MODIFIED_BY="Jenny Bellorini">
<P>Series of case reports</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-01-28 02:37:36 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Mayordomo_x002d_Colunga-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-01-28 02:37:36 +1000" MODIFIED_BY="[Empty name]">
<P>Series of case reports</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-01-28 02:53:50 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Montaguti-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-01-28 02:53:50 +1000" MODIFIED_BY="[Empty name]">
<P>Series of case reports</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-08 14:51:57 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Paret-1996">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-08 14:51:57 +1000" MODIFIED_BY="[Empty name]">
<P>Case report</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-08 14:52:00 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Tobias-1997">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-08 14:52:00 +1000" MODIFIED_BY="[Empty name]">
<P>Not about bronchiolitis</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-08 14:52:02 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Tobias-1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-08 14:52:02 +1000" MODIFIED_BY="[Empty name]">
<P>Case report</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-02-09 05:10:53 +1000" MODIFIED_BY="Jenny Bellorini" STUDY_ID="STD-Ulhoa-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-02-09 05:10:53 +1000" MODIFIED_BY="Jenny Bellorini">
<P>Series of case reports</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-02-09 05:10:57 +1000" MODIFIED_BY="Jenny Bellorini" STUDY_ID="STD-Williams-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-02-09 05:10:57 +1000" MODIFIED_BY="Jenny Bellorini">
<P>Series of case reports</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-08 14:52:11 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Winters-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-08 14:52:11 +1000" MODIFIED_BY="[Empty name]">
<P>No bronchiolitis</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES MODIFIED="2009-06-17 19:15:23 +1000" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<ONGOING_CHAR MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Rotta-2015">
<CHAR_STUDY_NAME MODIFIED="2015-04-08 00:15:01 +1000" MODIFIED_BY="[Empty name]">
<P>ClinicalTrials.gov identifier: NCT02373683</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2015-04-08 15:53:29 +1000" MODIFIED_BY="[Empty name]">
<P>Prospective pilot study</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-04-09 13:51:16 +1000" MODIFIED_BY="[Empty name]">
<P>&#8226;Children 0 to 24 months<BR/>&#8226;Admission to the Paediatric Intensive Care Unit<BR/>&#8226;Diagnosis of bronchiolitis, with respiratory syncytial virus infection confirmed by laboratory testing</P>
<P>&#8226;Mechanical ventilation<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-04-09 13:51:21 +1000" MODIFIED_BY="[Empty name]">
<P>Heliox delivered via a heated and humidified high flow nasal cannula (HFNC) system</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-04-09 13:51:31 +1000" MODIFIED_BY="[Empty name]">
<P>The aim of this prospective pilot study is to determine the effect of heliox delivered via a proprietary calibrated heated and humidified high flow nasal cannula (HFNC) system (Vapotherm Precision Flow Heliox) in children ages 0 to 24 months with severe bronchiolitis</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2015-04-08 00:18:46 +1000" MODIFIED_BY="[Empty name]">
<P>February 2015</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2015-04-08 00:17:23 +1000" MODIFIED_BY="[Empty name]">
<P>Katherine N Slain, DO</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]">
<P>&#8212;</P>
</CHAR_NOTES>
</ONGOING_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2015-09-16 02:01:43 +1000" MODIFIED_BY="[Empty name]">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-07-08 14:47:55 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Cambonie-2006">
<DESCRIPTION>
<P>Computerised random listing</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chowdhury-2013">
<DESCRIPTION>
<P>Computer-stratified block randomisation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hollmann-1998">
<DESCRIPTION>
<P>Coin tossing</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-04-09 13:48:23 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kim-2011">
<DESCRIPTION>
<P>Randomisation was predetermined using a random number generator and occurred in blocks of 10</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-07-08 14:49:09 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Kneyber-2009">
<DESCRIPTION>
<P>No randomisation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-07-08 14:49:59 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Liet-2005">
<DESCRIPTION>
<P>Computerised random listing with stratification by centre</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-07-08 14:51:14 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Martin_x00f3_n_x002d_Torres-2008">
<DESCRIPTION>
<P>Coin tossing only for the first infant; then alternately</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-07-08 14:47:58 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Cambonie-2006">
<DESCRIPTION>
<P>Sealed envelopes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-04-09 13:45:19 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chowdhury-2013">
<DESCRIPTION>
<P>Patients were enrolled and allocated by telephone to Gas A or B</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-03-02 22:36:52 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hollmann-1998">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kim-2011">
<DESCRIPTION>
<P>Assignments were kept in sealed, opaque envelopes and opened immediately after informed consent by the study investigator</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-06-17 19:10:54 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Kneyber-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-07-08 14:50:02 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Liet-2005">
<DESCRIPTION>
<P>Sealed envelopes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-03-02 22:35:43 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Martin_x00f3_n_x002d_Torres-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Cambonie-2006">
<DESCRIPTION>
<P>1 investigator was not blinded: the physiologist<BR/>The labelling of intervention gases as cylinder A and B potentially exposed the study to assessment bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-04-09 13:45:26 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chowdhury-2013">
<DESCRIPTION>
<P>The labelling of intervention gases as cylinder A and B potentially exposed the study to assessment bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hollmann-1998">
<DESCRIPTION>
<P>1 investigator was not blinded: the respiratory therapists; blinding was maintained by covering the on-off valves to the air and helium sources with tape</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-04-09 13:48:27 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kim-2011">
<DESCRIPTION>
<P>The respiratory therapists were unmasked to the type of gas because they controlled and monitored the mixing of gases at the blender</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2009-07-08 14:49:12 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Kneyber-2009">
<DESCRIPTION>
<P>Unblinded study</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-03-18 08:10:15 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Liet-2005">
<DESCRIPTION>
<P>1 investigator was not blinded: the respiratory therapists; identical tanks at the bedside of all patients and gas flow meters covered with opaque bags to hide the dials</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Martin_x00f3_n_x002d_Torres-2008">
<DESCRIPTION>
<P>Non-blinded study: obvious changes in ventilator noise because of the expiratory branch of the flow generator</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="GROUP" NO="7">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" NO="8">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2015-09-16 02:01:43 +1000" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-09-16 02:01:43 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Cambonie-2006">
<DESCRIPTION>
<P>All patients completed the study and there were no losses to follow-up, no treatment withdrawals</P>
<P>31 infants with the diagnosis of respiratory distress attributable to RSV bronchiolitis were admitted to the PICU during the study period. Among them, 11 were excluded for clinical scores below 5. 20 infants were thus randomised into the 2 groups, with 10 in each group. One infant randomised into the control group was excluded for an oxygen haemoglobin saturation &lt; 90% that persisted under the maximum 40% Fio2 authorised by the protocol</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chowdhury-2013">
<DESCRIPTION>
<P>Consent was obtained for 319 participants who were randomised and enrolled into the study. Authors reported that analysis was performed by intention-to-treat, but provided results from a subgroup of 281 infants</P>
<P>3 participants were excluded (2 withdrawal of consent and 1 screening failure). An additional 35 participants were excluded because of protocol violation, consent withdrawal, screening failure, hospital clinician's decision or premature disruption of therapy</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-04-09 13:47:33 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hollmann-1998">
<DESCRIPTION>
<P>All patients completed the study and there were no losses to follow-up, no treatment withdrawals</P>
<P>21 eligible patients were admitted during the study period. 3 patients were excluded from the study because of technical difficulties in setting up the gas delivery system (n = 1) and because of marked agitation (n = 2). 1 of the patients with agitation was intubated shortly after admission to the ICU. A total of 18 patients were studied, 13 of whom were randomised. Of the 13 randomised patients, 12 patients had Clinical Asthma Scores of &lt; 6 and 1 patient had a Clinical Asthma Score of 7.5 but only mild signs of expiratory obstruction</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kim-2011">
<DESCRIPTION>
<P>All patients completed the study and there were no losses to follow-up and no treatment withdrawals</P>
<P>A total of 2580 patients were ineligible due to a m-WCAS lower than 3. Eligibility criteria were met by 256 infants. Of these 256 infants, 187 met the exclusion criteria. Of these 187 excluded patients, 141 were excluded for the following criteria: vapotherm issue (44 patients), direct admission (41 patients), corticosteroid use within 72 hours (28 patients), declined to participate (15 patients) and chronic lung disease (13 patients). The remaining 46 patients met other exclusion criteria. 34 infants completed treatment with helium-oxygen therapy and 35 with oxygen therapy</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kneyber-2009">
<DESCRIPTION>
<P>All patients completed the study and there were no losses to follow-up, no treatment withdrawals</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Liet-2005">
<DESCRIPTION>
<P>All patients completed the study and there were no losses to follow-up, no treatment withdrawals.</P>
<P>157 infants were screened for inclusion and 39 met the eligibility criteria. Reasons for non-enrollment included intubation and institution of mechanical ventilation before PICU entry (83), age &gt; 9 months or weight &gt; 10 kg (16), negative RSV test (10), PICU stay &gt; 8 hours (8), uncorrected cyanotic heart disease or cardiac failure (8), unavailable equipment (6), history of a previous bronchiolitis episode (5), parental refusal of consent (4), bronchopulmonary dysplasia (4) and pneumothorax (1). 1 child in the helium group was removed from the study from the first day at the parents' request and was not included in the final analyses</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Martin_x00f3_n_x002d_Torres-2008">
<DESCRIPTION>
<P>All patients completed the study and there were no losses to follow-up and no treatment withdrawals</P>
<P>During the study period, 40 infants with acute bronchiolitis were admitted to the PICU; 12 of them (7 boys and 5 girls) fulfilled the inclusion criteria and were enrolled in the study</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Cambonie-2006">
<DESCRIPTION>
<P>All results for outcomes were reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-04-09 13:46:25 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chowdhury-2013">
<DESCRIPTION>
<P>All outcome results were reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hollmann-1998">
<DESCRIPTION>
<P>All results for outcomes were reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kim-2011">
<DESCRIPTION>
<P>All results for outcomes were reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kneyber-2009">
<DESCRIPTION>
<P>All results for outcomes were reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Liet-2005">
<DESCRIPTION>
<P>All results for outcomes were reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Martin_x00f3_n_x002d_Torres-2008">
<DESCRIPTION>
<P>All results for outcomes were reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" MODIFIED="2015-04-07 19:21:24 +1000" MODIFIED_BY="[Empty name]" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-04-07 19:19:23 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Cambonie-2006">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-04-07 19:19:57 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chowdhury-2013">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-04-07 19:20:22 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hollmann-1998">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-04-07 19:20:35 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kim-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-04-07 19:20:49 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kneyber-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-04-07 19:21:09 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Liet-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-04-07 19:21:24 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Martin_x00f3_n_x002d_Torres-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES MODIFIED="2015-09-15 22:50:55 +1000" MODIFIED_BY="[Empty name]">
<SOF_TABLE ID="SOF-01" MODIFIED="2015-09-15 22:50:55 +1000" MODIFIED_BY="[Empty name]" NO="1" NOTES="&lt;p&gt;The authors did not include the Primary outcome &lt;b&gt;Need for mechanical ventilation &lt;/b&gt;&lt;i&gt;This primary outcome is unavoidable but not relevant to a clinician who uses heliox that is inert gas. This data would unnecessarily overburden the table.&lt;/i&gt;&lt;/p&gt;&lt;p&gt;&lt;i&gt;&lt;/i&gt;&lt;/p&gt;&lt;p&gt;&lt;b&gt;Why does SoF table report on a secondary outcome?&lt;/b&gt;&lt;i&gt; &lt;/i&gt;&lt;/p&gt;&lt;p&gt;&lt;i&gt;This secondary outcome was the most investigated outcome and was the primary endpoint of four trials. Nevertheless, this outcome was classified in our protocol as a secondary outcome as it involves an element of subjectivity.&lt;/i&gt;&lt;/p&gt;" NOTES_MODIFIED="2015-09-15 22:50:55 +1000" NOTES_MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2015-02-02 20:19:21 +1000" MODIFIED_BY="[Empty name]">Summary of findings</TITLE>
<TABLE COLS="7" ROWS="13">
<TR>
<TD ALIGN="LEFT" COLSPAN="7" VALIGN="BOTTOM">
<P>
<B>Heliox inhalation compared with air/oxygen for acute bronchiolitis</B>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="7" VALIGN="BOTTOM">
<P>
<B>Patient or population: </B>infants with bronchiolitis</P>
<P>
<B>Settings: </B>paediatric intensive care unit and emergency department</P>
<P>
<B>Intervention: </B>heliox inhalation</P>
<P>
<B>Comparison: </B>air or oxygen inhalation</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="BOTTOM">
<P>Outcomes</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM">
<P>Illustrative comparative risks* (95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="BOTTOM">
<P>Relative effect<BR/>(95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="BOTTOM">
<P>No. of participants<BR/>(studies)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="BOTTOM">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="BOTTOM">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Assumed risk</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Corresponding risk</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Placebo</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Heliox</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Need for mechanical ventilation (invasive or not)</B>
<BR/>Follow-up in the acute phase of bronchiolitis</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>155 per 1000</B>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>148 per 1000</B>
<BR/>(94 to 235)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>RR 0.95</B>
<BR/>(0.61 to 1.49)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>408<BR/>(4 trials)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8853;</P>
<P>
<B>high</B>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<SUP>1, 2, 3, 4</SUP>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Rate of intubation (all reasons)</B>
<BR/>Follow-up in the acute phase of bronchiolitis</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>19 per 1000</B>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>54 per 1000</B>
</P>
<P>(18 to 168)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>RR 2.73</B>
</P>
<P>(0.96 to 7.75)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>408<BR/>(4 trials)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8853;&#8853;&#8854;&#8854;</P>
<P>
<B>low</B>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<SUP>1, 5, 3, 6</SUP>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Rate of emergency department discharge</B>
<BR/>Follow-up at 240 min</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>229 per 1000</B>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>118 per 1000</B>
<BR/>(39 to 355)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>RR 0.51</B>
</P>
<P>(0.17 to 1.55)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>69</P>
<P>(1 trial)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8854;</P>
<P>
<B>moderate</B>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<SUP>7</SUP>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Length of treatment</B>
<BR/>Follow-up in the acute phase of bronchiolitis</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>The mean length of treatment<BR/>ranged across control groups<BR/>from <B>2.04 to 2.63 days</B>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>The mean length of treatment</P>
<P>in the intervention groups<BR/>was <B>0.19 days lower</B>
<BR/>(0.56 lower to 0.19 higher)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>320</P>
<P>(2 trials)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8854;</P>
<P>
<B>moderate</B>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<SUP>1, 2, 8</SUP>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Length of treatment - nCPAP</B>
<BR/>Follow-up in the acute phase of bronchiolitis</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>The mean length of treatment<BR/>ranged across the control<BR/>subgroup (with nCPAP)</P>
<P>from <B>1.70 to 3.06 days</B>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>The mean length of treatment</P>
<P>in the intervention subgroup (with nCPAP)</P>
<P>was <B>0.76 days lower</B>
<BR/>(1.45 to 0.08 lower)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>21</P>
<P>(1 trial)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8853;&#8853;&#8854;&#8854;</P>
<P>
<B>low</B>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<SUP>9</SUP>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Change in clinical respiratory scores (m-WCAS) within the first hour after starting heliox treatment</B>
<BR/>Follow-up at the first hour after starting treatment</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>The mean change in m-WCAS<BR/>within the first hour after<BR/>starting heliox treatment<BR/>ranged across control groups<BR/>from <B>-0.35 to +0.04</B>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>The mean change in m-WCAS</P>
<P>in the intervention groups<BR/>was<B> 1.04 lower</B>
<BR/>(1.60 to 0.48 lower)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>138<BR/>(4 trials)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8854;</P>
<P>
<B>moderate</B>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<SUP>10, 11, 12</SUP>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="7" VALIGN="TOP">
<P>*Basis for the <B>comparative risks: </B>
</P>
<P>The<B> assumed risk </B>is based on the Control group risk or the median control group risk (95% CI) across studies.</P>
<P>The <B>corresponding risk</B> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI).<BR/>
<B>CI:</B> confidence interval; <B>RR:</B> risk ratio (Fixed effect); <B>nCPAP</B>: nasal continuous positive airway pressure; <B>m-WCAS</B>: modified Wood Clinical Asthma Score</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="7" VALIGN="TOP">
<P>GRADE Working Group grades of evidence<BR/>
<B>High quality:</B> Further research is very unlikely to change our confidence in the estimate of effect.<BR/>
<B>Moderate quality:</B> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<BR/>
<B>Low quality:</B> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<BR/>
<B>Very low quality:</B> We are very uncertain about the estimate.</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>1</SUP>The largest trial was at unclear risk of bias for blinding but at low risk for other bias.<BR/>
<SUP>2</SUP>No serious inconsistency: statistical heterogeneity was low: I<SUP>2</SUP> statistic = 0%.<BR/>
<SUP>3</SUP>No serious indirectness: the four trials were conducted in France, the United Kingdom and the USA.<BR/>
<SUP>4</SUP>The 95% CI around the risk ratio is narrow and excludes clinically important effects.<BR/>
<SUP>5</SUP>Downgraded by 1 for serious inconsistency: heterogeneity is present: I<SUP>2</SUP> statistic = 20%.</P>
<P>
<SUP>6</SUP>Downgraded by 1 for serious imprecision: the 95% CI around the risk ratio is wide.<BR/>
<SUP>7</SUP>Downgraded by 1 for serious risk of bias: only one trial is included.<BR/>
<SUP>8</SUP>Downgraded by 1: the 95% CI values around the mean change are under the unit (fraction of a day) and could be imprecise.<BR/>
<SUP>9</SUP>Downgraded by 2: only results from a subgroup of one trial are included.<BR/>
<SUP>10</SUP>The two trials are at low risk of bias.<BR/>
<SUP>11</SUP>Downgraded by 1: statistical heterogeneity was high (I<SUP>2</SUP> statistic = 80%) and remained when we kept only low risk of bias trials.<BR/>
<SUP>12</SUP>No serious indirectness: the four trials were conducted in France, the USA, the United Kingdom and Spain.</P>
</FOOTNOTES>
</SOF_TABLE>
</SOF_TABLES>
<ADDITIONAL_TABLES MODIFIED="2015-09-14 20:59:54 +1000" MODIFIED_BY="[Empty name]">
<ADDITIONAL_TABLE ID="TBL-01" MODIFIED="2015-01-28 02:55:50 +1000" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2013-10-17 08:19:27 +1000" MODIFIED_BY="[Empty name]">Mortality</TITLE>
<TABLE COLS="5" ROWS="5">
<TR>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P/>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Experimental</P>
<P>events</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Experimental</P>
<P>total</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Control</P>
<P>events</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Control</P>
<P>total</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Cambonie-2006" TYPE="STUDY">Cambonie 2006</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>0</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>10</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>0</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>9</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Chowdhury-2013" TYPE="STUDY">Chowdhury 2013</LINK>
</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>140</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>141</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Kim-2011" TYPE="STUDY">Kim 2011</LINK>
</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>34</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>35</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Liet-2005" TYPE="STUDY">Liet 2005</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>18</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>0</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>21</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-02" MODIFIED="2015-07-28 03:54:01 +1000" MODIFIED_BY="[Empty name]" NO="2">
<TITLE MODIFIED="2015-07-28 03:54:01 +1000" MODIFIED_BY="[Empty name]">Need for mechanical ventilation (invasive or not)</TITLE>
<TABLE COLS="5" ROWS="5">
<TR>
<TH VALIGN="BOTTOM">
<P/>
</TH>
<TH VALIGN="BOTTOM">
<P>Experimental</P>
<P>events</P>
</TH>
<TH VALIGN="BOTTOM">
<P>Experimental</P>
<P>total</P>
</TH>
<TH VALIGN="BOTTOM">
<P>Control</P>
<P>events</P>
</TH>
<TH VALIGN="BOTTOM">
<P>Control</P>
<P>total</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Cambonie-2006" TYPE="STUDY">Cambonie 2006</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>10</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>9</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Chowdhury-2013" TYPE="STUDY">Chowdhury 2013</LINK>
</P>
</TD>
<TD>
<P>24</P>
</TD>
<TD>
<P>140</P>
</TD>
<TD>
<P>27</P>
</TD>
<TD>
<P>141</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Kim-2011" TYPE="STUDY">Kim 2011</LINK>
</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>34</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>35</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Liet-2005" TYPE="STUDY">Liet 2005</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>18</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>21</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-03" MODIFIED="2015-07-28 03:54:35 +1000" MODIFIED_BY="[Empty name]" NO="3">
<TITLE MODIFIED="2015-07-28 03:54:35 +1000" MODIFIED_BY="[Empty name]">Rate of endotracheal intubation</TITLE>
<TABLE COLS="5" ROWS="5">
<TR>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P/>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Experimental</P>
<P>events</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Experimental</P>
<P>total</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Control</P>
<P>events</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Control</P>
<P>total</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Cambonie-2006" TYPE="STUDY">Cambonie 2006</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>10</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>9</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Chowdhury-2013" TYPE="STUDY">Chowdhury 2013</LINK>
</P>
</TD>
<TD>
<P>6</P>
</TD>
<TD>
<P>140</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>141</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Kim-2011" TYPE="STUDY">Kim 2011</LINK>
</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>34</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>35</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Liet-2005" TYPE="STUDY">Liet 2005</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>18</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>21</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-04" MODIFIED="2015-09-14 19:43:01 +1000" MODIFIED_BY="[Empty name]" NO="4">
<TITLE MODIFIED="2015-01-30 17:16:08 +1000" MODIFIED_BY="[Empty name]">Rate of emergency department discharge</TITLE>
<TABLE COLS="5" ROWS="2">
<TR>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P/>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Experimental</P>
<P>events</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Experimental</P>
<P>total</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Control</P>
<P>events</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Control</P>
<P>total</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Kim-2011" TYPE="STUDY">Kim 2011</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>34</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>8</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>35</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-05" MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]" NO="5">
<TITLE MODIFIED="2015-03-05 23:59:13 +1000" MODIFIED_BY="[Empty name]">Length of treatment for respiratory distress</TITLE>
<TABLE COLS="5" ROWS="3">
<TR>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P/>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Experimental</P>
<P>n</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Experimental</P>
<P>days (SD)</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Control</P>
<P>n</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Control</P>
<P>days (SD)</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Chowdhury-2013" TYPE="STUDY">Chowdhury 2013</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>140</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>2.268 (1.66)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>141</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>2.487 (1.86)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Liet-2005" TYPE="STUDY">Liet 2005</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>18</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1.25 (0.87)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>21</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1.29 (1.87)</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>SD: standard deviation</P>
</FOOTNOTES>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-06" MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]" NO="6">
<TITLE MODIFIED="2013-10-17 08:19:43 +1000" MODIFIED_BY="[Empty name]">Length of PICU stay</TITLE>
<TABLE COLS="5" ROWS="3">
<TR>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P/>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Experimental</P>
<P>n</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Experimental</P>
<P>days (SD)</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Control</P>
<P>n</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Control</P>
<P>days (SD)</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Cambonie-2006" TYPE="STUDY">Cambonie 2006</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>9</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4.9 (0.9)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>10</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>5.1 (0.8)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Liet-2005" TYPE="STUDY">Liet 2005</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>18</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>5.9 (13)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>21</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3.4 (2.7)</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>SD: standard deviation</P>
</FOOTNOTES>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-07" MODIFIED="2015-09-14 20:08:39 +1000" MODIFIED_BY="[Empty name]" NO="7">
<TITLE MODIFIED="2015-09-14 19:43:42 +1000" MODIFIED_BY="[Empty name]">Change in O<SUB>2</SUB> needs after 1 hour of heliox treatment</TITLE>
<TABLE COLS="5" ROWS="2">
<TR>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P/>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Experimental</P>
<P>n</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Experimental</P>
<P>mean (SD)</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Control</P>
<P>n</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Control</P>
<P>mean (SD)</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Cambonie-2006" TYPE="STUDY">Cambonie 2006</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>10</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>+0.5 (3.98)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>9</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-1.56 (6.52)</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>SD: standard deviation</P>
</FOOTNOTES>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-08" MODIFIED="2015-09-14 20:59:54 +1000" MODIFIED_BY="[Empty name]" NO="8">
<TITLE MODIFIED="2015-03-06 00:00:09 +1000" MODIFIED_BY="[Empty name]">Change in SpO<SUB>2</SUB> in the first hour after starting heliox treatment</TITLE>
<TABLE COLS="5" ROWS="2">
<TR>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P/>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Experimental</P>
<P>n</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Experimental</P>
<P>mean (SD)</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Control</P>
<P>n</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Control</P>
<P>mean (SD)</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Martin_x00f3_n_x002d_Torres-2008" TYPE="STUDY">Martinón-Torres 2008</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>12</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>8.0 (3.8)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>12</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>6.9 (3.7)</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>SD: standard deviation</P>
</FOOTNOTES>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-09" MODIFIED="2015-09-14 20:59:54 +1000" MODIFIED_BY="[Empty name]" NO="9">
<TITLE MODIFIED="2015-03-05 23:59:42 +1000" MODIFIED_BY="[Empty name]">Change in CO<SUB>2</SUB> within the first hour after starting heliox treatment</TITLE>
<TABLE COLS="5" ROWS="3">
<TR>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P/>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Experimental</P>
<P>n</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Experimental</P>
<P>mmHg (SD)</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Control</P>
<P>n</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Control</P>
<P>mmHg (SD)</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Cambonie-2006" TYPE="STUDY">Cambonie 2006</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>10</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-2.2 (0.78)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>9</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-2.1 (0.93)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Martin_x00f3_n_x002d_Torres-2008" TYPE="STUDY">Martinón-Torres 2008</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>12</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-9.7 (3.3)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>12</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-5.4 (1.6)</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>SD: standard deviation</P>
</FOOTNOTES>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-10" MODIFIED="2015-09-14 20:59:54 +1000" MODIFIED_BY="[Empty name]" NO="10">
<TITLE MODIFIED="2015-03-06 00:01:30 +1000" MODIFIED_BY="[Empty name]">Change in clinical respiratory scores (m-WCAS) within the first hour after starting heliox treatment</TITLE>
<TABLE COLS="5" ROWS="5">
<TR>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P/>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Experimental</P>
<P>n</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Experimental</P>
<P>mean (SD)</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Control</P>
<P>n</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Control</P>
<P>mean (SD)</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Cambonie-2006" TYPE="STUDY">Cambonie 2006</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>10</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-2.35 (0.81)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>9</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-0.06 (0.98)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Hollmann-1998" TYPE="STUDY">Hollmann 1998</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>13</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-0.46 (0.19)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>13</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-0.04 (0.19)</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Kim-2011" TYPE="STUDY">Kim 2011</LINK>
</P>
</TD>
<TD>
<P>34</P>
</TD>
<TD>
<P>-0.77 (0.77)</P>
</TD>
<TD>
<P>35</P>
</TD>
<TD>
<P>+0.1 (0.79)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Martin_x00f3_n_x002d_Torres-2008" TYPE="STUDY">Martinón-Torres 2008</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>12</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-2.12 (0.6)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>12</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-1.08 (0.4)</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>SD: standard deviation</P>
</FOOTNOTES>
</ADDITIONAL_TABLE>
</ADDITIONAL_TABLES>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2015-09-14 19:58:42 +1000" MODIFIED_BY="[Empty name]">
<COMPARISON ID="CMP-001" MODIFIED="2015-09-14 19:58:42 +1000" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Heliox inhalation versus air or oxygen inhalation</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="80.35137681463924" CI_START="0.15017144040102418" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="3.473684210526316" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-001.01" LOG_CI_END="1.9049933227655431" LOG_CI_START="-0.8234126535874637" LOG_EFFECT_SIZE="0.5407903345890397" METHOD="MH" MODIFIED="2015-07-30 02:53:43 +1000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="0.4371830578415459" Q="0.0" RANDOM="YES" SCALE="100.0" SORT_BY="YEAR" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="202" TOTAL_2="206" WEIGHT="100.0" Z="0.7769588456910399">
<NAME>Mortality</NAME>
<GROUP_LABEL_1>Heliox</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours heliox</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="80.35137681463924" CI_START="0.15017144040102418" EFFECT_SIZE="3.473684210526316" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.9049933227655431" LOG_CI_START="-0.8234126535874637" LOG_EFFECT_SIZE="0.5407903345890397" MODIFIED="2009-01-03 00:16:46 +1000" MODIFIED_BY="[Empty name]" ORDER="52" O_E="0.0" SE="1.6026791763371584" STUDY_ID="STD-Liet-2005" TOTAL_1="18" TOTAL_2="21" VAR="2.5685805422647525" WEIGHT="100.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2009-01-03 00:16:29 +1000" MODIFIED_BY="[Empty name]" ORDER="51" O_E="0.0" SE="0.0" STUDY_ID="STD-Cambonie-2006" TOTAL_1="10" TOTAL_2="9" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2015-02-02 20:40:20 +1000" MODIFIED_BY="[Empty name]" ORDER="19" O_E="0.0" SE="0.0" STUDY_ID="STD-Kim-2011" TOTAL_1="34" TOTAL_2="35" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2015-02-02 20:38:36 +1000" MODIFIED_BY="[Empty name]" ORDER="20" O_E="0.0" SE="0.0" STUDY_ID="STD-Chowdhury-2013" TOTAL_1="140" TOTAL_2="141" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.6961300342899377" CI_END="1.4912406265078186" CI_START="0.6063413711035558" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="RR" EFFECT_SIZE="0.950894781835549" ESTIMABLE="YES" EVENTS_1="30" EVENTS_2="32" I2="0.0" I2_Q="0.0" ID="CMP-001.02" LOG_CI_END="0.1735477268418688" LOG_CI_START="-0.21728279853229115" LOG_EFFECT_SIZE="-0.021867535845211172" METHOD="MH" MODIFIED="2015-07-30 02:53:57 +1000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.874113843695264" P_Q="1.0" P_Z="0.8263963699598367" Q="0.0" RANDOM="YES" SCALE="100.0" SORT_BY="YEAR" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="202" TOTAL_2="206" WEIGHT="99.99999999999999" Z="0.21932566626530048">
<NAME>Need for mechanical ventilation (invasive or not)</NAME>
<GROUP_LABEL_1>Heliox</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours heliox</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="4.010082992079552" CI_START="0.33942217998966273" EFFECT_SIZE="1.1666666666666667" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="4" LOG_CI_END="0.6031533608070199" LOG_CI_START="-0.4692597815457934" LOG_EFFECT_SIZE="0.06694678963061322" MODIFIED="2009-01-03 00:17:51 +1000" MODIFIED_BY="[Empty name]" ORDER="53" O_E="0.0" SE="0.629940788348712" STUDY_ID="STD-Liet-2005" TOTAL_1="18" TOTAL_2="21" VAR="0.3968253968253968" WEIGHT="13.281670375297395"/>
<DICH_DATA CI_END="12.379954515299232" CI_START="0.06542835024143234" EFFECT_SIZE="0.9" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.092719049062868" LOG_CI_START="-1.1842340301842182" LOG_EFFECT_SIZE="-0.045757490560675115" MODIFIED="2009-01-03 00:18:06 +1000" MODIFIED_BY="[Empty name]" ORDER="54" O_E="0.0" SE="1.3374935098492586" STUDY_ID="STD-Cambonie-2006" TOTAL_1="10" TOTAL_2="9" VAR="1.7888888888888888" WEIGHT="2.9462445375548794"/>
<DICH_DATA CI_END="73.21457045001645" CI_START="0.13005106216612491" EFFECT_SIZE="3.085714285714286" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.864597518713366" LOG_CI_START="-0.8858860964400181" LOG_EFFECT_SIZE="0.4893557111366741" MODIFIED="2015-02-02 20:46:05 +1000" MODIFIED_BY="[Empty name]" ORDER="22" O_E="0.0" SE="1.6156476906545747" STUDY_ID="STD-Kim-2011" TOTAL_1="34" TOTAL_2="35" VAR="2.6103174603174604" WEIGHT="2.0191046481145327"/>
<DICH_DATA CI_END="1.4725308060407567" CI_START="0.544267898422052" EFFECT_SIZE="0.8952380952380953" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="27" LOG_CI_END="0.16806438920009853" LOG_CI_START="-0.2641872801405773" LOG_EFFECT_SIZE="-0.0480614454702394" MODIFIED="2015-02-02 20:45:00 +1000" MODIFIED_BY="[Empty name]" ORDER="21" O_E="0.0" SE="0.25390677025098457" STUDY_ID="STD-Chowdhury-2013" TOTAL_1="140" TOTAL_2="141" VAR="0.06446864797928627" WEIGHT="81.75298043903318"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="2.9855850864041393" CI_END="6.6985715492877125" CI_START="1.0690002856559166" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="RR" EFFECT_SIZE="2.6759624249370844" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="5" I2="0.0" I2_Q="0.0" ID="CMP-001.03" LOG_CI_END="0.8259822005510994" LOG_CI_START="0.028977821260014452" LOG_EFFECT_SIZE="0.42748001090555693" METHOD="MH" MODIFIED="2015-09-14 19:58:21 +1000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.5602406574514707" P_Q="0.9444535886946864" P_Z="0.035510691644946905" Q="0.00485438711561919" RANDOM="NO" SCALE="500.0" SORT_BY="YEAR" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="404" TOTAL_2="412" WEIGHT="200.0" Z="2.102486378383324">
<NAME>Rate of endotracheal intubation</NAME>
<GROUP_LABEL_1>Heliox</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours heliox</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="2.493008227515649" CI_END="7.752409287283537" CI_START="0.9587863277207418" DF="2" EFFECT_SIZE="2.726335274969452" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="4" I2="19.775635799122302" ID="CMP-001.03.01" LOG_CI_END="0.889436693159904" LOG_CI_START="-0.018278167627300255" LOG_EFFECT_SIZE="0.43557926276630193" MODIFIED="2015-02-02 21:46:01 +1000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.2875082284395708" P_Z="0.059967770551141" STUDIES="4" TAU2="0.0" TOTAL_1="202" TOTAL_2="206" WEIGHT="100.0" Z="1.8810304960614677">
<NAME>Rate of intubation (all reasons)</NAME>
<DICH_DATA CI_END="6.049406303598463" CI_START="0.3999984403395708" EFFECT_SIZE="1.5555555555555556" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.7817127545329604" LOG_CI_START="-0.39794170205513407" LOG_EFFECT_SIZE="0.19188552623891317" MODIFIED="2009-01-03 00:19:21 +1000" MODIFIED_BY="[Empty name]" ORDER="56" O_E="0.0" SE="0.6929348671835832" STUDY_ID="STD-Liet-2005" TOTAL_1="18" TOTAL_2="21" VAR="0.48015873015873006" WEIGHT="64.10114610618619"/>
<DICH_DATA CI_END="12.379954515299232" CI_START="0.06542835024143234" EFFECT_SIZE="0.9" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.092719049062868" LOG_CI_START="-1.1842340301842182" LOG_EFFECT_SIZE="-0.045757490560675115" MODIFIED="2009-01-03 00:19:08 +1000" MODIFIED_BY="[Empty name]" ORDER="55" O_E="0.0" SE="1.3374935098492586" STUDY_ID="STD-Cambonie-2006" TOTAL_1="10" TOTAL_2="9" VAR="1.7888888888888888" WEIGHT="24.36593273042165"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2015-02-02 21:46:01 +1000" MODIFIED_BY="[Empty name]" ORDER="23" O_E="0.0" SE="0.0" STUDY_ID="STD-Kim-2011" TOTAL_1="34" TOTAL_2="35" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="230.21266516484368" CI_START="0.744553578649872" EFFECT_SIZE="13.092198581560284" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="0" LOG_CI_END="2.362129212690378" LOG_CI_START="-0.1281040446213514" LOG_EFFECT_SIZE="1.1170125840345133" MODIFIED="2015-02-02 21:45:44 +1000" MODIFIED_BY="[Empty name]" ORDER="24" O_E="0.0" SE="1.4627753421983385" STUDY_ID="STD-Chowdhury-2013" TOTAL_1="140" TOTAL_2="141" VAR="2.1397117017434666" WEIGHT="11.532921163392157"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.5137777243826989" CI_END="17.131145762496786" CI_START="0.37153316844977513" DF="1" EFFECT_SIZE="2.522853318034041" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" I2="0.0" ID="CMP-001.03.02" LOG_CI_END="1.2337864103495975" LOG_CI_START="-0.43000240873598394" LOG_EFFECT_SIZE="0.40189200080680676" MODIFIED="2015-09-14 19:58:21 +1000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.47350812745063" P_Z="0.3437062709003822" STUDIES="4" TAU2="0.0" TOTAL_1="202" TOTAL_2="206" WEIGHT="100.0" Z="0.9468675810539469">
<NAME>Rate of intubation for apnoea</NAME>
<DICH_DATA CI_END="17.348683976928424" CI_START="0.07845615914851056" EFFECT_SIZE="1.1666666666666667" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.23926653600094" LOG_CI_START="-1.1053729567397137" LOG_EFFECT_SIZE="0.06694678963061322" MODIFIED="2015-02-02 21:46:53 +1000" MODIFIED_BY="[Empty name]" ORDER="28" O_E="0.0" SE="1.3772528441885306" STUDY_ID="STD-Liet-2005" TOTAL_1="18" TOTAL_2="21" VAR="1.8968253968253967" WEIGHT="64.94549627079748"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2015-02-02 21:47:37 +1000" MODIFIED_BY="[Empty name]" ORDER="25" O_E="0.0" SE="0.0" STUDY_ID="STD-Cambonie-2006" TOTAL_1="10" TOTAL_2="9" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2015-02-02 21:47:20 +1000" MODIFIED_BY="[Empty name]" ORDER="27" O_E="0.0" SE="0.0" STUDY_ID="STD-Kim-2011" TOTAL_1="34" TOTAL_2="35" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="103.95040543776952" CI_START="0.24392273704286288" EFFECT_SIZE="5.035460992907802" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.0168261875495723" LOG_CI_START="-0.6127477154221813" LOG_EFFECT_SIZE="0.7020392360636954" MODIFIED="2015-02-02 21:47:30 +1000" MODIFIED_BY="[Empty name]" ORDER="26" O_E="0.0" SE="1.544624727206357" STUDY_ID="STD-Chowdhury-2013" TOTAL_1="140" TOTAL_2="141" VAR="2.3858655478973128" WEIGHT="35.05450372920252"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.5517499450619276" CI_START="0.1707247653990715" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.5147058823529411" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="8" I2="0.0" I2_Q="0.0" ID="CMP-001.04" LOG_CI_END="0.19082173868169622" LOG_CI_START="-0.7677034753936176" LOG_EFFECT_SIZE="-0.2884408683559607" METHOD="MH" MODIFIED="2015-07-30 02:54:53 +1000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Q="1.0" P_Z="0.23816306483016025" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="QUALITY" SORT_BY_QUALITY_ITEM_ID="QIT-01" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="34" TOTAL_2="35" WEIGHT="100.0" Z="1.179590699014668">
<NAME>Rate of emergency department discharge</NAME>
<GROUP_LABEL_1>Heliox</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours heliox</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.5517499450619276" CI_START="0.1707247653990715" EFFECT_SIZE="0.5147058823529411" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="8" LOG_CI_END="0.19082173868169622" LOG_CI_START="-0.7677034753936176" LOG_EFFECT_SIZE="-0.2884408683559607" MODIFIED="2015-02-03 01:23:41 +1000" MODIFIED_BY="[Empty name]" ORDER="49" O_E="0.0" SE="0.5630424555241719" STUDY_ID="STD-Kim-2011" TOTAL_1="34" TOTAL_2="35" VAR="0.31701680672268906" WEIGHT="100.0"/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="2.194364734903328" CI_END="0.009030758811678363" CI_START="-0.6483689560689736" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.3196690986286476" ESTIMABLE="YES" I2="8.857448892236723" I2_Q="51.65113060678779" ID="CMP-001.05" MODIFIED="2015-07-30 02:55:14 +1000" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.3338105727458657" P_Q="0.15038905298010308" P_Z="0.056635211412493336" Q="2.06830069151605" RANDOM="YES" SCALE="2.0" SORT_BY="YEAR" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.010420620874479319" TOTALS="SUB" TOTAL_1="167" TOTAL_2="174" UNITS="" WEIGHT="200.0" Z="1.906115582652108">
<NAME>Length of treatment for respiratory distress</NAME>
<GROUP_LABEL_1>Heliox</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours heliox</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.12606404338727825" CI_END="0.18672543023223076" CI_START="-0.5624413030467285" DF="1" EFFECT_SIZE="-0.18785793640724885" ESTIMABLE="YES" I2="0.0" ID="CMP-001.05.01" MODIFIED="2015-02-02 23:44:36 +1000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.722548469960226" P_Z="0.3256345972800829" STUDIES="2" TAU2="0.0" TOTAL_1="158" TOTAL_2="162" WEIGHT="99.99999999999999" Z="0.9829448458201169">
<NAME>Length of treatment (all routes)</NAME>
<CONT_DATA CI_END="0.8580516404627806" CI_START="-0.9380516404627807" EFFECT_SIZE="-0.040000000000000036" ESTIMABLE="YES" MEAN_1="1.25" MEAN_2="1.29" MODIFIED="2015-02-02 23:44:36 +1000" MODIFIED_BY="[Empty name]" ORDER="34" SD_1="0.875" SD_2="1.875" SE="0.4581980319773717" STUDY_ID="STD-Liet-2005" TOTAL_1="18" TOTAL_2="21" WEIGHT="17.397800889805243"/>
<CONT_DATA CI_END="0.19314751324953178" CI_START="-0.6311475132495323" EFFECT_SIZE="-0.2190000000000003" ESTIMABLE="YES" MEAN_1="2.268" MEAN_2="2.487" MODIFIED="2015-02-02 23:44:11 +1000" MODIFIED_BY="[Empty name]" ORDER="33" SD_1="1.66" SD_2="1.86" SE="0.21028320749794335" STUDY_ID="STD-Chowdhury-2013" TOTAL_1="140" TOTAL_2="141" WEIGHT="82.60219911019475"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.07558348802648829" CI_START="-1.4464165119735115" DF="0" EFFECT_SIZE="-0.7609999999999999" ESTIMABLE="YES" I2="0.0" ID="CMP-001.05.02" MODIFIED="2015-03-06 00:23:03 +1000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.029548032551501062" STUDIES="1" TAU2="0.0" TOTAL_1="9" TOTAL_2="12" WEIGHT="100.0" Z="2.1760966743278902">
<NAME>Length of treatment - administration by CPAP</NAME>
<CONT_DATA CI_END="-0.07558348802648829" CI_START="-1.4464165119735115" EFFECT_SIZE="-0.7609999999999999" ESTIMABLE="YES" MEAN_1="1.619" MEAN_2="2.38" MODIFIED="2015-02-02 23:46:08 +1000" MODIFIED_BY="[Empty name]" ORDER="31" SD_1="0.487" SD_2="1.073" SE="0.3497087280072438" STUDY_ID="STD-Chowdhury-2013" TOTAL_1="9" TOTAL_2="12" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="1.2036260522260542" CI_END="1.712530037675454" CI_START="-1.5416775979341244" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0854262198706647" ESTIMABLE="YES" I2="16.91771724693535" I2_Q="0.0" ID="CMP-001.06" MODIFIED="2015-03-06 00:52:03 +1000" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.2725982153352129" P_Q="1.0" P_Z="0.9180407127010507" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="YEAR" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.6166507936507927" TOTALS="YES" TOTAL_1="27" TOTAL_2="31" UNITS="" WEIGHT="100.0" Z="0.10290204745988148">
<NAME>Length of PICU stay</NAME>
<GROUP_LABEL_1>Heliox</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours heliox</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="7.261824533029072" CI_START="-2.261824533029071" EFFECT_SIZE="2.5000000000000004" ESTIMABLE="YES" MEAN_1="5.9" MEAN_2="3.4" MODIFIED="2015-02-03 03:12:13 +1000" MODIFIED_BY="[Empty name]" ORDER="36" SD_1="10.0" SD_2="2.7" SE="2.4295469562653884" STUDY_ID="STD-Liet-2005" TOTAL_1="18" TOTAL_2="21" WEIGHT="10.571341476691261"/>
<CONT_DATA CI_END="0.5691454078305977" CI_START="-0.9691454078305963" EFFECT_SIZE="-0.1999999999999993" ESTIMABLE="YES" MEAN_1="4.9" MEAN_2="5.1" MODIFIED="2015-02-02 23:58:03 +1000" MODIFIED_BY="[Empty name]" ORDER="35" SD_1="0.9" SD_2="0.8" SE="0.3924283374069717" STUDY_ID="STD-Cambonie-2006" TOTAL_1="9" TOTAL_2="10" WEIGHT="89.42865852330874"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="6.982365859853104" CI_START="-2.8623658598531034" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="2.06" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.07" MODIFIED="2015-09-14 19:58:35 +1000" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="1.0" P_Q="1.0" P_Z="0.4120787973644754" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="9" UNITS="" WEIGHT="99.99999999999999" Z="0.8202409010436705">
<NAME>Change in O<SUB>2</SUB> needs after 1 hour of heliox treatment</NAME>
<GROUP_LABEL_1>Heliox</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours heliox</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="6.982365859853104" CI_START="-2.8623658598531034" EFFECT_SIZE="2.06" ESTIMABLE="YES" MEAN_1="0.5" MEAN_2="-1.56" MODIFIED="2015-07-28 03:39:25 +1000" MODIFIED_BY="[Empty name]" ORDER="30" SD_1="3.98" SD_2="6.52" SE="2.5114573016035484" STUDY_ID="STD-Cambonie-2006" TOTAL_1="10" TOTAL_2="9" WEIGHT="99.99999999999999"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="4.100836503184372" CI_START="-1.9008365031843728" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="1.0999999999999996" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.08" MODIFIED="2015-09-14 19:58:42 +1000" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="1.0" P_Q="1.0" P_Z="0.47247794186277126" Q="0.0" RANDOM="NO" SCALE="5.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="12" TOTAL_2="12" UNITS="" WEIGHT="100.0" Z="0.7184531315538972">
<NAME>Change in SpO<SUB>2</SUB> in the first hour after starting heliox treatment</NAME>
<GROUP_LABEL_1>Heliox</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours heliox</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="4.100836503184372" CI_START="-1.9008365031843728" EFFECT_SIZE="1.0999999999999996" ESTIMABLE="YES" MEAN_1="8.0" MEAN_2="6.9" MODIFIED="2015-07-28 03:44:42 +1000" MODIFIED_BY="[Empty name]" ORDER="31" SD_1="3.8" SD_2="3.7" SE="1.531067165955389" STUDY_ID="STD-Martin_x00f3_n_x002d_Torres-2008" TOTAL_1="12" TOTAL_2="12" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="13.80526540961881" CI_END="2.0245243157487827" CI_START="-6.195025903050368" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="MD" EFFECT_SIZE="-2.085250793650793" ESTIMABLE="YES" I2="92.75638699924414" I2_Q="0.0" ID="CMP-001.09" MODIFIED="2015-07-30 02:56:26 +1000" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="2.0276989618595032E-4" P_Q="1.0" P_Z="0.3199978583806793" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="YEAR" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="8.181113333333329" TOTALS="YES" TOTAL_1="22" TOTAL_2="21" UNITS="" WEIGHT="99.99999999999999" Z="0.9944623113176182">
<NAME>Change in CO<SUB>2</SUB> in the 1st hour after starting treatment</NAME>
<GROUP_LABEL_1>Heliox</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours heliox</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.6764525402880308" CI_START="-0.876452540288031" EFFECT_SIZE="-0.10000000000000009" ESTIMABLE="YES" MEAN_1="-2.2" MEAN_2="-2.1" MODIFIED="2009-01-03 00:29:42 +1000" MODIFIED_BY="[Empty name]" ORDER="62" SD_1="0.78" SD_2="0.93" SE="0.3961565347182853" STUDY_ID="STD-Cambonie-2006" TOTAL_1="10" TOTAL_2="9" WEIGHT="52.73212396069538"/>
<CONT_DATA CI_END="-2.224997567504718" CI_START="-6.37500243249528" EFFECT_SIZE="-4.299999999999999" ESTIMABLE="YES" MEAN_1="-9.7" MEAN_2="-5.4" MODIFIED="2009-01-03 00:30:02 +1000" MODIFIED_BY="[Empty name]" ORDER="63" SD_1="3.3" SD_2="1.6" SE="1.058694164210483" STUDY_ID="STD-Martin_x00f3_n_x002d_Torres-2008" TOTAL_1="12" TOTAL_2="12" WEIGHT="47.2678760393046"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="37.06721301979709" CI_END="-0.7738707254664916" CI_START="-1.7812019352043358" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="MD" EFFECT_SIZE="-1.2775363303354137" ESTIMABLE="YES" I2="89.20879215315256" I2_Q="72.00251997204678" ID="CMP-001.10" MODIFIED="2015-07-30 02:56:49 +1000" MODIFIED_BY="[Empty name]" NO="10" P_CHI2="1.7447936606629355E-7" P_Q="0.05877050272793627" P_Z="6.646977996244738E-7" Q="3.5717500253650725" RANDOM="YES" SCALE="4.0" SORT_BY="YEAR" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.3325393716463591" TOTALS="SUB" TOTAL_1="103" TOTAL_2="104" UNITS="" WEIGHT="200.0" Z="4.971403987474026">
<NAME>Change in clinical respiratory scores in the first hour after starting heliox</NAME>
<GROUP_LABEL_1>Heliox</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours heliox</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="-1.124795842041665" CI_START="-3.4352041579583346" DF="0" EFFECT_SIZE="-2.28" ESTIMABLE="YES" I2="0.0" ID="CMP-001.10.01" MODIFIED="2015-03-18 09:39:55 +1000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="1.095805788042036E-4" STUDIES="1" TAU2="0.0" TOTAL_1="34" TOTAL_2="35" WEIGHT="100.0" Z="3.8683360460277174">
<NAME>Respiratory distress assessment instrument (RDAI)</NAME>
<CONT_DATA CI_END="-1.124795842041665" CI_START="-3.4352041579583346" EFFECT_SIZE="-2.28" ESTIMABLE="YES" MEAN_1="-3.05" MEAN_2="-0.77" MODIFIED="2015-03-06 02:37:54 +1000" MODIFIED_BY="[Empty name]" ORDER="47" SD_1="2.53" SD_2="2.36" SE="0.5894007068856559" STUDY_ID="STD-Kim-2011" TOTAL_1="34" TOTAL_2="35" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="28.845872752531463" CI_END="-0.482587038588419" CI_START="-1.6019084928754832" DF="3" EFFECT_SIZE="-1.042247765731951" ESTIMABLE="YES" I2="89.59989865539178" ID="CMP-001.10.02" MODIFIED="2015-03-18 09:39:55 +1000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="2.4128156237424037E-6" P_Z="2.6222858002239186E-4" STUDIES="4" TAU2="0.27238400960823955" TOTAL_1="69" TOTAL_2="69" WEIGHT="100.0" Z="3.650011488617585">
<NAME>Modified Wood Clinical Asthma Score (m-WCAS)</NAME>
<CONT_DATA CI_END="-0.2739353865699483" CI_START="-0.5660646134300518" EFFECT_SIZE="-0.42000000000000004" ESTIMABLE="YES" MEAN_1="-0.46" MEAN_2="-0.04" MODIFIED="2015-03-06 02:38:40 +1000" MODIFIED_BY="[Empty name]" ORDER="32" SD_1="0.19" SD_2="0.19" SE="0.07452413135250993" STUDY_ID="STD-Hollmann-1998" TOTAL_1="13" TOTAL_2="13" WEIGHT="29.336329849120908"/>
<CONT_DATA CI_END="-1.4763880210631173" CI_START="-3.1036119789368826" EFFECT_SIZE="-2.29" ESTIMABLE="YES" MEAN_1="-2.35" MEAN_2="-0.06" MODIFIED="2015-03-06 02:35:05 +1000" MODIFIED_BY="[Empty name]" ORDER="31" SD_1="0.81" SD_2="0.98" SE="0.4151157803686956" STUDY_ID="STD-Cambonie-2006" TOTAL_1="10" TOTAL_2="9" WEIGHT="18.33501849721143"/>
<CONT_DATA CI_END="-0.6320009613204804" CI_START="-1.4479990386795196" EFFECT_SIZE="-1.04" ESTIMABLE="YES" MEAN_1="-2.12" MEAN_2="-1.08" MODIFIED="2015-03-06 02:34:37 +1000" MODIFIED_BY="[Empty name]" ORDER="34" SD_1="0.6" SD_2="0.4" SE="0.20816659994661327" STUDY_ID="STD-Martin_x00f3_n_x002d_Torres-2008" TOTAL_1="12" TOTAL_2="12" WEIGHT="25.82587493681925"/>
<CONT_DATA CI_END="-0.5019144646156013" CI_START="-1.2380855353843987" EFFECT_SIZE="-0.87" ESTIMABLE="YES" MEAN_1="-0.77" MEAN_2="0.1" MODIFIED="2015-03-06 02:34:16 +1000" MODIFIED_BY="[Empty name]" ORDER="33" SD_1="0.77" SD_2="0.79" SE="0.18780219345243607" STUDY_ID="STD-Kim-2011" TOTAL_1="34" TOTAL_2="35" WEIGHT="26.502776716848416"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2015-09-16 02:01:44 +1000" MODIFIED_BY="[Empty name]">
<FIGURE FILENAME="Risk of bias graph.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2015-09-16 02:01:44 +1000" MODIFIED_BY="[Empty name]" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_GRAPH_PLOT">
<CAPTION>
<P>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAiMAAADnCAMAAAD7EqYIAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2015-09-16 02:01:44 +1000" MODIFIED_BY="[Empty name]" NO="2" REF_ID="CMP-001.02" SETTINGS="SHOW_MORE_DECIMALS:NO;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;SHOW_ROB_TABLE:NO;SHOW_EFFECT_SIZE_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 Heliox inhalation versus air or oxygen inhalation, outcome: 1.2 Need for mechanical ventilation (invasive or not).</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAyAAAADACAMAAADLAvdFAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-03" MODIFIED="2015-09-16 02:01:44 +1000" MODIFIED_BY="[Empty name]" NO="3" REF_ID="CMP-001.03" SETTINGS="SHOW_MORE_DECIMALS:NO;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;SHOW_ROB_TABLE:NO;SHOW_EFFECT_SIZE_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 Heliox inhalation versus air or oxygen inhalation, outcome: 1.3 Rate of endotracheal intubation.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAxYAAAGQCAMAAAAEFgZ5AAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-04" MODIFIED="2015-09-16 02:01:44 +1000" MODIFIED_BY="[Empty name]" NO="4" REF_ID="CMP-001.04" SETTINGS="SHOW_MORE_DECIMALS:NO;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;SHOW_ROB_TABLE:NO;SHOW_EFFECT_SIZE_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 Heliox inhalation versus air or oxygen inhalation, outcome: 1.4 Rate of emergency department discharge.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAABAoAAACQCAMAAAC2yHkoAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-05" MODIFIED="2015-09-16 02:01:44 +1000" MODIFIED_BY="[Empty name]" NO="5" REF_ID="CMP-001.05" SETTINGS="SHOW_MORE_DECIMALS:NO;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;SHOW_ROB_TABLE:NO;SHOW_EFFECT_SIZE_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 Heliox inhalation versus air or oxygen inhalation, outcome: 1.5 Length of treatment for respiratory distress.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAA1sAAAEgCAMAAAB1mJkcAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-06" MODIFIED="2015-09-16 02:01:44 +1000" MODIFIED_BY="[Empty name]" NO="6" REF_ID="CMP-001.10" SETTINGS="SHOW_MORE_DECIMALS:NO;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;SHOW_ROB_TABLE:NO;SHOW_EFFECT_SIZE_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 Heliox inhalation versus air or oxygen inhalation, outcome: 1.10 Change in clinical respiratory scores in the first hour after starting heliox.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAA1oAAAFACAMAAACSrv14AAADAFBMVEUAAADAAAAAwAAAAMDg4ADA
AMAAwMD/gADAwMD/gICA/4CAgP/g4OBAAAAAQAAAAECAgID///8AAAALCwsWFhYhISEsLCw3NzdC
QkJNTU1YWFhjY2Nubm55eXmEhISPj4+ampqlpaWwsLC7u7vGxsbR0dHc3Nzn5+cAAAAAADMAAGYA
AJkAAMwAAP8AMwAAMzMAM2YAM5kAM8wAM/8AZgAAZjMAZmYAZpkAZswAZv8AmQAAmTMAmWYAmZkA
mcwAmf8AzAAAzDMAzGYAzJkAzMwAzP8A/wAA/zMA/2YA/5kA/8wA//8zAAAzADMzAGYzAJkzAMwz
AP8zMwAzMzMzM2YzM5kzM8wzM/8zZgAzZjMzZmYzZpkzZswzZv8zmQAzmTMzmWYzmZkzmcwzmf8z
zAAzzDMzzGYzzJkzzMwzzP8z/wAz/zMz/2Yz/5kz/8wz//9mAABmADNmAGZmAJlmAMxmAP9mMwBm
MzNmM2ZmM5lmM8xmM/9mZgBmZjNmZmZmZplmZsxmZv9mmQBmmTNmmWZmmZlmmcxmmf9mzABmzDNm
zGZmzJlmzMxmzP9m/wBm/zNm/2Zm/5lm/8xm//+ZAACZADOZAGaZAJmZAMyZAP+ZMwCZMzOZM2aZ
M5mZM8yZM/+ZZgCZZjOZZmaZZpmZZsyZZv+ZmQCZmTOZmWaZmZmZmcyZmf+ZzACZzDOZzGaZzJmZ
zMyZzP+Z/wCZ/zOZ/2aZ/5mZ/8yZ///MAADMADPMAGbMAJnMAMzMAP/MMwDMMzPMM2bMM5nMM8zM
M//MZgDMZjPMZmbMZpnMZszMZv/MmQDMmTPMmWbMmZnMmczMmf/MzADMzDPMzGbMzJnMzMzMzP/M
/wDM/zPM/2bM/5nM/8zM////AAD/ADP/AGb/AJn/AMz/AP//MwD/MzP/M2b/M5n/M8z/M///ZgD/
ZjP/Zmb/Zpn/Zsz/Zv//mQD/mTP/mWb/mZn/mcz/mf//zAD/zDP/zGb/zJn/zMz/zP///wD//zP/
/2b//5n//8z///9BjlLGAAA6wElEQVR42u19DXAcx3Xmw8/O7OyCAGYBWKREUgBBSylbVmySAokf
WvGCto6hc8opsnMVxzrZdaUoictO6liOrXJFds53Nl3x5VwV25J8dYpKURw7uvgnpqU4AkoSsBC5
piCfIisnGSBAiiREApwBQCwWuwNgr7tnZnd+d2axP9gF30dip6en+/Xv637d029enQgIBKL0qMcq
QCCQtRAIZC0E4vpGg1BrOY52TWk/+m3upgxoz9Q3/OkLDWbPke8p9jxVouhdbzaMnOtyT42EuBjY
tkIzJEKd0AT1QaV2O2dtl3crzFrDw+Wj3bHY8PbCeKvF9+FDm1XWG+Dfe1TG2/XvS9IqSfRdfivR
9/Zbtd22NVze2mUt6TjHZyQ2dEUBmnmuBZRACKQg31HCVJIDwYgwnCAJcHwzTSopBCMccRBnKKSl
WznwaUjztPAk3eMSdIQ5LjhCsvK4ENS3eiNhaCc+3ADcu538RbR6ikabBMi6WXiJlCmk6LSqErVc
3toTCLtgiv08UicF+j6bIi7yv+XAIz/cJyvbeub/58HZUlZb3e6RE/Tauv9q436JpLYYOnCWXIZJ
Fv7v1a+p6a6wPFWi6C+trTZcuAmmvn3gkR9l/iyVuVp/4ef/ba0LHhcOTK1qlXPh+9PEZ4LkcY3m
M1tPv5BOEPdPz1M3C//tA1eF/VdWHznwv/+R0KrKpq7l8tbirBWl0xSswMQkpDWvFDRPQhKmxpZX
xkray/shos5eMHkWDhDHc7Owrs9obXq6FUOgV+kLkGsamidIDSR3NX8SMuR+KpcrkuE6Y5RsPSUj
1H0bc7PwKZicHV4hlyClVZWo5fLW1dwr4ygZmegPkQAARhTiIv8Dh4chGktBy354eaGkEkn/0xH1
ShIYTdPE1RTVfGjpMncliv7Ux04ffOpjtLzkNpYS3xcP3m7IDvuV7mUZ0j1z9QRGtxaCdl9KazRd
lU1dy+Wt3bVWHTw9PKxvBzWAJBEfJTUWS8ZLOmzCLfraTnKoLC3dimFHTIntYOmSwqdgCc6/aQuz
DRrd6slUZxADCXRa6eps5Foub+2yVhC6Z6Ih7YaD8W7i09YXOjkQLWUqwt4VKRkN09T2kFTMjZRN
t4IS0kBAS7eD5KoBbh23be+IMOdWT6Y6U+8EnVaVSoS1W97aZa2pM4nO089rN9NnjiXOzCsHXpKO
vNTTXsJUZv9xbXvLmXmY2pfYf2ZR9w2P3mRMt4KlblSH6OmhYwun5yEUW3jWKkRtP/yK4FZPzJ0V
mEmZbj71gk6rOlHD5a3D47kIBM5aCASyFgKBrIVAIJC1EAhkLQQCWQuBQJSNtaQmnhsMx6HdfGI3
6v4KNp4Z5Piw4iNkYYhGowqMRP3TUzIcz326g0bkgxELKQOdkZBzsUgQUu4CEtTrikThgqJ7goa6
tBAnJZT4KCeBEuVtITRXe8hMORSlh/o7okezSXHc0XbHCnRvsyaOO66QVFk2W7lHAb4xotXOUW6w
KW6NLEikuAJXUTWoaDSoFTVoKKqgFFZU0isGM3GQ9KK2ADRF9HbhuYxSuh7rwVpP9mxL/+Tg++H2
Xr+RPzD4t+n5g39cjnx56umYIA62pJpfWyKu4ZmG944YnlBdrpw+Vx49q7vg7wtIcJdWV7q+kFuC
eepyFW7ph4FbyDVgiGrC7ZbsckDPa1+Bl7KJpZtTywX22p6m8HgbSXVomKT30cSnYeZzh9mTmSMj
b7/S8xvWCL2dAHt6Q4HKDvkCO1Wbyp10GU4v9G4rjEbjYPPnB49AN5ymRV05twLxVfUUjbLYMDM0
2FqxWeuzpL6F4ZWAqozExgMlTIdkgYwgijp+HOdVraUmNhor8C4S4zE9NEDLUTKyxEPB1qhZn0kL
EI0+ThVmfMCHno4RKdIQc8Osh0eehX/nEILlg+lZMVq2oX5Mgt8eYwlyfLNEysAFQkmSYCTEP+7I
F6yuWIJUX8ghQarfxRLUaFlB6hRGyF8HBKQMzzVTtSK97uj8yo+w2EachX7y+5swm/OaIxSUMMcL
I5oumdZmAJQmrfXWMN/aGuT1DKRBogfDtwML9EQgA7+mzZrb+4WINGzj1LFUe0fi1LyWx2xa4fIe
77rCzqanjEUVYN3SLpJwVMzWNfUU+JbWB7JiCw9z+0hR19UDams7MnBEEyJaB4KRw1QLr0KsVQ/7
SKWRpsod4248GJLoYKnAk0AboGU8dPIAVf2bvUgfN8D7BOMUAZlTvd+COw79ZJXdXX0LWg6cDO83
jA6fCR9q9JOtkTVYo5Q7D5xsGu+Cpbn0ub4j5P5PmvqcVDgCsP9Tev9+N6zaA6j5SNOiLfGE1jVr
gOQfgEIpdx0Ihw90wp1X08uHaLOtTfY/6Fht+7IlfwMcRovWA2HhQAtLMEvLjDWST578rcGVzsHQ
woEu6pmtu2OT/R9Mg+VAfeR0qh1GUqcNM0g7KXvLM+ml3ifpVN/Ut6y1GTQPngyzpsrM9+/LXOv/
jBbhfnr8MUPSTXLhq6S175dSZ9UnQVISB2zLJH63fgG0PGbTeuZSWftl4FT/CCT7TxmKOkL6m7ld
nuw9ta7XdTMd8Bb7969/s08fHepoUe8jRU3wYQnqO+qV9KQ+Mr5Z0bXW4hj0Phw2nRvnYeLnAG8T
1v8UY/0VmGxmQkmSjQwvWGNMT8KPSRM1y2p3teszTU8A76tmfejpGLDAw+u3f1rt4REW0DatZfOR
rNdomUXKiY7+iFrCCTI3JM8cbyadniS4w4mcqa4iTkffs/pdkKNlQl1vPB07P6rEe+sCd8BkklVr
ru6mdzgVlCOj+AAEDAuN2+MLsPw7zc3wBGi6ZGqbwR2wb5KN/FMk+FyAPVdTEPbSItUtNR28GYTw
/j18F88GP101zYLZUO/rwQBoeVyu19K6LVLejvlNOEZWBX9lKOrDp16wtMtnYXJKr+s7aPkD7E+v
60bYK9C8xkZDB3eBsBDs4PfQtaVrUcvGWoFL42Nw8E7j0wGI9JCZOLY6szpGp+YMvV9j3Ymi59LL
5hiRCBlb1qEnoPU5ErbHVIhIxJ8KxuvQSv5o/M/dSzv+7es/hwGV5IATJz71SgxeUzXpHZU8DPnI
0jJ3ICKCXGElvPdeGILnHv52ExzOk6ChrlyUmlldUGRpmXAKXjrcGGkciBLXCE2UcZKx7hzSnRwJ
SsLI2dzC7heja9dAfM+6Kir20EhqmxGaEXWQibBZnT2n+Hq8ORWrg8RQYIIMXPPpj6zMpZqZZDvq
UpJ5MnSBnkfxz7W0yt037479Ryk1+slcUV8dgb2WdumnZTTUdY/6p9f1W6eXIjGARKpnksxT8+mz
K1N0bQkGzYVKbb5H5i+9orF8jAmGtLZpHgID7xzgNGlCgiOGGAuXxkl9j+r9iykvNYCUlZA0faYR
PUDcZ5H86OmY+rE8M64JgreAg8hp0KtKONIKxPixAGgaPmkyYr71Rv4Ec3W1DRxl3Kx+lzOtABlz
OTLFKOS3PqtBZKw7p1T5frGPN/RqKdQr0hIZRIGY2mb1LppkgSUlkanXJSaAvY2Bvtk1dUq8NW9H
YXk0p1VGRBondvc3GuTBuaZDnZa61IrqoksHkUQ6mTG0TTcXmQhk1PnsloqyVjAaifyYzqJs4J9p
Z3LU3k5y+SkZC1iJvgfd4zBmiJGM/BOJcT+0dzKPrm7SZZIw3piTYJg+UwN0qAGO7PUnEPrQ0zHt
J0VHIo2qoCStgOAkSbF80NGqHrY50WocaFBFYKbTQ4renS9Bva7Ari+ky11Mv2svG1KcaP0bGXMn
CIV+UjgO9iiqWhGpu7ZcGPs8wsEg2xvJbm/Mv4tX6k21s6K2mV2TTI0k8B2RAQFCD7SrTZGUYWyG
9QKB+4IUiYZcSqzlsd6jJUqHOdLpgsaiyi8lFXNdBqC7U69r3l7U0AOKSKYEgZ9Ri5p6A2LK/ezJ
qKqFVynWunY6wX0x/jw8PboL5NgnaUddPbX0DZr3URijcwjVfzl2Jqcg/2L8w4Ej8XnojS2pWoIN
y2PDpAq+LtKJjC0ZVH0meezaT9Xklk5f9bdx6qWnY176xAf5xSGqgxPdsfoLh56u5YPqWYViYSda
/0PlzGlVp2c+1rmWL0G9rhz0hVRo+l20LsN7nWjtIHXaBrNjMPomyd3+cHxB7T5fr9frDuDR0Z2W
WBOjMDrBmE7HUwOtwtjCPYbNS7XNps98JWH5lgGTT8P1C4mPSxB+avF9Q9PEryEAfCcrwOwPnt2e
YGVygpbHkCmtciJZBzFzUbnDreZ2GX5puV6va3NRWaR/fiucHJehqaFz6cw03fHZQdeWrKhDqzta
h8qss+VHX0uCG/tenfNNkgudnfjcaaedzQp9QqKGQepu212nPF9VdVzbwGdTZvYka7BG2hMbyPWG
6mczWIvP1IcKWPaNfGgNAqFZR6EijdyzwbozIewdxI6mZw7XYI2E5zbwOb8N1c9msBYCgUAgrlf8
TpXlpxFnLcQWQZV1ZVQqQSCQtRCIWmWtcPb9XIi4lOMc16SfEGxSH6k6Qi62QCzqLyP53slFo+Co
R1U2aGnYVHR8p63rXkWCTC+MC7Xn9MOo+lMHI340gp0KYWUtJXQw66KaQm3jTT/tuYN5zIR79FBU
R8jlOL5F4ejhg/nT9qVHVTJoadiUonynreleSffSN/vDqeZDtBY0/bAXiPO77HFsWcFehbCw1l0W
Vxom9mmnhj5mPIZNdYQ0vaYOgePCVFtT5IU46FpaisBzQoRn6ka6Lk04GIoqEGeHiDQ9GxJcjZ+z
V6XpZ42EOY7Q6yB0wjM0SU1Px+xvzoP2jGntNIt0MtGeG2xi6bOlGOaT5rTDQk6pTAxxra38AyOQ
1aOi4QMagT0TDVotsHMBqn7YPXAaBpn35b53YK9CWFgrnrWoF79AfzP0RPF9zOPui0bJCAK6XtO1
3pmWg/TE+drJXk3SuroAzVIq0bucoupGqt4SUP2eAIn4IXacSNOzIVDja4pJV9/S9bM+ePDtc713
wiJ9uoeG0/R0zP7mPGjPSFYW+w+sLfUt689VPSaT8tN6qP8z5rSfvZAr39rkwL716YkjkNWjouF1
PTYFJlRBUjuVy/TD0sBrg1AjvhZH2FhrKXsydIktGJgegqrn85mIYZFEdYQ0vaZ++P3Vp+m5nOlm
0MQ/MrwndzV/SlM3yuot3Rb5CemDCtAjhJqeDUtCi8/Ctun6Wetw47NP0wMuNylfZedcND0ds785
D9lnVEFpOkDutecmm1gqpmZJuUxpv9twKnZ6B2Fzqg+U1aNi4XVhmelTRKMPax8Tp6obUt+oFOtj
kuA1OIS9CgFWq5A564bUdWn3FHSdXzM96oLhhUmYO9Gw+/vfhxfWvvPVG3eMTyW74MHvdI2sMwuN
DwK0vvcPH71hN7XWCI27HzzRNbpGvR+/tDZ74hLt43cC8WTWHLPxSUo0Zt3Nz30f3lpbutL/6p9s
W2k+27fjS0t0nnvuv/4wfMPNU2b/RjUP82cZjf/1LfaMkmF/u6e0513wEL3LFmBKe6zFy6atOtSn
cJ6GuEgJnFvTwmsEGmmtwPDrV+rmaCFA+v5bax9+/u20cNMbAXJ/gtQDdqvNQGVMtW90h9D6zFEP
RhJ6RV2v6cjMydMT9HMvigQ5K/XL8PGcVk2ORmBg12F2vDyrZ5OLr3O6qp8lvP2LISLRyTNfivcz
BUdNT8fqz/Igz5y8eyIBn1CfmZDXkJIWLwtNR81UAQ4EMqqmhxCi32MBVT/sGPREe+AGVlx8n4Fw
Ya3c7jQH3d3wV/bt6vkxvkPTaxLunX+L8VTbawY9/fvhlm6Vg0x2qTgiMzK1Gk3PhnZQNb7RXhXV
zwrd27BKuFe49z+c1zmW6emY/YPZPPwR8Qzd+4xF9y+o615pnGM5YqzFy/prOmoG5PSoKFTdq6yR
rfmxFbrDwvTDVuHk8C/UbY1t8DXsVQiPWWtuXyIR3+/wQBhY1vSaXjjduf0UfX1V/8FTcvZ5b+zX
aS8MxXaa7FJdjgH7DICuZ0Ogxc/Zq1L1sxZuW2g6tY08Xdx+uon1Y1VPx+yv2UtaPN0ZPtVEnh2+
8ZTpc1racw3ZNHRo8bL+mo6aATk9KjYFju5Sx4W9GucOvFPTD5NWycx1GdK00H8LX8RehYBSnXz3
pYhF1b5OCjVfY9KOYD5ryc3pS/jSeFMQHd6KrMXVpbwD8Zn64PwWaMKRD+VTzhOCMvZyZC1AfS0E
slaZ0IhNgqg47BJ1y/W1jYFAIJC1EAhkLQQCWQuBQCBrIRBVBOMOoSyqv7JtQ15Wv+mhXbSAIJd9
417OfksklwPz10VMIahTzv/5kexj58znHgMjp108suQjQVvG9dq2Esl6iPkr2D0fcq4IojkxG0FZ
dMiN7Fjgirf9lmItvc5EBz/6p11AzvXlMnOWmON3zSW6hTC0fJ5mzz6WPRIUzVzhniW/CYp21nAi
kvNwGuL85UO0VY1Li8mOuRHlamj7rcda2ZqUDeOXdbiVDZdywpHHXULIonMUD4oejG1LU3QiJXom
aMt4sbUneiYu+iigbHaJnmR8t31+I8E/KDD88BZgrWwXkFXGcho4xcJ7aRkkxEIe5etVhXGWc8Ji
4RkXfbN2SWZ/R4YQCx9xfLd9ocywBY0BNLq0plWG2STZ2tptRff1Qk7UE4tmBH9dXiUli/krR9br
spAqpEKD7JFX80JJtA8tGymqUyZxXVU8a+UX7zdjerJ0W2/JC8Cjp4suvCAXPg+rdEQ/oQqu1jxM
65xTy9LKWHkO869cdd+a3eKsRbqAS7esOMv5Tm9jOZNtEUW/8mClqsJVZhWdJq38ZcluQcgeEh1O
WqVDvV0SgaqpXdnTwyiduYRwIiCK4kZHbWuC/oogl4HzPBonl6RWWh+FRs4q3zYGOM5bsipAiJUW
I7QE5WzSthxoOcsTwpGid4LurLKhBN1CmR/LhjpW3aJ3Ptwax60seTxkcFqwbU7b1z5QX2vLwWOa
8bHlWfY+URalkmrT18KDTluQtzY1OsJNIETUOop9a14hOeZQGt7sfPX26duAexEFQgSiBOhYS73/
ubWrbVfV27ar72jkGi4HUCBEIDYKKdka4uU3Jy/83ZWroHEWuV65ND251CA0P9cubaHCGlhLauK5
wXA8Owiox7rac+anDPaytIcRAeJNHHdcYQamiGcr9yjAN0a08Ee5wSZmvyRYJd8P6whzfIgaB5O4
aGUSDDE7XFrtWGCwYUbrPsO+3RtvGqT12cK3Ahx3+XTUaIhEUtTW4blPk9on5QorasNozUbttmgf
A1YGmZ+9zE1ZD2pYTaPlkNFSIN7aFNxdtzJ18W2XAHOXzu3/VR3X1JLcIlaUDN98v3Fp/trrH/iL
Ve1W+8T5oZ3ZT2mfyznVh9Lpi6nv9kgBmE+lbxmanpqC+2JDazO/9RgLM7PvwsWH9n9ZIWHDH/2X
E1UxkCgt/P7+lwG+fQgq8oXwurVt0m9MrqZvib8xZUlQaeoleRDrpB+e/XzdVw/P8X3z9Itzjx1+
6IekPuual1eVV12ofnf93OP7rtIeuL7eLDVL6eaD8z/91ewqa5hhvaRvxi+r3+uP7GCFtZZ55pGD
mkdHPXVptKa6Slw1M19uIyv6E/OLS5fbtLHC/ZpYnF9NNwvpSNNyoelU8TffPwurIAyv6HamAFqD
Qlw1S0XtTAGzl0XHR0GblaA7dRLSIE2Sn+3q6veJQAZ+jVefbu8XItIwq6GGiT1VUdql9Ox5eIr0
pf4KJZhIzd0AdXAD2FcSd7GPaGs2zH4Tzk6o1oME2Efrc312Ddp4F6rJ1I431NArqdlrxJWGucNm
YyykpBPaN73j6jciZ6xlztlMe8+qgVYp5b8RsSnYcNPKuQtrRPprI7IftQfjfb1yoeHsr/qD4ZaR
WhYQ643OfVmmYVj/WW+UmZ9qGTwZPtDC7GW1PJNe6n1SC5CCd8H99EvoGcKVSS5M6k+5X0qdVZ8G
IWtTYQKqZZI/euyl8wBXTlUswQfeO3aR9PrlB8JXLRISe7mj2TAbopcM9bhPddXP1Evps+5ku7PW
K7pJw/HQnrRyb/DhMfX1kfbV+u3WMudspp2+lKU1WKJiKy9mBP63bjv71szcVbaeKvjvJzMXpm+r
44JNEaXmWWtxDHofzq21AKaDms2sA3QkXWHO5frm5qytKTKwEgYS9tJOUbfUdPBmEML79/BddJ1A
bWcZVljVUj1Pfbz3ZlBClXt389Xxvl2QiTX3HvySZQYNqJVE53oYUNmMjULMFewU9nDdXKsL1ZEE
aGvg9gSZ6M6P3X4sdt4c5NLv9v0XdT+ODf1xW5lzNtMSkSytko05k1CXealoKm3rH9gKs1bg0vgY
HLwz5xHpAfWNwwgdSVWIf75+FnTRgvaFr8ebU7E6SAwFqEQzn/7IylyqmbHhaM40SMRsQmQTEbmb
5LI1XMEEz5IZPZGavRsecXocU+txlC3M1FpjrvnU2eT0cuKjLrsjgwPjauW2Xxt4SAax79Uv9e+y
JPwRNcWkGvAD3mVWaZUGgU/ULafnbunctf3XVVmv4L+OP9t5czC1+sySFKh51oLI/KVXyEyUtTOV
tYxVn7WHBQk4n1sB1BHmCSwpiUy9fg+wtzHQN8uWzxzcmhW6q6vIB2+Peum1lmNLwzkzUpz8DNIa
ZgEa9Lrew0f6A0/YItANPGmx/qT69fz4NTh5hFY1WWutGoPkUuw5xgprKrPjLiCh9YsjpR1WZheW
Uud/1d3Jb1fXUUzW876+g7t5zy1XHkssCjXKVVbWCkYjkR9DY87OVOdrRAqkcw8H491E8osxu2y3
jmdjNJLxVuA7IgMChB5o38uMZyVlGJthVAXuC1JEFfS3QXXUkcB1vEZyOTw8XCG91iA/s5fKzGq6
TqM7dN8FJ0jVkhrm6O4R8djLhO8UD3sdxGia9+/BNoExCNxRNy0wKiPJnOlAGkR4oKObpEiCaIXV
LipPsRudy3TXkbrpsgyBPdJCMiWu7And+GF2n3uf5XC9YWdna0ZZWZRna97ei4G1rp1OcF+MP5+z
M9XwoZd+Do+O7oTpM19JvLzA7GWFxhbuycb4ayLwh+sXEh+XIPzU4vuGpons2BAAvpPt6M/+4Nnt
CUKPYLVKDlQ1BRY+eGahgglea+hcIgmydKedAlylNsx6YTp+LDHE+tZz8cTSPjIBtdfPwv6ws82k
P+1/jzbvBPs+Rl0L8cHW06ZyNT21sE+3a2aXQB2RUmmVCTvkpWQsE7x55/Y2F3F0+84978ykEwvS
FjGiVNRBJ+lGbtFXwNbkDBqdqgi8LJ11XFsplkTxu4fvkIT1y2yXQp2xOviGy41b7qBTcWcIIyv+
XuwFv/0J7PUVAQeZvJuxYWHOawOiPpOuQEalveurCmGyQCDwRmmGXbSvhUCUZ8LG47kIxPUAZC0E
AlkLgUDWQiCQtRAIBLIWAlGDrCUbfs0un5CtcQqgKLvaqMEvDCGu+1nL8UvqxURHILYYa8myrH03
lbmMTnJhDJN9IIPxDnLhGbfINorWuDoJ0MjmAkD2SdYDgagVOB6b1a0DGowBikZ7hQCWBznbh7oR
ANGNoi2uySCHmZwsWo1CIhA1yVqyP1nNaHLB3t9Fkykhp0/Ii+araHsqooSI2FqsJWbFMm9uk32u
qZzNM3jvhxSxZkMgqlUg9GOKU9z4DoTB3LTfADh/IbbGNkb+iUvOP3FZ5ilHi12yIYbsRF22PcGJ
C1H7s5ZuTIluPOSWRFlTUMxlsrdkuLNbUzQG1/Y6VH7T7EcZzUipbksAQOtOiNrDhvS1irbg5MKE
CMTGUW36WgV/s0L2XPkgryAQG2AtsQQhTOGQERHX1zYGAoFA1kIgkLUQCGQtBAKxYRi2MfTD6uYA
+hZ5QdsNxhO3enQLhdyJXMdUc+/JmEs2hNFOANvyY41jueAZX8RmsVa+nldkl7SxGpiStT3McYHm
EnOsL4s+45gvGncibyE2USCUDUpTmnKWRXUr9xSclbrMtGRNySun8aWqdrkyrlgW7kYgNmfWsgz/
RhUri+qWRbqy619ZaIkmNSz2X9SmIrAKpF7zplXQzBfHgVtx2kJsHmt5zB5GP4tulu/3v6IT11gX
Z1oKbt8FEP0yFQJRLawl5+nUzjOKo9N+L/sX1fLrFyNHIWqStUTvbQ23nm7TtBL9c0Re4c4lJzJy
GqK2BMJ8W3pglgitXV/OyxW5ucj2WNzAngMyFaKGWCunmGXa5HbV0AKzUpdJ9dEUyaDxxejK6pa6
w1sqLSTd6pBtH+YQ3bjcEsdSjgKZFoEoDrVnX6s45kDW2rJA+1rFQpSRsxA1gBo8QyhuUlwEYouz
FgKBrIVAIGshEAhkLQQCWQuBQNZCIBDIWggEshYCgayFQCCQtRAIZC0EAlkLgUAgayEQyFoIBLIW
AoFA1kIgkLUQCGQtBAJRQtYKR3VXiLiU4xzXFKd37WGODyvUFY1GFWgnv8Zo5I78F3k+ZPMHCJII
EhflJVCiQXsGtBgjR7lBkpZKyfzIFraDJN+e9RwJOYQ0QMlwPPfpDo96EI9aPI6q2eZoto9Cu8Bz
GVIBCkm6I0czGMEehPDBWkroYNZ1iPy2jTf9tOcOep9QEtsOtmgPX4BVO53hYVjqn7kwbP+qThJu
gFsGoP8Wck26ZWPmyItvv9LzGxqlHE1HrGl/Kh4+5ME0gy2p5teW8geSkjGLzwgp5y8HYOCX5Dqi
LDbMDA220rIDfDdHk79Xwi6E8GatuyyuNEzsA4GxRzrwpt6bx+6B1THqOM7zzaRTCkdFNqEEDsO9
ETJ9SMc5PiPp/vRLL2nyb5T9itDMcy3WuATb+0MRaXg5OwU+LgRF6pKa+QCZLjvCHBcc0XOXhtNA
ZpAOgePCCkdisLmLHyERIgLfLPJkMlHIPCuwGCkSfm44SfLFcwKZgzM810xTCYVAom7GHN19l9XY
La0PqFMRB/fAhyFG/u6BQOtAMHJ4OAHEfRoGczQbJvZgF0J4s1b8razrAv3NQCQC92le41CnOhrv
g9+jHwZtGQ+dPNACT/aeUnmOdHY2y3SNN4UGO3P+s4QnV0lnXCXX2ZYDJ8P7Ww1x11WiQXjDlK0/
aepjM1zngZOtZLpcmkuf6zuSm7Xm6MR5rXem5WBLWk322GT/B8lldbH/wNpS3zK0PJNe6n2Shg7A
/k+1s3yFz/XeCc2DJ8MHKHdfXYDOwdDCgS6VWxvV2PvXv9nHOPyXpORpEpmOCK+vwps6V/N0sNFp
ToCCXQjhzVpLbVkXG7j76c8Tmlh3DEKqK/B6+0SAzQaTzeTnxzA5baK4AhOTpAtm/QOx3vjqqBxb
lXpjgRQ0TxKxcEWN+1mYnFIj9YN51TI1C+tqV943Syaz5K7mTxJO14S33pgQ64uTOL+/+vSy5jm9
g0WYDrC/dViub25W877Aw+u3k5mP5GsHmWjugH2TxE1KFCDuySTJBsEhoEV6LsD+2JCwI/a6sj56
fnRd6RvdoWdP6huVYn2KSvPTijqgIBBOaBCMd10wZXBd2j0FXedZR5t5pP8VWfV/4rlzN726F6Ya
dj/4na7p9S548AQJrP6n0Rp2f//7kPWnM9LO/9576cvBvuM3zSh1Nz90ouutNS3undkwF3e/fEJL
lv1/ELp2U9f7iYsKle+9cOUG5kFuvrN9Rgnu/Mvk/Nkbd4xPJdVktQgP6k7x/12Y/MfdNHhD/PNn
d++cU+5USV3cTdI8v0aDETfJ6jlawAs3UyIPqX83s0pY3XPuzpkvC73zN76dvqRl78PPv50Wbnoj
wGhemVNoWbAPVQm6pqp5h9D6TJLUAEoXfEn/aG3PWDoWUMdwCY6Q1YhkXsrXwdPDw4rBn2NiVIDI
cAFooL51cL81Lge3OmZhDFiAJTj/pmEX42D0IKEmz5y8eyLhkvcEnOc1Z0SeeZkEj6mk6tUcaAUk
WU1rvuatyChZF9JMN5JZrZH8u4X5H4OeaA/cwGiOE5q4iYEogLVyG9kcdHfDX1GPtszS4WyAEwNf
U5dH3eOk6wegu8sUn/jPREMG/wYYgCvwb9AH/0RIjneTEN/Lxu3UIsW+IEWiIVtmSPgO4t0At47n
NjLhleFfkF/h3vk/IkwSc+zg9dkYQnQkEiBJBWHvTFTQc6BR36OoiX4Ntpn3O4dJjAGyTpwlcmcA
QqMrUjIaJsx0kiS9xmg2Ev9tEMAuhCh81prbl0jE97Ndtv67cq+yHoYvsuXQmcSxMwsw/NJynXmZ
dCbRefp5g//cKIwFYMcYjL4bps8cS5yZN8TV0p+b//z2RPx5Wxamh44tnF6AUGzhWd1LWoV/hsuw
Li2e7gyfaoLw6E0OeQ+NLdyjuhbjg/ziEE1zqfP0IsnBVxIvL2jUz+wPx5n7i/C3Vgqzo8ATluRh
9A2YHVrd0To0T5JuJEmnJZ3mqodVTcR1jDr8Cjrj1xu5xQ1Ea03O4EvjakG1WSpB1tIWZMnkBmIF
v/0JrDpkLWQtBLJWlay1EAgEshYCgayFQCBrIRAIZC0EooqArzwRNQntrX9LbbCWap4+Z6SeuPxa
rNeiqna4zZdiYCQhO9I0eJjy4C+neRLMuuRKJGhLV6a/+WrfvWrk7NVAkzjZIVAxX2nVELK1isvT
tjhr+WUBrQ00dsxdiiJrICFbPawhZHAMkS+neRLMumTXLJUwQVu67H9esnmqRrSFEPUfOW9pNZ6W
K9G21+taS5ZlQ9XSG9VD9Vd99AtUuJbFfJODv9m1JCNuSRIUfZZuw9Vik0M8IttCVCkHydmeWluz
lnlQoqMUiMbByjx8VUQ2kLWxVAax4K5VTM+VRRkqmmDhndo9i1bBz5uiLJawAGUdYBeqOns21pJd
e4d57BVdiyUbhPtyyON+ln++xjG5hHkrLkGTeKkHFJlcVmAm5Txzo3etiT6LWba23dJrLdGro+Tv
RGp/0C/FyeOWtpNFn4OUaFsruPU29+2JgjrchhN0I6IGFN3HEZeqcQ/hTcNH9kvYtriN4SIoeks/
pahz0d4X/LWlWKIEfadbZGldRWpXOc+tanL59F6Ois7P8nF/lQlgLVXPWoW+MvYxp5VjYSmKor9W
laF0oXylW2SCskVSkDdcNe5sIftl8M1p2+tq1nITpT2EHy2a+VIUQ8mWdYKNpncIKLCAGjnvECVJ
UFZFM4d0Vbfou2pkmxjoUhZb1tk2lVcpSt62Wx+or7Xl4DEDbWSbsCaA+lqIsvPWpkZHbGQbA1EL
EIt6jJIezloIBLIWAoGshUAgkLUQiOqFeRvD9XWF436s7KT8U1K9Hgc1Jg+VI597z771tfIoiBVU
RI+aLUZfy5oPu76Wa6Fly+suWdXrKnu7qmAnbFuuD9Yq8GiY6BC3pHo9DupTolcI2bOLQwH6WnkU
xAoqomso2ZWqX30tez5s+lpuhZYtTjWEKJe7Xa+/WUvtu1r/FNVTbNlBTDaMVuoDyIWEPINYES1g
O/Pmpw/LRTwudQGg4OyKG62aPCHcCu2rMopvVznvYkTejGrfBIFQK5JRLwtE00gKZk0tz+FLLm0V
eQoiYqnZRC5rG4ueomsZExGLGHIKqBYxr0C4dee+xnyVYZDARB+15aTeIBbZQ7KxZT03LvTKdKwt
bwEKUl3KqzJgXBf51deyKQ/LxY4Kom/NmqLb9brbxvDTDQoKWSp9LU2NyefHIko4H3rqWPlL1+Ng
s/k7FoXpazmkIOujomvGnHW+/NdhSdiq5XpjLV3uK3i2L+kwJpaBZok7i1he8l76WtZJSywksULU
4XB62hjqLfKAu3DhNXHJ5RHHzGlUUc3JZQksF1w1NpWvDeQvn1oaclYpZi1d1nYQX0TZUU9HNLxN
MWoelUavR6Mpi670vBWsClqY2ch5J1icvpZ7MTz0tXJVY654J5puHjbeccplOdr1+gDqa205oL5W
9QmEiC3CW5saHeG6jYGocaC+Fs5aCASyFgKBQNZCIGqQtXCNi0D4Qj77Wtqd7H7iQva78N2g0o9v
Y1YOdrHcSOY3imV8SS36StBrs9qvfS2zlpWnvpYtp4a3/fajLLI/ZbfK6mv5hmo6oaWGWcvlgFOe
z4f7PXO2QaUf38asHBS78s66HupT4KmNZTNvtcEEbXpofvW1bDk1+Njz5TwEuuh8ob5WGVjLMlLJ
6vFTtZnt6lqOEUQ1vGVs22Ar2FSOija840FnI+pcXoNK3gQ3fFTSh+UfUXaZ5lyzUtj55DJDtq5a
5CrI1IZZS+UMsKtlualrWce/so1tYiFNIm6Yjrhx5imOouxq4cA3XWs+7NpY+aQ4ueq6q2gVCGtt
lvTU13Jqybyapy5BHYyi+RHYC7ZS6FeTyKfyROkWFXI++yHZQSh3SK9w+1o+OmueTMiiG4dtsOlQ
IPSYjAsaaM3xPRog76S24bbbaIu7awH62aUo2QitJ1iwvpZps8lRG0vMQyM3mBaydkYUzFq+9LV8
iCvGtb64oc5WNtO6NjrFKG36yZRcqA1m3/a17Pnw1sYSi6mqiqM2dSbrLRO9WMC85dnjim6eynHW
xiccf5a/8nOWXNZ8aI9kP21WjZy1lWYtkzK46EPEtjywafVsUOknp5Rk9nBL37faloc9KW9tLDfd
p0IT3LB9LVtOvXk6jwJXntKivtZGgfpaWw6or1WNAiFiS/DWpkZH5BMIEbUM1NfCWQuBQNZCIBDI
WggEshYCsVXhpK9l33y1nGSXTfpBZYThxRioqkTgpnLkGsKNougnXXs4a4JeR7LcDIM512w2YMH2
tXIFt+truRXaIVUvfa3Ktb0Ntaa1ZdshdPqyuuUke8U+ZZs7qmbWwiskhAtF2V+69q8IWxP0OE7n
ZhjMuWZz7FGwfS1Doaz6Wm6FdkrVQ1+rGj9jXCusla1Jg2ktq11ETUVBrGz9eg+XPgZUseBEZe8s
5YPHEUrbh9qLsgghOmddLDBmnhqrfNvLlrWLvOG23GTWkg1ykOxyDlrclJKVhLN8soxPVpQL0iLz
oGX/AEGhXOZ5AjdPof0eXKp824sWgbB23ro1urSOVYbZMoc0y6DzJ/tI0F1slM36I9lDfX71tTam
9mbvwHnMiOFL5KJZy+NzDJXlgDKNT2KJza55WM7yNgxmHouNWqj+9LUcFnsFa3Qh75SbtUQQZd8G
HyslB5RDHvSrZOVnJhBLQqUAmdVb8cvlWwB5NLpKJfeWE7WmtVXvIF5sYZFA30Pzp2RVvDTouaPm
sLdfrnVqnkLLNcBZtT1rqbzlsP51MeFU9qnLUyuqUL2pgqxhyaKPR/4sZ7mF2rC+lm8NtZwFLvt6
unB9LYR/oL7WlgPqa1WnQIjYMlLvJkVHIGttVYien/IsKv4mQGkNcM1SrbVDg4B9EVHNkB6rg0uJ
xMKX7pGSeQN2TSFrIRB+MfK9r168prLUv8pHzq821A5rGQRCqYnnBsPx7Kowyi7toVwxw2B5GBEg
3sRxxxVQohTQyj0K8I0RLfxRbrApTsMGI9UiLPG80K7nuRJoPcoJI6A0cXzGJtGESCUqxzmO1BGt
+wzLUbxpkOathW8FOO4+TIei2TZj8ZTBqNYwUT1IOGou86C5zEqG45u0PCk8zUqI58KKkcJmI57h
brs4m7v/yfwS/2jNCIaGWevGpflrr3/gL1b1QQDYKHBoZ3YwOJdzqg+l0xdT3+2RAjCfSt8yND01
BffFhtZmfusxFmZm34WLD+3/skLChj/6LyeqobTJ9//rO1ZWV7/b86/tmflUJVh538ty498p4h2P
P933B3XmBURTL6lEsU764dnP13318Bzfx3L02OGHfkjqs655eVV51XXxse2Q2jrZeJEdqkcXaPtk
HXUHVZ/k+yWBlFmja8jawNXAgeNpdYikYZt6H//h/jllSmv4TRcEH4GvhDW+akvq16V/+KbQslxr
s9ZnYRWE4RU2I7GRqzUoxDniBsjwXDPw1KmEOV7QZiXoTp2ENEiT5Ge7ujx+IpCBX+PVp9v7hYg0
zKqhYWJPVZS2LSbMppIku8IEVIKzQBmVAullWIHDk/Cb5kd3MU5Lw8Q+EMizsxPAurkA+2h9rs+u
QRvvRvYu3aHHi9tK8561bJklWmaNbg5pmJyEw2ouWex1ODwHq1WywIqE6q69DVfbaAHAdJ1b+RXX
HK+BWave6NyXZRqG9Z/1RkljDEPL4MnwgZYUcz6TXup9UguQgnfB/UBm6AxpkiQXvkpa6X4pdVZ9
GoQ3dEoToFRFadf+U/gBkkuW54ogXSdwYQnqaIJDFmmHneTOQCQC95Fn5JKhHveprvqZeil91lVS
uqA59Hh3hKxB7r5kLLOi082Bpazm6VssdgCSI5UZcLww09wxeRFIb3L5u3zuUChZS6y1OAa9D4cN
48F0EA4yxwE64q0w53J9czM8obcaGUmCIOylTVa31HTwZhDC+/fwXXSdANAPhhVWdbBW/wTfS3IZ
hL17Td2sbBjo/1bTwV2k1+79kfXRUkCtJDrXw4Da2dkoxFzBTmEP1821OpNd0mtWi9cRso0Vn4kY
y9yq0zXURdbV/iyLfX7s2MOxqpi13rPW4RUk8/e1xFqBS+NjcPDOnEekB15U9yPoAKdJ6H++fjbb
KrSlvh5vTsXqIDEUoJLJfPojK3OpZsaGo7m5IQJ1VVLeibtJLr8ev0bzXBHcPUFm9PN3J/445vg4
ptbjKL3UqbXGXPOps8np5cRHPahroZclzzLnUjCmzLDyELs82felV/ur4p3WXOL1PTe2qzKg0987
OlPJT9QSa0Fk/tIrZCaK6XOMJGmP66lTRQLO51YAVM4JLCmJTL1+D7C3MdA3y+R8Dm7Nis5VUlqt
f7E8N1QiQY1zIp9JLWcCzvUvxcnPIK1h1vEb9Lrew0f6A0/YIpg38LR4B49F2ZrYKciomkxDrg3V
EHXUY5De9TzMYn+WrrXS1dFQETm50nWDKv+1gfm6s1tZCNTWWisYjUR+DI2kzmfamUfna0QKpHMP
B+PdRIqKAeW1W8ezMRpJrxH4jsiAAKEH2vfSjQ5IyjA2w6gK3BekSJSJ8dugOupCgG6BlInlOViJ
BHkY/yWpuRCnvDjguCkRgO674ASpWlLDHN09Ih57mfCd4mGvgxg9PDycYxA9HvMcdg4iqAQ1uirX
0RCE/Dj8lHposevpWqt6+mxgPr2y68Pa+gr06/bOTKJGtt8NrHXtdIL7Yvx5kGOfVCu44UMv/Rwe
Hd0J02e+knh5AUKxnRAaW7gnG+OvIQTh+oXExyUIP7X4vqFpIjs2BIDvZDv6sz94dnuC0CNYrZIP
YC+8nGiNy3qeK4DFM8cGh67CPzeEvvKKY4JX9yUS8V6Yjh9LDLG+81w8sbSPrHja62dhf9jrhX4u
nnuZz5AU5CzdrBw4N7R0LG48L7h4unXw9Hw1dc4dS7Hg77Xl7tt3vTO1EIEaQVEn36UbuUVfAVuT
MzVTI7WNKOQ//91xbaVYEhWG1LXydhsZPdr+8z9M5u1E1XbyvTilksjKsq9wwW9/Ant9RcBBJu9m
bFiY8xLE6jPpKiuUIiprIc4r41uLtRCI6pmwUV8LgbgegKyFQCBrIRDIWggEshYCgUDWQiBqBE72
tcz3BcD6JWWzURqDp5vNKputKOPj7Odx3SlYCdkSk0X7V99NxrSc7XM50bVfrN+I9pFTuaCvKCJq
lbWKhmi/t3cbMY+dJ7utKHuHFd0p2Ag52+twS51dxLxBzAk52Z4yfSLVK6eeZrQQW00glGVZ+24q
cxmd5MK6S/aBDMY7yIW30gPtT3bvS6Jlesmygqgn7UzB/bvp5lw4ZM3LNk9Bc7Ytmox8g7OWfWgV
jQOyaaA1DOSyaJouRN0IgOgyMeQsKXrzhNWWhi5v+qJgE/a0nIsG+4iix3xW2LeYdUsFBsMkfnKK
zHc9sJbsT9Qzmlyw9wvRLuKITj0QCu5pYj4Ksumb5brLIpI6G0o0Lb5yy6MS9HnRbbGZy49fM1qI
mmYt3VSMcaHjT1TyZ6+j3HBctPlhAEcDOmWxIGAxx5XHjBZiS25jiN4rES/rnrYu78htbpagRB+T
mYlCgZ3TjzBZus07Y2p2w2H4jfXribUg7x687LxJIOYkQtd5y8vIs+woYEI+m8r5OMvVepXoc61T
mtnEb2qILc9aYvZNkkEoytlgYi7ZRXZyMs6Yi+M4ROfsPDlagvIhmLmZqTJZw3JJ3rhAE12lOEe6
jmap5LyTnTWKhxktRO1iQ/paRVtwKkkypSdUkgRlfAm8Oag2fa2CXxnLvlZWtYlSvL1FrkJskLXE
EoQoWVKlJiSWKC1kLwQez0UgkLUQCGQtBAJZC4FAlAGGbQxH7arse6qClua2szuy7e2N8bgueGpw
GTcmi1Gqwv07xCawVr73MUV2yXzH5HwpSFleJG9YqQqVoxCbKRDKBh0sTTnLorqVewrOSl1mWrKm
5JXT+FJVu1wZ13ZAsXiOQJZCbNqsZRn+jcO8RXULzGcO7EpdFlqiSauL/Rft59LdDuyaVfOtgmaB
bIPTFmLzWMtjqDcfDhTN+hg++63oJG0661BpLCnatHgLfjeLR/UQm81a2lTgX11JdnTa72X/6zjR
zHA+FfY9+BlnLMTmspZY6BLH6ZMWTkwg+mDQMuhdIRDVIxD61XwVZZsqopx3VrKrOsqinfHsKmJi
sZsTOGMhNp21LCpFsllfC+x3ZqUuk06UKZJB44vR1T4A4/CWyk1BCopWqkIOQ1QItWdfqzjmQNba
skD7WsWiqG9JIGchkLXceWuT4iIQW5y1EAhkLQQCWQuBQCBrIRDIWggEshYCgUDWQiCQtRAIZC0E
AoGshUAgayEQyFoIBAJZC4FA1kIgkLUQCASyFgKBrIVAIGshEAhkLcQmQ64CCvB/qiETMrIWAoGz
FgKBrIVAIDTU4efDENWwSNkqyPFTI1YGopQdaqPMWfwQL1dFJlAgRCBwrYVAIGshEAgNuI2BQJQF
uI2BKB2K2AeQi90LKZpACbIgImshysNZxfXKojboiiZQgizgWgtRfRC3XhaQtRBVIA5uxeIjayGQ
M8uSBVxrIUqyyBI33C/lrWGs01Z8ZC1EqZYp8saGfXGLTFrW4iNrIUrHX8Vsvtc6Z4m4+Y6oTpGy
SLlQLMGLsdKKpngaA4EoC3CHEIFA1kIgkLUQCGQtBAJhgFQaMriNgdgMROnPsP/gw5a76HBpCDsh
uOKedAHAzXfEpmC4XNGHi85a33BJSogCIWIT0SFwfASCHaAIEA9xQlyddshftOUojAR4oV0NKPKB
EQCliQsr+uSkhg8nIdlkJzwiBIIiBOOgBEEJB2gsnbAYhAjPCUkWThG4x7N0SZrcCAlD/rUE9fwg
ayFqEb8bTocTkFyFdwTgjmA6eEfuUcNT8GRT6mf3qHfrM4uDAG1y+pk2PYAafqJNajtnJ/whSQkt
A7cIL/DQ9iOFazM8uwSJUFpSV0LiP7X8IZHdAukfMfntqaEnybRHZq2GS9b8IGshamSxFaWzyF/P
gdQPf6NAmofgBEwGcwEmIvB3SvLdj6l3UxFhACAVgPensksiFn5H/a7GNjvhpEAJX/5t+HEAVvbB
pGH5NBmBRiWZVH3S+2aJIzgJzTxL5fBENnVLfnAbA1EbnKWuZ5QOZb13WLpxhchn1CugsIu2T6G0
puu3zenBqSdxjqa1x1r4jvnLETthqWte6BuWPvdYcIV58Skj4fid67AUyAW3hdBcen5w1kLUGloy
c2ShFGkQGwBiEkhqd9R3vwOJy6ElY/DR4eHhtH6jhb/CdTkQvqmu7UVC+NGWpBoQTIR7kjOhJp0I
pUtCZKwkcvlB1kLUHFbnklTA4943Sxjpl9BNhLNYUtIlqWAy8uP7jMFTCrwY0m/U8DOht9JX7YTX
/23iCF1K7R8BWHkNuom4NzoidWpPhWSkTiMy3kGEvtReGM8KmsApBvrIWoiaxMK2j9AeeGWUTC7y
XXxKBphv2f432tNtIjf4cRMntnJfCes3avh3/iwi3GwnHP7kDkr4Z6O3kVhHOcp9C9EdDfrTewKJ
eZXJvr5I0lxNcXevZuOONBno41oLgagy4KyFQCBrIRDIWggEshYCgUDWQiCQtRAIZC0EAoGshUAg
ayEQyFoIBKKU+P8BMlFyyv0rggAAAABJRU5ErkJggg==
</FILE>
</FIGURE>
<FIGURE FILENAME="Funnel plot.png" FILE_TYPE="PNG" ID="FIG-07" MODIFIED="2015-09-15 23:53:35 +1000" MODIFIED_BY="[Empty name]" NO="7" REF_ID="CMP-001.02" SETTINGS="SHOW_EFFECT_ESTIMATE:YES;SHOW_CI_LINES:YES;SHOW_AUTOGENERATED_NUM_FOR_STUDY_NAMES:NO;DISTINGUISH_SUBGROUPS:YES;SHOW_STUDY_NAMES:NO;" SHORT_VERSION_FIGURE="YES" TYPE="FUNNEL_PLOT">
<CAPTION>
<P>Funnel plot of comparison: 1 Heliox inhalation versus air or oxygen inhalation, outcome: 1.2 Need for mechanical ventilation (invasive or not).</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAlgAAAGQCAMAAABF6+6qAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Funnel plot.png" FILE_TYPE="PNG" ID="FIG-08" MODIFIED="2015-09-15 23:55:24 +1000" MODIFIED_BY="[Empty name]" NO="8" REF_ID="CMP-001.10" SETTINGS="SHOW_EFFECT_ESTIMATE:YES;SHOW_CI_LINES:YES;SHOW_AUTOGENERATED_NUM_FOR_STUDY_NAMES:NO;DISTINGUISH_SUBGROUPS:YES;SHOW_STUDY_NAMES:NO;" SHORT_VERSION_FIGURE="YES" TYPE="FUNNEL_PLOT">
<CAPTION>
<P>Funnel plot of comparison: 1 Heliox inhalation versus air or oxygen inhalation, outcome: 1.10 Change in clinical respiratory scores in the first hour after starting heliox.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAlgAAAG8CAMAAAA1hSvnAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK/>
<APPENDICES MODIFIED="2015-09-14 20:02:54 +1000" MODIFIED_BY="[Empty name]">
<APPENDIX ID="APP-01" MODIFIED="2015-09-14 20:02:41 +1000" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2013-10-17 08:39:50 +1000" MODIFIED_BY="Jenny Bellorini">Previous search</TITLE>
<APPENDIX_BODY MODIFIED="2015-09-14 20:02:41 +1000" MODIFIED_BY="[Empty name]">
<P>We searched the Cochrane Central Register of Controlled Trials (CENTRAL 2009, Issue 2), which includes the Cochrane Acute Respiratory Infections (ARI) Group's Specialised Register, MEDLINE (1966 to June Week 3 2009), EMBASE (1974 to June 2009), LILACS (1982 to May 2009) and the NIH website (ClinicalTrials.gov) (May 2009).</P>
<P>We used the following search terms to search MEDLINE and CENTRAL. The MEDLINE search was combined with the Cochrane Highly Sensitive Search Strategy for identifying RCTs in MEDLINE: sensitivity- and precision-maximising version (2008 revision); Ovid format (<LINK REF="REF-Lefebvre-2011" TYPE="REFERENCE">Lefebvre 2011</LINK>). The search terms were adapted to search EMBASE and LILACS.</P>
<SUBSECTION>
<HEADING LEVEL="5">MEDLINE (Ovid)</HEADING>
<P>1 Helium/<BR/>2 helium.tw,nm.<BR/>3 heliox.tw,nm.<BR/>4 heo2.tw.<BR/>5 he-o2.tw.<BR/>6 or/1-5</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Embase.com</HEADING>
<P>1. 'helium'/exp<BR/>2. helium:ti,ab OR heliox:ti,ab OR heo2:ti,ab OR 'he-o2':ti,ab<BR/>3. #1 OR #2<BR/>4. random*:ti,ab OR placebo:ti,ab,de OR 'double blind':ti,ab<BR/>5. #3 AND #4</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">LILACS</HEADING>
<P>The <B>LILACS</B> search (heliox OR helium) retrieved a total of 41 citations.</P>
</SUBSECTION>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-02" MODIFIED="2015-09-14 20:02:54 +1000" MODIFIED_BY="[Empty name]" NO="2">
<TITLE MODIFIED="2015-09-14 20:02:54 +1000" MODIFIED_BY="[Empty name]">MEDLINE (Ovid) search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2015-03-30 13:40:26 +1000" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="4">MEDLINE (Ovid)</HEADING>
<P>1 Helium/<BR/>2 helium.tw,nm.<BR/>3 heliox.tw,nm.<BR/>4 heo2.tw.<BR/>5 he-o2.tw.<BR/>6 or/1-5</P>
</SUBSECTION>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-03" MODIFIED="2015-04-08 19:46:28 +1000" MODIFIED_BY="[Empty name]" NO="3">
<TITLE MODIFIED="2013-10-17 08:40:24 +1000" MODIFIED_BY="[Empty name]">Embase search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2015-04-08 19:46:28 +1000" MODIFIED_BY="[Empty name]">
<P>#10. #6 AND #9 499 25 March 2015<BR/>#9. #7 OR #8 878,114 25 March 2015<BR/>#8. random*:ab,ti OR placebo*:ab,ti OR factorial*:ab,ti OR crossover*:ab,ti OR 'cross-over':ab,ti OR 'cross over':ab,ti OR volunteer*:ab,ti OR assign*:ab,ti OR allocat*:ab,ti OR ((singl* OR doubl*) NEAR/1<BR/>blind*):ab,ti AND [embase]/lim 838,011 25 March 2015<BR/>#7. 'randomized controlled trial'/exp OR 'single blind procedure'/exp OR 'double blind procedure'/exp OR 'crossover procedure'/exp AND [embase]/lim 245,411 25 March 2015<BR/>#6. #1 OR #2 OR #3 OR #4 OR #5 6,546 25 March 2015<BR/>#5. 'he-o2':ab,ti OR heo2:ab,ti AND [embase]/lim 1 25 March 2015<BR/>#4. heliox:ab,ti AND [embase]/lim 410 25 March 2015<BR/>#3. helium:ab,ti AND [embase]/lim 4,794 25 March 2015<BR/>#2. 'helium'/de AND [embase]/lim 3,672 25 March 2015<BR/>#1. 'helium oxygen breathing'/exp AND [embase]/lim 219 25 March 2015</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-04" MODIFIED="2015-03-30 14:00:34 +1000" MODIFIED_BY="[Empty name]" NO="4">
<TITLE MODIFIED="2013-10-17 08:44:55 +1000" MODIFIED_BY="[Empty name]">LILACS search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2013-10-17 08:43:04 +1000" MODIFIED_BY="[Empty name]">
<P>"HELIUM" [Subject descriptor] or helium OR heliox OR helium-oxygen OR heo2 OR he-o2 [Words]</P>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS/>
</COCHRANE_REVIEW>